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Background: Conservative kidney management (CKM) is recognised as an alternative to dialysis for a
significant number of older adults with multimorbid stage 5 chronic kidney disease (CKD5). However,
little is known about the way CKM is delivered or how it is perceived.
Aim: To determine the practice patterns for the CKM of older patients with CKD5, to inform service
development and future research.
Objectives: (1) To describe the differences between renal units in the extent and nature of CKM, (2) to explore
how decisions are made about treatment options for older patients with CKD5, (3) to explore clinicians’
willingness to randomise patients with CKD5 to CKM versus dialysis, (4) to describe the interface between
renal units and primary care in managing CKD5 and (5) to identify the resources involved and potential
costs of CKM.
Methods: Mixed-methods study. Interviews with 42 patients aged > 75 years with CKD5 and 60 renal unit
staff in a purposive sample of nine UK renal units. Interviews informed the design of a survey to assess
CKM practice, sent to all 71 UK units. Nineteen general practitioners (GPs) were interviewed concerning
the referral of CKD patients to secondary care. We sought laboratory data on new CKD5 patients aged
> 75 years to link with the nine renal units’ records to assess referral patterns.
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Results: Sixty-seven of 71 renal units completed the survey. Although terminology varied, there was general
acceptance of the role of CKM. Only 52% of units were able to quantify the number of CKM patients.
A wide range reflected varied interpretation of the designation ‘CKM’ by both staff and patients. It is used to
characterise a future treatment option as well as non-dialysis care for end-stage kidney failure (i.e. a disease
state equivalent to being on dialysis). The number of patients in the latter group on CKM was relatively small
(median 8, interquartile range 4.5–22). Patients’ expectations of CKM and dialysis were strongly influenced
by renal staff. In a minority of units, CKM was not discussed. When discussed, often only limited information
about illness progression was provided. Staff wanted more research into the relative benefits of CKM versus
dialysis. There was almost universal support for an observational methodology and a quarter would definitely
be willing to participate in a randomised clinical trial, indicating that clinicians placed value on high-quality
evidence to inform decision-making. Linked data indicated that most CKD5 patients were known to renal
units. GPs expressed a need for guidance on when to refer older multimorbid patients with CKD5 to
nephrology care. There was large variation in the scale and model of CKM delivery. In most, the CKM service
was integrated within the service for all non-renal replacement therapy CKD5 patients. A few units provided
dedicated CKM clinics and some had dedicated, modest funding for CKM.
Conclusions: Conservative kidney management is accepted across UK renal units but there is much
variation in the way it is described and delivered. For best practice, and for CKM to be developed and
systematised across all renal units in the UK, we recommend (1) a standard definition and terminology
for CKM, (2) research to measure the relative benefits of CKM and dialysis and (3) development of
evidence-based staff training and patient education interventions.
Funding: The National Institute for Health Research Health Services and Delivery Research programme.
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Plain English summary
Some older frail adults with stage 5 chronic kidney disease (CKD5) choose conservative kidneymanagement (CKM) rather than dialysis. Dialysis can impose a heavy treatment burden and it is also
resource-intensive with a high cost to the NHS. Little is known about patients’ and staff views of CKM or
how CKM is provided. This study aimed to determine the practice patterns for the CKM of older adults
with CKD5 in the UK.
Older adults with CKD5 and their renal staff were interviewed. Some patients had never heard of CKM.
Others who had chosen CKM had little knowledge of how their disease would progress. Staff wanted
more training to help them discuss CKM with patients.
Interviews helped to develop a questionnaire sent to all UK renal units, asking about how CKM was
delivered. All units accepted CKM but there was variation in the definition of CKM, the number of
CKM patients and how CKM was delivered. Some units had dedicated clinics and/or funding for CKM.
Finally, general practitioners (GPs) were interviewed. GPs said that they needed guidance about when to
refer older patients with other conditions. Most had limited experience of caring for CKM patients.
There is a need for agreement on the definition of CKM. Research needs to establish the benefits and risks
of CKM compared with dialysis and to clarify which patients might benefit most from CKM. This would
help improve training for staff, inform patients in making treatment choices and support commissioners
and providers in improving services.
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Scientific summary
Background
Conservative kidney management (CKM) is increasingly recognised as an alternative treatment option to
dialysis for older adults with multimorbid stage 5 chronic kidney disease (CKD5). CKM is management
of CKD5 without dialysis and it has two main phases:
i. early conservative care – CKM is opted for and this is the time before clinical manifestations of the
kidney disease occur that would have triggered dialysis if that had been the chosen mode of care
ii. alternative to dialysis – care after this time point.
End-of-life and bereavement care are part of both CKM and dialysis pathways. There are no data across
UK renal units on the way CKM has been developed or how it is delivered. A better understanding of
patients’ and clinicians’ needs and values, and of the timing and organisation of CKM, would inform
service development and health policy.
Study aim
To determine the practice patterns for the CKM of older patients with CKD5, to inform service
development and future research.
Objectives
i. To describe the different approaches and variation between renal units in the extent and nature of
CKM (staff interview study, survey).
ii. To explore how and when decisions are made in renal units about the main treatment options for older
patients with CKD5, and what are the main clinical and patient factors that influence the decisions
(staff interview study, survey, patient interview study).
iii. To explore clinicians’ willingness to randomise patients with CKD5 to CKM versus dialysis and to assess
the feasibility of a subsequent prospective study (survey).
iv. To describe the interface between renal units and primary care in managing CKD5 patients [staff
interview study, survey, general practitioner (GP) interview study, data linkage].
v. To identify the resources involved and potential costs of CKM (staff interview study, survey).
Methods
This was a mixed-methods study divided into five parts:
1. patient interview study: a qualitative study in nine renal units with patients with CKD5 aged 75 years
and over, exploring their experiences of choosing between CKM and dialysis
2. staff interview study: a qualitative study in the same nine renal units exploring the views and
experiences of staff members who provide care for CKD5 patients
3. survey: a national survey of all UK renal units assessing the delivery of CKM
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4. data linkage: linking data on new CKD5 patients aged 75 years and over from laboratory records with
renal unit patient data, achieved in three of the nine renal units
5. GP interview study: a qualitative study of GPs exploring their views and experiences of managing CKD
patients and referring patients to four of the renal units.
Interview studies
These three studies were undertaken in a purposive sample of UK renal units that were selected based on
a previous estimate of the scale of their CKM programme and geographical spread.
Patient
Semistructured interviews were carried out in nine renal units with a purposive sample of patients with
CKD5 aged 75 years and over, selected by unit staff in three groups: (1) those who had opted for
a CKM pathway, (2) those who had opted to have dialysis in the future but had not yet started dialysis
(pre-dialysis pathway) and (3) those who were established on dialysis (dialysis pathway). Patients were
interviewed using a semistructured interview guide.
Staff
In the same units, clinical directors identified staff members who were involved in the care of CKM patients.
For units that had very few CKM patients, staff were recruited who cared for patients in low-clearance
clinics or for those whose estimated glomerular filtration rate (eGFR) was less than 20ml/minute/1.73 m2.
Staff members included a minimum of one lead nephrologist and one nurse per unit. Participants were
interviewed using a semistructured interview guide.
General practitioners
General practitioners were identified from general practices in the catchment areas of four of the nine
renal units. Interviews were carried out by telephone using a semistructured interview guide.
Qualitative analysis
A similar approach was used in all three studies. Interviews were audio-recorded and transcribed verbatim
by an independent transcriptionist, and checked by the interviewer to ensure accuracy. Thematic analysis
was used to analyse the transcripts.
For the staff interviews, a content analysis of all 60 interviews was undertaken as well as a more detailed
thematic analysis in 28 interviews sampled using maximum variation sampling to ensure variation of units
and experience of being involved with renal patients.
Survey
The content of the survey was developed using existing literature, findings from the staff qualitative study
and feedback from the steering group. It focused on the management of patients aged 75 years and over
with CKD5 with whom a decision had been made not to start dialysis. Data analysis was conducted using
basic statistics and cross-tabulation to explore the relationship between practice patterns and selected
key factors.
Data linkage
The same nine renal units were contacted to identify an information technology (IT) professional who could
obtain patient data. Data sets were requested from the renal unit and its associated biochemistry laboratory.
Laboratory data identified patients aged 75 years and over with two eGFR results < 15ml/minute/1.73m2 at
least 3 months apart on record for the first time between January 2010 and June 2011. Laboratory data were
matched with data from their respective renal units by an IT professional to identify patients with new CKD5
who were known to a renal unit. Cross-matched data were sent to the research team for them to identify
patients with CKD5 not known to renal units. Approval was obtained from the National Information
Governance Board and the linkage was undertaken in a secure setting at the UK Renal Registry.
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Results
Patient interview study
Forty-two patients were interviewed, 14 in each category. Four themes emerged: (1) patients’ understanding
of the management of CKD; (2) patients’ perceptions of their CKD; (3) patients’ experiences of making a
management decision for their CKD; (4) patients’ experiences of revising management decisions.
While all categories of CKD patients considered the same factors when making a treatment decision,
patients who chose different treatments held contrasting beliefs about what dialysis could offer. These
beliefs appeared to be influenced by the information provided by renal staff, which differed between units,
particularly in regard to CKM. Few patients were aware of CKM as an option if they had not chosen it,
although patients from units with a more established CKM pathway were more aware. While most
acknowledged the severity of their CKD, some CKM patients did not appear to think of their CKD as
serious, despite information from staff.
There was a divide between CKM patients and dialysis/pre-dialysis patients in their belief about whether or
not they would live longer on dialysis and whether their quality of life would be better or worse on dialysis.
Information from units with less established CKM pathways focused on the number of additional years a
patient could live on dialysis. Patients from units with more established CKM pathways were told that
living longer on dialysis was not a guarantee and that choosing CKM was ‘not unusual’.
Overall, few patients reported speaking to staff about the future, in terms of the consequences of either
starting dialysis or receiving CKM. Patients from units with more established CKM pathways had discussed
the future with renal staff and some indicated that they had begun conversations about advanced care
planning. For others, being unaware of how their disease was likely to progress added to misperceptions
about their CKD and the need for dialysis.
Staff interview study
Twenty-eight detailed analyses were performed, based on interviews with 14 nephrologists, nine renal
nurses and five allied health professionals. Three themes emerged: (1) providing CKD care; (2) discussing
management options with patients (preparation for renal replacement therapy/CKM); (3) working with
other health-care professionals to care for patients approaching the end of life.
Staff generally accepted CKM as a treatment option. Most staff found it difficult to assess if a patient was
suitable for CKM, but all supported having open discussions informing patients of their treatment options,
and ensuring family members were involved.
Decision-making about treatment options, including CKM, was acknowledged as challenging for both
patients and staff. Some CKM patients subsequently changed their minds and had dialysis, and many staff
emphasised the importance of revisiting patients’ decision over time. Having a good relationship with the
patient and interpersonal continuity were reported as facilitating good decision-making.
Towards the end of their life, many CKM patients were referred back to their GP. Staff felt it was vital for
renal units to care for CKM patients in collaboration with the primary, community and palliative care
teams, while providing teams with renal-specific education.
General practitioner interview study
Of 353 GPs invited, 25 responded and 19 were interviewed, three to six in each of the four renal unit
catchment areas. Five themes emerged: (1) managing CKD in primary care; (2) explaining CKD to patients;
(3) getting advice on managing CKD; (4) referring patients with CKD to secondary care; (5) managing
CKM patients and palliative care.
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Previous experience of treating patients with CKD was a good indicator of how familiar GPs were with
guidelines and when to refer. Some GPs had little experience of managing patients with stage 4 chronic
kidney disease (CKD4) or CKD5. GPs with older patient populations felt more comfortable managing
patients with CKD, who were usually older adults with comorbidities. All felt that patients with CKD4 and
5 would be aware of their CKD and were happy to be referred.
Most GPs reported that they had good communication with their local renal units. They sought advice about
when to refer and how to manage patients who were not referred or had been discharged. Referral practice
was influenced by the eGFR level and rate of decline, the well-being of the patient, age, comorbidities and
occasionally the distance to the renal unit. Most GPs identified older adults with multiple comorbidities as
patients for whom referral decisions were more difficult.
Most had little experience of palliative care for CKM patients. Those who had experience were comfortable
with this as long as the patient had made an informed decision in secondary care that had been
communicated to primary care.
Survey
Of the 71 renal units in the UK, 67 (94%) responded. All but one had an ‘alternative to dialysis’ pathway.
A range of terminology was used, ‘conservative management’ being most frequent. Only 52% of units
reported numbers of CKM patients, and the very wide range (0–152) implied a lack of an agreed
definition for CKM and differing interpretation of the designation ‘CKM’. This hampered evaluation
of these data. The number of patients reported who were at a stage equivalent to postdialysis was
small (median 8).
Conservative kidney management practice patterns varied across units: some showed considerable
investment of staff time with evidence of dedicated clinics, a written CKM guideline and staff training
initiatives. Only one quarter of units had clinics exclusively for CKM patients.
Similar criteria were used across units to assess suitability patients for CKM, foremost being patients’
preference. The CKM decision-making process was similar across units. Most undertook informed, shared
decision-making, presenting treatment options including CKM to all patients with CKD5 aged 75 years
and over. Decision aids were widely used, both locally and nationally produced. Family and carers were
actively involved in decision-making. After the initial CKM decision, the decision was reviewed at clinic
visits. All units had patients who had changed their mind after deciding not to have dialysis, although they
could not quantify them.
Only a minority of units had funding dedicated to CKM. This was modest (median £40,000). Most CKM
care is funded out of the overall renal budget. Having funding was associated with greater numbers of
CKM patients; however, our survey could not identify cause or effect.
All responding units worked collaboratively with primary and palliative care teams; many provided GPs and
their practice team with information or advice regarding CKM patients, and all liaised with palliative care
services for patients approaching the end of life.
Many units felt that increasing communication and involvement with GPs, community teams and palliative
care teams was very important to improve CKM. Information sharing was reported as vital for better
collaborative work, with integration of primary care and renal unit data. All units had some staff trained in
palliative or end-of-life care but the extent varied widely.
Lack of funding and time was an issue for many units. Although many units thought that more funding
could help develop CKM services, only a minority were planning to apply for funding.
SCIENTIFIC SUMMARY
NIHR Journals Library www.journalslibrary.nihr.ac.uk
xxiv
There was strong support for further research into the relative benefits and costs of CKM and dialysis.
There was almost universal support for an observational study and 18 units reported being definitely willing
to participate in a randomised clinical trial.
Data linkage
Compatible data from both laboratory and renal units allowed linkage in only three units. One per cent,
9% and 18% of patients with incident CKD5 were not known to those three renal units. These limited data
suggest that most patients with CKD5 are known to local renal units, and that GPs were referring most
patients, though this requires further confirmation.
Conclusions
The findings support the following conclusions:
l Conservative kidney management is widely recognised and delivered across the UK, but through
differing models of care and sizes of CKM programmes.
l An agreed terminology and definition of CKM are needed to enable future evaluation.
l The designation of a patient as having CKM must recognise two key points on the CKM pathway:
(1) stating an informed preference or intention to opt for conservative care rather than have dialysis
in the future, made at an unspecified level of kidney function and time before dialysis is indicated,
and (2) a decision to reaffirm or opt for CKM made at a level of kidney function or despite symptoms
that would otherwise justify starting dialysis.
l Communication and information given to patients with CKD5 should (1) support patients and their
carers/families to understand the underlying kidney disease, (2) routinely include details of the CKM
pathway, (3) include realistic discussions of what is likely to happen in the future and (4) recognise
that decision-making in this setting is a process rather than an event and that decisions need to be
reviewed periodically.
l Renal staff need education and training in (1) advanced communication skills, adapted to include the
specific issues around dialysis decision-making, and (2) how to discuss and address palliative and
supportive care needs.
l Research is required to measure the benefits and costs of CKM and dialysis, and to inform
decision-making by staff, patients and their families.
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Chapter 1 Introduction and background
Chronic kidney disease and end-stage kidney failure in
older adults
Chronic kidney disease (CKD) is categorised into five stages depending on the estimated glomerular
filtration rate (eGFR) and evidence of kidney damage, as recognised by the National Institute for Health
and Care Excellence (NICE) and other international guidelines.1,2 The most severe of these stages, termed
end-stage kidney failure (ESKF) is termed stage 5 CKD (CKD5) where the eGFR is< 15ml/minute/1.73 m2.
National guidelines state that renal replacement therapy (RRT) should be considered in all patients with
CKD5. The symptoms of ESKF are largely due to the failure of erythropoietin (EPO) production and
consequent anaemia, accumulation of toxic metabolites (‘uraemia’), acid base and electrolyte imbalance,
and fluid retention. While a lower eGFR is associated with more severe and more frequent symptoms,
the effects of a decrease in kidney function can vary between individuals, with some CKD5 presenting
as asymptomatic.
The rate of decline of kidney function in CKD5 to a level of eGFR and/or symptoms that would justify
starting RRT is variable between patients and can be difficult for clinicians to predict. Clinicians are faced
with complex decisions about whether RRT should be started or not and, if so, when. The rationale for
initiation of dialysis may be to prevent imminent death from hyperkalaemia (high potassium), fluid overload
or uraemic coma, or to maintain quality of life and prevent complications of severe uraemia. These decisions
depend on the rate of deterioration of kidney function, on the development and attribution of symptoms
and on whether or not clinicians believe that dialysis will improve outcomes. Such decisions are especially
difficult in older patients, who often have symptoms related to multiple comorbidities.
Planning for renal services over the past decade has been largely dictated by the National Service
Framework for Renal Services published in 2004/5.3 Services for ESKF (CKD5 which has progressed to a
disease state at which dialysis is the default treatment) have been commissioned as specialist rather than
general acute services and development of renal services in England has remained centred on teaching
hospitals and large district general hospitals. Personalisation of choice in ESKF care has been an explicit
policy goal. Increasing emphasis has been given to preparation for ESKF and choice of treatments including
conservative kidney management (CKM). The majority of patients with stage 4 chronic kidney disease
(CKD4) or CKD5 approaching ESKF are now seen in multidisciplinary renal clinics, where risk factors
for progression and major cardiovascular events are managed, advanced CKD metabolic abnormalities
and symptoms are treated and preparation for RRT is organised.
The population rate of starting RRT has increased steadily over the last few decades, though with a recent
stabilisation.4,5 This is in part because of the ageing population, the rising prevalence of type 2 diabetes,
a decline in competing mortality risk from cardiovascular disease and considerable expansion in the supply
of dialysis facilities.4 This increase in RRT is highest among those over 75 years old, with disproportionate
numbers who are frail and have multiple comorbid conditions.6,7 In 2011, there were over 1500 patients
aged 75 years and over who started RRT in the UK.4 Several small retrospective or prospective cohort
studies have raised the possibility that the balance of benefit versus burden in this older frail group may
favour non-dialysis (conservative) management,6–12 especially when the patient has a significant burden of
morbidity. Those aged 75 years and over with ESKF who have dialysis do have a survival advantage, but
this advantage may be small in those with high comorbidity, especially when the effects of establishing
access for dialysis, time spent travelling to, receiving and recovering from dialysis three times a week, and
complications of dialysis per se, which often result in hospitalisation, are also considered. Moreover, quality
of life can be maintained on conservative care pathways.11 Conservative management may increase the
likelihood of dying at home and with input from palliative services.12,13 Dialysis per se leads to loss of
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functional status in older frail patients.14 For selected patients, and in the context of increasing frailty and
loss of independence,13,15,16 RRT may therefore be a costly intervention both for patients (in terms of quality
of life and treatment burden) and to the NHS (in terms of resource usage).
Providing an alternative to dialysis for end-stage kidney
failure patients
We have used the term CKM to describe the management of ESKF without RRT, but with active symptom
management, communication and advanced care planning (ACP), interventions to delay progression and
minimise complications, psychological support, social and family support, and spiritual care. It is expected
that a recent Kidney Disease Improving Global Outcomes (KDIGO) consensus conference will produce a
definitive definition.
Such an approach might contribute to a cost-effective strategy for managing the rising number of older
people with CKD5. However, there has been a perception that CKM might be seen as rationing care.
Rationing means the limiting of access to (usually) expensive interventions from which patients would
benefit, in order to control resource utilisation where resources do not permit such patients to be treated.
However, consideration of CKM is not to deny dialysis but to recognise that for some patients dialysis may
be futile or detrimental to their well-being, and CKM a more appropriate option. Historically the UK RRT
programme has had lower uptake rates than in many other countries with comparable populations. It is
not easy to disentangle the role of rationing (implicit or explicit) in this, as compared with careful and
appropriate use of treatment. CKM is now more accepted in the UK than in many other developed
countries; this means that the UK is in a key position to provide the evidence base for its appropriate and
effective development.
In recognition of the gap in provision of high-quality care for those dying with ESKF, there have been a
number of initiatives to raise the profile of care for kidney patients in the last year of life. The 2005
National Service Framework for Renal Services: Part 23 recommended that people with ESKF receive timely
evaluation of prognosis, information about their choices and, for those near the end of life, a jointly
agreed palliative care plan, built around individual needs and preferences.16 Guidelines have been
developed for managing the symptoms of kidney patients in the last days of life.17 The Department of
Health introduced policies to improve end-of-life care across conditions, through initiatives such as the End
of Life Care Strategy18,19 and, in primary care, the Gold Standards Framework.20,21 To consolidate and help
embed these policies, the Framework for End of Life Care in Advanced Kidney Disease was published22 and
piloted across the UK along with advice from NHS Kidney Care.23
The pathway through ESKF to CKM includes regular CKD management work, dialysis/CKM education
to ensure informed decision-making, ongoing discussions about CKM versus dialysis for patients who have
chosen CKM, activity to manage sequelae/symptoms of advancing CKD, and when the patient becomes
symptomatic escalation of palliative care. It is not simply a ‘no dialysis’ option.7 Maximum care to slow
disease progression,24 management of other comorbidities, assessment and active management
of symptoms (e.g. by correcting anaemia and acidosis, maintaining fluid balance and treating troublesome
symptoms with drugs) including dietary restrictions,25,26 optimising communication and ACP,27 and
improving care at the end of life,28 are all recommended. Services have increasingly been developed to
focus on optimising conservative care.29,30
Potentially, the delivery of such care can be undertaken by renal unit teams in outpatient departments
or community outreach, or both, with varying input from specialist palliative care expertise and from
primary care.31 There may be crossover from intended CKM to dialysis and vice versa. Some patients with
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CKD5 may not be referred to a nephrologist at all or may be referred back to primary care, so receiving
all their CKM outside specialist renal services. The physical health of patients and the attitudes of patients
and physicians towards the added value of attending kidney clinics for CKM are likely to influence the
decision to be referred and then remain in secondary care. Variation at centre level in the spectrum of
older patients with CKD5 referred to renal units and managed by dialysis or CKM needs to be taken into
account when examining outcomes of CKM patients in renal units.
Assessing optimal delivery of conservative kidney management
Major questions remain unanswered about how to commission and deliver CKM. Analysis of UK Renal
Registry data4 suggest there is significant variation between renal units in the mortality rate during the first
year of RRT. Although this could reflect variations in the quality of care delivered, variation in case-mix is a
more likely explanation. This variation in case-mix is likely to be driven by variation in whether RRT or
conservative care is recommended to frail, elderly patients with comorbidities, and by whether or not such
patients are referred to the centre at all. There are no recent data on practice patterns for CKM. The last
survey, conducted over 5 years ago before the National Service Framework for Renal Services: Part 23
suggested that only half of units even recorded the pathway choice for conservatively managed patients,
and only five units had nursing or professions allied to medicine staff devoting over 12 hours per week
to CKM.31 Yet it has been reported that, if late referrals are excluded (patients referred with ESKF
who start RRT within 3 months of referral), about 15% of elderly patients in managed nephrology care
with CKD5 opt for CKM.6,8,32 Decisions regarding these choices have been based upon clinical consensus
and experience, supported by a very limited number of UK studies.6–13,33,34 These studies have focused
predominantly on survival, and few have captured evidence on other outcomes10 (such as patient
preference, symptom burden, quality of life or quality of death) or clarified which patients in the older
cohort would or would not benefit from RRT. Given the cost to patients (in terms of quality of life and
dialysis treatment burden) and the cost to the NHS (in terms of resource usage), addressing this question
has become imperative. The outcomes and costs of different models of care may vary substantially.
Currently there is no financial payment for CKM under the Payment by Results tariff scheme and a better
understanding of the resources and costs of CKM is needed.
The current study, Conservative Kidney Management Assessment of Practice Patterns Study (CKMAPPS),
follows the guidance on developing and evaluating complex interventions.35 CKM is clearly a complex
intervention with multiple components and outcomes, and variable patterns of delivery. We first need to
understand the intervention and how it is delivered, before we explore how it can be evaluated.
Study aim
The overall aim of this study was to determine the practice patterns for CKM of older patients with CKD5.
This information should inform future service development and the design of a future prospective
multicentre study to evaluate the effectiveness, cost-effectiveness and appropriateness of CKM compared
with dialysis for treating elderly patients.
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Objectives
The main objectives were:
i. to describe the variation between renal units in the extent and nature of CKM, its relative scale
compared with dialysis, the factors influencing service developments and future plans (staff interview
study, survey)
ii. to explore how and when decisions are made in renal units about the main treatment options for older
patients with CKD5, and what are the main clinical and patient factors that influence decisions to opt
for CKM (staff interview study, survey, patient interview study)
iii. to explore clinicians’ willingness to randomise patients with CKD5 to CKM versus dialysis and to assess
the feasibility of a subsequent prospective study (survey)
iv. to describe the interface between renal units and primary care in managing CKD5 patients [staff
interview study, survey, general practitioner (GP) interview study/data linkage]
v. to identify the resources involved and potential costs of CKM (survey, staff interview study).
Methods
The research programme was a mixed-methods study divided into five parts:
1. patient interview study: a qualitative study with patients over the age of 75 years exploring their
experiences of choosing between CKM and dialysis for the treatment of CKD5 in a purposive sample of
nine renal units
2. staff interview study: a qualitative study across the nine renal units exploring the views and experiences
of staff members who provide care for CKD5 patients over the age of 75 years
3. survey: a national survey of all UK renal units assessing the delivery of CKM
4. data linkage: linking routine data on new ESKF patients from the local clinical biochemistry laboratory
records of the nine renal units with subsequent referral to the associated renal units
5. GP interview study: a qualitative study of GPs exploring their views and experiences of managing CKD
patients and referring patients to secondary care.
Ethical considerations
Ethical approval to conduct the study was obtained from South Birmingham National Research Ethics
Committee (11/WM/0240). Various secondary and primary care NHS trusts were involved in recruiting
patients and staff in this research. Site-specific approval was obtained from all the relevant trusts.
Research staff had NHS research passports and letters of access.
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Chapter 2 Patient interview study: making
decisions about treatment for stage 5 chronic kidney
disease – a qualitative study with older adults
Introduction
This study set out to address objective 2 of the CKMAPPS project by exploring patients’ decisions to
opt for CKM.
Few studies have explored why patients opt for CKM.36–39 Patients who reported making an autonomous
decision gave the following reasons: they felt they were too old for dialysis, they thought dialysis was too
strenuous for them to undertake, they felt well without dialysis, they did not want to be a burden on their
family, they knew other patients who had had bad experiences on dialysis and they found it difficult to travel
to dialysis.36–39 In addition, some patients believed they had no decision to make if they were told dialysis
was unsuitable for them.36 Researchers also identified that some patients were reluctant to think about the
future, which meant decision-making about treatment potentially needed in the future was difficult.38
While these studies give some indication of the reasons patients choose between treatment options,
studies have been small and of a single centre. No research has explored, across different units with
different CKM policies and practices, the views of patients on choosing between CKM and dialysis, and
the reasons for their choice.
This qualitative study aimed to explore the views and experiences of older adults with ESKF, who had
chosen different treatments for CKD5, on their treatment decision and reasons for their decision across
nine UK renal units.
Methods
Design and setting
Qualitative study with semistructured interviews with patients recruited from nine renal units in England
(Birmingham, Heartlands; Bristol, Southmead; Hull; London, King’s College; Manchester; Middlesbrough;
Reading; Stevenage, Lister; Stoke-on-Trent). Renal units were purposively sampled to produce a diverse
sample in terms of location in England and the scale of CKM delivery. The latter was estimated by
responses provided by clinical directors to a previous survey by the UK Renal Registry.40
Participants
Consultant nephrologists and nurses in each renal unit were asked to identify patients who were 75 years
old or older and whose records indicated that they had an eGFR of less than 15ml/minute/1.73m2 or
were on dialysis. Patients were required to speak English fluently and be judged by their health-care
professionals (HCPs) to be sufficiently fit, physically and mentally, to take part in an interview. The
researchers aimed to sample patients purposively by stage of illness and management pathway as follows:
(1) following the decision to opt for CKM (CKM pathway), (2) following the decision to have dialysis in
the future, but before starting dialysis (pre-dialysis pathway) and (3) following the start of dialysis
(dialysis pathway). Staff in each unit were responsible for identifying patients in each of these groups
who met the inclusion criteria, and patients were invited to take part in the study either by post or in
person. Demographic and other information for all patients invited to take part in the study was recorded
(gender, age, ethnicity, date first seen at renal unit and date started CKM or dialysis if applicable).
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Interviews
Patients were interviewed by an experienced qualitative researcher (ST-C), either face to face, in the
patient’s own home or in their renal unit while they were on dialysis, or by telephone. The type of interview
was determined by patient preference except for some interviews which had to be carried out by telephone
because of the distance between the researcher and participant. The interviewer introduced herself as
a non-clinical researcher to explain that she had both no medical training and no specific allegiance to the
nephrology field. All patients gave written informed consent, either at the time of interview or before
the interview if carried out by telephone. Interviews followed a semistructured interview guide which asked
patients about their medical history in relation to their CKD, their contact with their renal unit, their
knowledge and understanding about management options and their reasons for their management
decision (see Appendix 1). A semistructured format was deemed suitable to ensure relevant questions were
asked to all patients but also to allow patients the opportunity to talk about issues which were important
to them. Interviews were audio-recorded and transcribed verbatim by an independent transcriptionist.
Transcripts were checked by the interviewer to ensure accuracy. Recruitment and interviews continued until
the interviewer was satisfied that the data indicated saturation.
Data analysis
Thematic analysis41 allowed an inductive approach to exploring the data, which lessened the likelihood
that findings would be influenced by the existing literature or the researchers’ preconceptions. Transcripts
were coded line by line, with codes being assigned to each meaningful segment of text. Transcripts were
then compared with one another, using a constant comparison approach taken from grounded theory,
to search for similarities and differences between interviews.42 ST-C independently coded 20 interview
transcripts and developed an initial set of themes. NVivo 9 (QSR International, Warrington, UK) was
used to facilitate coding. Initial themes were discussed with the wider research team, and themes and
subthemes were amended and renamed until a consensus was reached. This agreed framework was used
to code the remaining 22 transcripts. Any new data occurring in transcripts which did not fit into the
existing themes were highlighted and discussed further. New themes and subthemes were added,
and existing themes amended, in the light of these new data.
Results
Participant characteristics
Ninety patients were invited to take part in the study and 44 agreed. Eleven patients declined, five patients
were unable to take part for health reasons, four patients died after being invited and 26 did not reply.
Patients who did not take part were mostly CKM patients, which meant that more CKM patients had to
be invited to take part (Table 1).
TABLE 1 A comparison of the demographics of patients who agreed to take part in the study with those who
declined/were unable to take part
Characteristic
Patients who agreed to
take part (n= 44)
Patients who refused/did not respond/
were unable to take part (n= 46)
Age (mean, years) 81.7 82.7
Gender (male) 30 (68%) 31 (67%)
Ethnicity (white British) 40 (91%) 44 (96%)
Pathway
CKM 14 (33%) 22 (48%)
Dialysis 14 (33%) 11 (24%)
Pre-dialysis 14 (33%) 13 (28%)
PATIENT INTERVIEW STUDY
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Forty-two patients were interviewed, 14 patients in each group (Table 2). All dialysis patients were on
hospital haemodialysis (HD) except for two on continuous ambulatory peritoneal dialysis. Interviews ranged
from 27 to 87 minutes with a median of 47 minutes. Interviews were carried out between May 2012
and February 2013 and were carried out in person except for five interviews carried out by telephone.
There was no indication from the data that interviews carried out by telephone differed substantially from
face-to-face interviews in content although interviews were slightly shorter on average. While some
interviews took place with a family member in the same room, three of the CKM patients specifically
wanted to be interviewed with a family member for support.
Sociodemographic characteristics did not differ substantially between the three groups. Participants’ ages
ranged from 74 to 92 years with a mean of 82 years, most were men and most identified themselves as
white British. Many patients were married or had a partner (n= 24, 57%) and most were living with their
partner (n= 22, 52%). Other patients lived alone (n= 14, 33%), with their children (n= 3, 6%), their
friends (n= 1, 2%) or in a care home (n= 2, 4%). Compared with the pre-dialysis and dialysis groups,
patients opting for CKM were slightly older, were more likely to be female and were more likely to live
alone or in a care home, but group numbers were small (Table 3).
At the time of interview, patients had been in contact with their renal unit for a median of 49 months (range
from 5 to 131 months). Dialysis patients had been on dialysis for a median of 10.5 months (range from 1 to
120 months) and patients who had opted for CKM had done so a median of 11 months previously (range
from 1 to 83 months). Although recruitment had aimed to interview CKD5 patients, some patients reported
that their eGFR was between 20ml/minute/1.73m2 and 15ml/minute/1.73m2 in interviews, indicating that
they had CKD4.
Renal unit characteristics
Results from the national survey (see Chapter 4) confirmed variation in the scale of CKM delivery in the
nine units sampled (Table 4). Three of the nine renal units reported that, of their patients over 75 years
old, under 10% were receiving CKM, as opposed to other units, where up to 50% of over-75-year-olds
TABLE 2 Numbers of patients recruited from each renal unit and on each management pathway
Unit Pre-dialysis pathway Dialysis pathway CKM pathway Total for unit
1 2 1 2 5
2 2 2 2 6
3 2 1 1 4
4 1 2 1 4
5 3 2 1 6
6 1 3 1 5
7 2 1 1 4
8 0 1 3 4
9 1 1 2 4
Total 14 14 14 42
TABLE 3 A comparison of the characteristics of patients in the pre-dialysis, dialysis and CKM groups
Characteristic Pre-dialysis patients (n= 14) Dialysis patients (n= 14) CKM patients (n= 14)
Age (mean, years) 81.3 80.4 83.5
Gender (male) 11 (78%) 10 (71%) 7 (50%)
Living alone 2 (14%) 6 (43%) 6 (43%)
Living in a care home 0 0 2 (14%)
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were opting for CKM. The same three units reported that the terminology used to refer to CKM was
usually phrased as ‘non-dialysis’. Based on these data, units were classified into two groups: those with
more established CKM pathways (units 1, 2, 5, 6, 8 and 9) and those with less established CKM pathways
(units 3, 4 and 7).
Qualitative findings
Four themes emerged from the analysis of all interview transcripts (Figure 1). All themes were relevant to
all patients, but differences within themes emerged between patients who had chosen different treatment
options and between patients from different units.
The diagram indicates how interaction with staff fed into patients’ conceptualisation of the process
between understanding CKD and making (and occasionally revising) a management decision for their
own CKD.
Theme 1: patients’ understanding of the management of chronic
kidney disease
Patients mentioned that information about management had been provided through discussions with
staff, written information and education days (meetings at the unit for patients to come and hear about
different types of treatment). Although patients reported being given a large amount of information,
some felt overloaded by the amount of information and described feeling unclear about what treatment
options entailed, and others felt that the information given to them could be improved.
My wife was enraged with the brochure to such an extent that she brought it home and re-wrote
parts of it . . . The pictures were meaningless; a woman sitting at a desk with a tube somewhere didn’t
mean anything to anyone. So the information was bad.
Male, 79 years, dialysis, unit 5
Education days seemed to be well received by patients, particularly when they were able to hear about
others’ first-hand experiences of dialysis. Education days were not available in all units; however, this
appeared to be a popular option among patients and may be of benefit if delivered in more units.
1. Understanding
management of CKD
In
te
ra
ct
io
n
 w
it
h
 r
en
al
 u
n
it
 s
ta
ff
2. Perceptions of own
CKD
3. Making a
management decision
4. Revising decisions
FIGURE 1 A thematic map of the four themes identified from the analysis of 42 interviews.
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Some pre-dialysis and dialysis patients stressed that they did not want, or had not wanted, to know about
the details of dialysis until it was time for them to start.
I wouldn’t come down and see the [dialysis] machines. No, I thought wait till it happens and – I don’t
want to know until I have to, you know?
Female, 76 years, dialysis, unit 8
All patients were aware of dialysis and the majority had an idea of the differences between peritoneal
dialysis and HD, with most describing them as dialysis ‘at home’ or ‘in hospital’. In most units, knowledge
about CKM was not common among patients who had not opted for it.
It was presumed that dialysis would work for me, I presume . . . I can’t remember [unit] ever – ever
suggesting to me or saying that there is a third option – of not having dialysis. There were two sorts
of dialysis.
Male, 82 years, pre-dialysis, unit 5
However, in units with more established CKM pathways, some dialysis patients were aware of CKM as an
option which some patients chose.
[The nurse] was leaving the low clearance to go to people who were having – non-dialysis, I think
tablets and things.
Female, 76 years, CKM, unit 8
In relation to this, some patients described how dialysis had, in their view, always been inevitable for them.
Going to low clearance, you saw people go off onto dialysis, so you knew that it would come to you,
you know?
Female, 76 years, dialysis, unit 8
Conservative kidney management patients also reflected that, at first, they had also been guided towards
dialysis because other patients were preparing for it.
Well initially, because you think that’s the right way to go, you’re on the dialysis track. So you’re going
that way, everybody’s going that way . . . So that’s the track you’re on. At some stage – then the
conservative management comes into play – and it’s when you realise that the dialysis is perhaps not
the best track, but something has to tell you that . . . what told me was [the experience of my friends].
Male, 82 years, CKM, unit 5
Theme 2: patients’ perceptions of their own chronic kidney disease
Most pre-dialysis and CKM patients reported that they had no symptoms from their CKD. Others were
unsure whether their symptoms were due to their kidneys, another comorbidity or just ageing. A lack of
symptoms seemed to be interpreted by some CKM patients as an indication that their CKD was not serious.
They wanted to put me on dialysis, nearly five months ago, but I didn’t want to go on dialysis.
Everything is all right, you know, I don’t have to go on dialysis.
Male, 81 years, CKM, unit 2
In addition, two CKM patients felt they could prevent their kidney function from decreasing through diet
and medication.
I think if I try, I can sort of get a bit better than what I am, if I had the right – materials, you know, the
medication and all that. And what to eat, I think that’s the main thing, what to eat and what not to eat.
Female, 88 years, CKM, unit 6
PATIENT INTERVIEW STUDY
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It was clear that discussions with staff had helped other patients to realise how serious their CKD was.
Most had been told when dialysis would need to be started in terms of the level of their eGFR. In addition,
patients from one renal unit all reported that they had been given an estimate of which calendar year
they would probably need to start dialysis if chosen.
They’ve been watching this graph going down . . . they talked to me about dialysis and they said that
in 2012 it looked as if I would reach the time when I should need it.
Male, 83 years, pre-dialysis, unit 5
However, in other examples, patients reported that they had been told different things by different
members of staff about their CKD, which had influenced how serious they felt it was and appeared to
influence their treatment decisions.
This nurse came to have a talk with me . . . and she says ‘we’ve given you a score of 6 [eGFR]’.
So I thought – 6/10, that’s not bad, I can live with that. Then I thought, 6 out of how many? She said
‘6/100 that’s how poorly you are’ and that brought me down to earth.
Male, 87 years, CKM, unit 9
It went from 6 to 5 and the doctor said, ‘don’t worry, it’s alright’, she says, ‘I’ve got a patient on 4,
been on 4 for years and she’s still alive, don’t worry’. I said, ‘oh well, that’s alright’.
Male, 87 years, CKM, unit 9
Theme 3: patients’ experiences of making a management decision for their
chronic kidney disease
Patients’ assessments of dialysis
Patients who had opted for different treatments appeared to hold contrasting beliefs about the advantages
and disadvantages of dialysis. Some dialysis and pre-dialysis patients believed that dialysis was the only way
they could continue to live and described a belief that others who chose not to have dialysis were ‘cutting
their lives short’.
I don’t fancy the idea of having to lay on the bed there for 4 hours, but, you know, it’s – the
alternative is death, isn’t it, so there’s no choice.
Male, 77 years, pre-dialysis, unit 4
Patients from units with a less established CKM pathway reported that they had been told they would live
for many more years on dialysis.
[Consultant] said, ‘well it looks as if you will probably have 6 years [on dialysis]’.
Male, 82 years, dialysis, unit 3
In contrast, some CKM patients, from units with more established CKM pathways, believed that dialysis
did not guarantee longer life. This appeared to reflect what they had been told by renal staff.
I decided – after seeing this [dialysis] demonstration – that I didn’t want dialysis. I’m told that’s not
terribly unusual – and I was told that – if you say no to dialysis, you don’t necessarily live any longer
anyway. And as I’ve no discomfort or pain or anything like that, I thought I’d carry on.
Male, 84 years, CKM, unit 9
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Alongside longevity, patients considered quality of life. Many CKM patients believed that they would have
a better quality of life without dialysis and prioritised this over living longer. In these situations patients
seemed to have formed their own beliefs about dialysis rather than from discussing quality of life
with staff.
It did occur to me that [on dialysis] you were, sort of, living for tomorrow, for your next treatment, for
tomorrow, for your next treatment, for tomorrow. And it made me think, well, I wonder if it’s better
to live as best you can, as you can and let time take its course.
Male, 82 years, CKM, unit 5
In contrast, some pre-dialysis patients believed that dialysis could offer them a better quality of life or help
them to maintain their current quality of life.
Well I’ve been promised that I shall be ten times better [on dialysis]. (Laughs) I’m being optimistic.
Male, 76 years, pre-dialysis, unit 9
Conservative kidney management and dialysis patients spoke very differently about the time one would
have to spend on dialysis. CKM patients saw this time as a ‘waste’ whereas others felt they were gaining
additional days or that it was similar to how they would usually spend their time. Again these views
seemed to be based on the patients’ own interpretations rather than on information they had been given
by their unit.
I don’t want to waste a week of my life all the time – when I can be sat at home, enjoying myself, you
know. I mean, to me, I’m going to lose my life if I’m going to have to be on dialysis.
Female, 82 years, CKM, unit 7
I’m 81 so it really don’t matter to me, I thought 4 hours out of your life twice a week, what difference
does it make . . . I mean I would only be sat watching the television anyway.
Female, 81 years, dialysis, unit 7
Additional factors which influence patients’ decisions
Transport to and from dialysis was a major concern for patients and was a reason for some not to have
dialysis when home dialysis was not an option for them.
Well, I can’t drive and I live out of town and so it’s relying on hospital transport and I mean you could
be waiting hours . . . I just couldn’t cope with it.
Female, 82 years, CKM, unit 7
Many patients talked about how family was a consideration in their decision. Several patients on dialysis
had family support which made it possible for them to undertake dialysis. Two patients reported that they
were carers for their spouses, which had been the major influence on their decision.
I can understand [people choosing CKM], I can quite easily understand that, but whilst the wife is
about, if dialysis helped me along, to keep her out of a nursing home, then that would be a good
achievement as far as I’m concerned.
Male, 82 years, pre-dialysis, unit 5
PATIENT INTERVIEW STUDY
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Some CKM patients indicated that they did not want to be a burden to others or the health-care system
by having dialysis and indicated that it was of little benefit to have dialysis when they felt they had already
reached old age. This appeared to stem from patients’ own beliefs rather than anything they had discussed
with staff.
At 80, there is a lot of younger people that could benefit from dialysis which, you know, what’s really
the good of dialysis when you reach 80 years old?
Male, 82 years, CKM, unit 5
I could see a big disruption to my husband [if I had dialysis], he’s had quite enough to do without
having to get me ready to go in [to hospital]. If I was younger, say 50s I might think about it, but I
shall be 87 in a couple of weeks’ time, so what’s the point?
Female, 86 years, CKM, unit 1
Four patients said that they knew of a friend or relative who was, or had been, on dialysis. Some had
heard about others’ bad experiences with dialysis, which appeared to have influenced their decisions.
I decided not to have dialysis . . . at that time, actually, two of my close friends had dialysis and I don’t
ever want to be involved in that, that’s no way to live . . . There was no fun in their lives, it was just
hopeless really. We tried to go on holiday but every 2 . . . every 4 hours you had to go back to change
and we didn’t get nowhere at all.
Male, 81 years, CKM, unit 3
Staff influences on patient decision-making
Patients also appeared to have been strongly influenced by staff when making their decision. Many patients
talked about how staff had explicitly recommended dialysis or presented it as the best option in most units.
[The staff] said ‘well it’s entirely up to you, you’ve got the choice. You can have dialysis or you can
have the other thing . . . But if you want not to have dialysis it’s your choice but you’ve got to realise
that it is going to kill you . . . But if you’re on dialysis you could last for 10, 15, 20 years’.
Male, 76 years, dialysis, unit 2
However, in some units with more established CKM pathways, staff appeared to have discussed CKM as
an alternative to dialysis with patients, presenting this alongside information on dialysis.
They went to great lengths to tell us about the fact that we could opt in or out of the dialysis and that
there was an alternative to dialysis, which is this care path.
Husband of female, 74 years, CKM, unit 8
Theme 4: patients’ experiences of revising management decisions
Only patients who had opted for CKM talked about having the option of changing their decision and most
seemed to have been told that this option was always available to them.
Two dialysis patients, from the same unit, reported that they had changed their treatment decision in the
past. They reported that they had initially chosen CKM because they felt well but then opted for dialysis
when they had felt ill as a result of their CKD.
I said at the time no [to dialysis] and then within a fortnight I’d changed my mind. Because my health
wasn’t very good at all.
Male, 88 years, dialysis, unit 4
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In three of the 14 interviews with CKM patients, participants implied that they would have dialysis if they
‘had to have it’ or if they ‘got really ill’, although this was not usually revealed until late in the discussion.
An example is this discussion thread taken from one interview with a CKM patient.
Interviewer: One of the nurses told us that you had decided not to have dialysis?
Female, 82, CKM, unit 7: No. She said that if I did change my mind – you know – but – I don’t think
I will, definitely not.
[later in interview]
Interviewer: And [nurse] said to you more recently that you’re able to change your mind if you decide
you want to have dialysis?
Patient: Oh yes.
Interviewer: And what do you think about having that – that option still available?
Female, 82, CKM, unit 7: Well it’s nice, I think, that it’s there; whether I’ll ever take it up, I don’t
know – but – in a way, I suppose it’s a comfort that I could go back, you know, if I was really ill.
[later in interview]
Interviewer: Yes, so do you think that – you might change your mind then, if you got – if you got
more symptoms from it or got quite ill?
Female, 82, CKM, unit 7: Well yes, if I got really ill and I wouldn’t be having any – type of life anyway,
would I? If I was that ill, you know, so there wouldn’t be that much choice.
This may indicate that the goals of CKM had not been fully explained to patients. These patients attended
both types of units, those with more and less established CKM pathways.
Well if it came to the point, I’d have to do [dialysis], wouldn’t it, you know? But it comes to the stage,
you know, that then there’s no alternative. You have to do it.
Male, 81 years, CKM, unit 2
The revision of a decision from CKM to dialysis appeared to be linked to a lack of consideration of what
would happen in the future. CKM patients differed in whether or not they had discussed the future with
staff. CKM patients from units with more established CKM pathways appeared to have discussed the
future with staff more than patients from other units. This included talking about how their CKD would
progress and setting up ACP.
I mean I don’t think it’s an agonising death like people suffer with bone marrow, cancer and all that
. . . they said ‘you could suddenly start to feel very ill . . . and then ultimately probably go into a coma
and just disappear.’ Which doesn’t sound pleasant but it’s not that bad to worry about.
Male, 75 years, CKM, unit 1
[Nurse] arranged care to come – they took her away and put her in a hospice for a couple of weeks,
just down the road here. They were marvellous, but she went to the hospice and they discussed the
end of life with her and, so, I think [nurse] did as well and I think they spoke about it.
Husband of female, 74 years, CKM, unit 8
PATIENT INTERVIEW STUDY
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Summary
Main findings
While CKD patients consider the same factors when making a treatment decision, patients who choose
different treatments hold contrasting beliefs about what dialysis can offer. These beliefs appear to be
influenced by the information provided by renal staff, which can differ between units, particularly in regard
to CKM. It was noticeable that few patients were aware of CKM as an option if they had not chosen it,
although patients from units with a more established CKM pathway appeared to be more aware of CKM.
While most acknowledged the severity of their CKD, some CKM patients did not appear to think of their
CKD as serious because of its asymptomatic nature, despite information from staff indicating otherwise.
There was a distinct divide between CKM patients, and dialysis and pre-dialysis patients in whether people
believed they would live longer on dialysis or not and whether they expected their quality of life to get better
or worse on dialysis. Information from units with less established CKM pathways appeared to focus on the
number of additional years a patient was likely to live on dialysis. Patients from units with more established
CKM pathways, however, described being told that living longer on dialysis was not a guarantee and in
addition that choosing CKM was ‘not unusual’. Finally, few patients reported speaking to staff about the
future, in terms of the consequences of either starting dialysis or opting for CKM. Patients from units with
more established CKM pathways appeared to have discussed the future with renal staff and some indicated
that they had begun conversations about ACP. For others, being unaware of how their disease was likely to
progress added to the misperceptions some patients appeared to hold about the severity of their CKD and
the need for dialysis.
Comparison with existing research
Particular results mirrored those identified in previous qualitative research.36–39 CKM patients reported that
they had chosen CKM because they felt too old for dialysis, they were worried about being a burden on
family/society and they were concerned about travelling to have dialysis. While these factors can be valid
reasons for making a decision there is also a sense that some patients may feel dialysis is not really a
possibility or that they do not have a right to dialysis. Thinking of oneself as a burden on society, if dialysis
is chosen, may lead to feelings of guilt for patients, who may benefit from extra time to talk through
their decision with staff. Equally, concerns about whether transport is a possibility or not, rather than a
preference to avoid transport, are different thought processes, and equity of access to treatments needs to
be assured.
Reluctance to think about the future and feeling well without dialysis have been identified in previous
studies37,38,43 and they linked to the current findings about perceptions of CKD severity and revising
decisions. Feeling well, with few symptoms, seemed to make some patients think their CKD was less
severe, which meant they did not see a reason to consider dialysis. A reluctance to think about the future
and possibilities of becoming more ill had led some to choose CKM initially and then change their decision
later on. This may be unavoidable for some patients who are unable to understand their CKD until they
feel symptoms, although clinicians should be wary about using the term ‘CKM’ to refer to such patients.
Patients who are in ESKF often want to know their prognosis but clinicians may feel uncertain or
uncomfortable about when to discuss this with patients.43 Open discussions about prognosis are likely to
have a substantial influence on discussions about treatment options and feed into better shared
decision-making.
Results also supported previous qualitative and quantitative work which showed how CKM patients may
choose quality of life over length of life.39,44,45 While this indicated different priorities between patients, the
current results highlighted how patients held contrasting beliefs about whether dialysis would extend life
or not, indicating the importance of patient expectations as well as priorities. Results also supported
previous work which indicates that patients may choose CKM if they feel they have achieved everything
they have wanted to in life.39 This contentment and feeling of having had a ‘complete life’ has been
suggested to lessen anxiety about death and end of life.39
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In addition to existing research, the current study identified the influence staff, and information from the
renal unit, had had on patient decision-making. Patients from different units reported being provided with
varying types of information, which presented CKM in a more or less positive light. It appeared that
patients from units with a more established CKM pathway were more likely to know what CKM was,
had been given more information about CKM and, for those who had chosen it, had discussed the
consequences of their decision in more detail. While there may be recall issues with patient reports,
results suggest that there are unit variations in the way in which older CKD patients are informed.
Strengths and limitations
This was the first qualitative study to explore patients’ views of choosing between dialysis and CKM across
different renal units. Including nine units in the study meant that the sample contained diversity in terms
of both patients’ treatment decisions as well as the service delivery experienced. We were able to include
units which had more or less established CKM pathways in order to explore variation in what patients
had been told.
Qualitative results cannot be generalised to other populations but data gathered can identify important issues
and offer conceptual transferability. Indeed, the findings presented resonate with the existing literature.
While interviewing methods run the risk of obtaining socially desirable responses, the interviewer presented
herself as an impartial observer who had no link to the renal units or staff. Moreover, patients mentioned
negative aspects of the care they had received, which suggests that they felt able to speak freely and in
confidence. Finally, as with all interview studies, the findings do not provide a window on events as they
happened but rather provide insight into how participants construct their experiences of relevant events.
Although the study had clear entry criteria, one participant under 75 years was invited to take part
and three participants reported they were CKD4 rather than CKD5. Recruitment was difficult and
time-consuming for renal staff and it was not always clear that participants did not match the inclusion
criteria until part way through an interview. Data on patients’ eGFR over time were not collected. It is
likely that patients with both advanced but stable kidney function and those with a linear, progressive,
predictable decline in kidney function were recruited. Such differences may have had implications for how
treatment options were discussed because of the clinician’s (un)certainty of how likely a patient was to die
from their CKD rather than another condition.
The study excluded participants who did not speak English fluently, in order to ensure that participants
were able to provide full responses to questions without the need for a translator. This limitation meant
that the study was less likely to recruit patients from black and minority ethnic groups. Recruitment of
such patients would have required additional resources which were unavailable and somewhat unfeasible
for this study and may be better suited to a more focused qualitative study looking specifically at
this population.
Recruitment of advanced CKM patients was particularly difficult. CKM patients most often had an eGFR
of over 10ml/minute/1.73m2 and few felt they had any symptoms from their CKD. This meant CKM
patients who were symptomatic and who otherwise would have started dialysis were not well sampled;
interviewing more of this type of patient might have provided additional insights into why CKM is chosen
by some and would have allowed more direct comparison of CKM versus dialysis patients. However, such
patients may not have been physically and mentally well enough to take part. This is likely to be a
limitation of any qualitative work carried out with a chronically ill older population across several centres.
The views of dialysis, pre-dialysis and CKM patients were compared. While all patients were similar in age,
patients differed greatly in their physical and mental health, within and between treatment groups. The
choice between dialysis and CKM is most relevant to older adults who are frail with other comorbidities.
While we tried to recruit such patients, this was not always possible and some CKD patients who were not
frail or burdened with multiple comorbidity were recruited to the study. For these patients it may be
unsurprising that less emphasis had been placed on CKM as an option by renal unit staff.
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The number of renal units in the study captured variety in CKM delivery. However, this influenced the
number of patients interviewed per unit, which had to be limited in order to obtain a manageable data set
which could be explored in depth. Future qualitative work may benefit from sampling more patients from
fewer units in order to follow-up initial data which suggests that patients attending different units are
receiving different information about treatment options.
The categorisation of units into two groups representing units with a more or less established CKM
pathway was relatively crude. Inevitably there was some overlap in policy and practice between the
two groups; however, the categorisation helped us to look at general trends in the data.
Implications
Patient reports indicated that they had been given different types of information, at different time points,
by their renal unit and that units with a more established CKM pathway appeared to have provided more
detail about the option of CKM than others. While this may have reflected the suitability of dialysis or
CKM for the individual patient, it was interesting that patients from units with a more established CKM
pathway were aware of both treatments regardless of what their final decision had been. Having fewer
resources dedicated to CKM may reflect a general trend in a unit to encourage dialysis for all patients.
However, it may also reflect less experience in providing care for CKM patients. Staff with access to fewer
resources and less experience in providing a type of care may be less likely to discuss such care with
patients, which may bias discussions towards dialysis. Staff may also be less supported in these discussions
if they are not provided with materials which help to explain the CKM pathway or with training in how to
have such discussion with patients. Finally staff may not feel comfortable discussing CKM with patients
if they believe that dialysis will always offer more benefit despite comorbidity or frailty. Research which can
provide data on the comparative outcomes of CKM and dialysis patients will help to clarify whether
dialysis is beneficial for certain patients or not.
It was interesting to note that some patients had opted for CKM several months before interview, in one
instance 7 years previously. It was also apparent that some patients had initially opted for CKM when they
were well and changed their mind once they had experienced symptoms from their CKD. Both situations
suggest that the label of CKM is being used for a very broad population, arguably one that is much larger
and more diverse than the label ‘CKM’ would initially suggest.
Conservative kidney management is an alternative to dialysis and therefore could be strictly defined as
applying only to patients who have passed the point at which dialysis would usually have been started,
though this point can be difficult to define, especially in patients who may have symptoms related to other
comorbidities. While this time point will be different for individual patients and judged differently between
clinicians, a consensus based on eGFR or symptoms linked to kidney failure may be possible and would
reduce the number of patients with asymptomatic, stable CKD being labelled as receiving CKM. Delaying
a label of CKM would allow patients more time to think about their decision. It may lead to patients
experiencing more symptoms from their CKD and give them greater awareness of how much their CKD is
affecting their life. Having a more standard approach to the labelling of CKM, specifying separately those
patients who currently plan to have CKM in the future and those who are currently receiving CKM,
would provide a clearer view of the numbers of patients on this pathway and the variation between units.
Our interviews emphasise that both categories of patients retain the option of changing their plan or
choice of treatment.
Both dialysis and CKM patients reported they had not discussed the future with staff. Regardless of what
treatment decision is made, it is important that renal staff discuss the likely trajectory of illness with
patients. Previous literature has highlighted this issue and recommended earlier, rather than later,
conversations about ACP to promote optimal end-of-life care.46,47
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Finally, quantitative results from the CKMAPPS survey indicate that units use different terminology for CKM
and that there is a subgroup who refer to CKM as ‘non-dialysis’. CKM is accepted by most as an alternative
to dialysis for a subset of patients, and patients may benefit if the option of CKM is presented in a consistent
and unbiased manner across renal units. Units that are organised to support staff in the discussion of
CKM options with patients will deliver patient benefit by promoting greater shared decision-making.48,49
Clinicians should consider the implications of having a pathway framed as a negative option. Consistency in
terminology would help establish CKM as a clearly defined and appropriate pathway for some patients.
Conclusion
Our results indicated that older adults with CKD5 who have chosen different treatment options have
contrasting beliefs about what dialysis will offer them. Patients’ decisions were influenced by the
information provided by their renal units, which differed between units with more and less established
CKM pathways. Supporting staff in discussing CKM as a valid alternative for a subset of patients across all
renal units will promote informed decision-making and thereby stand to benefit patients.
PATIENT INTERVIEW STUDY
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Chapter 3 Staff interview study: treating older
adults with stage 5 chronic kidney disease who opt
for conservative kidney management – a qualitative
study with renal unit staff
Introduction
This substudy addresses objectives 1, 2 and 4. Semistructured interviews were conducted with renal
HCPs to explore the organisation and provision of CKM to patients in their units, and their views and
experiences of treating patients who opt for CKM. The primary aim of conducting these interviews was to
inform the development of the national survey questionnaire.
Only a few qualitative studies have explored renal staff’s experiences with patients on RRT. One study
identified that physicians and nurses found it difficult to meet the complex needs of elderly patients and
faced dilemmas when making decisions concerning withholding or withdrawal of dialysis.50 Another study
found that nephrologists working in HD care faced ethical dilemmas where they were forced to make
‘life or death’ decisions, such as whether or not to start or discontinue dialysis. These decisions were made
particularly difficult if patients and relatives were in disagreement about a treatment option, and when
they were faced with time restraints and professional and personal demands.51 Nephrologists also found it
difficult to explain the complexity of advanced kidney disease to patients with difficulties in managing a
disease over which they have little control. Consequently, discussions with patients focused on present
clinical status and avoidance of discussions of prognosis and the future.44
While these studies identify difficulties that renal staff face, they do not give a detailed account of staff’s
experiences of discussing alternative treatment options such as CKM with patients. None of these studies
was conducted in the UK. This study focused on exploring UK renal staff’s views about CKM and their
experiences of the provision and delivery of the CKM option for older adults with ESKF.
Methods
Design and setting
Semistructured interviews were conducted with staff members in nine renal units across England.
These units were the same as those involved in the patient interview study (see Chapter 2) and were
purposively sampled to obtain a range of locations and scale of CKM practice.
Participants
Consultant nephrologists in each participating unit were approached by the principal investigators and
asked to identify a minimum of five staff members who were involved in the care of CKM patients in their
unit. For units that had very few CKM patients, staff who cared for patients in low-clearance clinics or for
those whose eGFR was less than 20ml/minute/1.73 m2 were recruited. We stipulated that the staff
members interviewed had to include a minimum of one lead nephrologist and one nurse per unit. Allied
health professionals were also invited to participate in the study.
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Interviews
Participants were interviewed by IO and ST-C, either face to face at their renal unit or by telephone.
All participants signed a consent form either at the time of interview or before the interview if they were
interviewed over the telephone. Semistructured interviews were conducted following an interview
schedule (see Appendix 2). The interview schedule was initially constructed from a literature review and
discussion with steering group members and was then developed iteratively as interviews were carried out.
The interview schedule asked participants to discuss their views of CKM, their experiences of being
involved in decision-making about CKM, how CKM was delivered in units and the role of primary and
palliative care services in caring for CKM patients. Interviews were digitally audio-recorded and transcribed
verbatim, and interviewers verified the accuracy of transcription by listening to the interview and
reading transcripts.
Data analysis
A content analysis of the 60 interviews was carried out to inform the survey questions (see Chapter 4). This
consisted of several steps and included rereading the interview transcripts, identifying frequency of words,
phrases and themes, and then developing categories of words, phrases or themes with similar meaning.52
The data from the qualitative study helped to identify the sections of the survey and facilitated the
formulation of the survey questions and multiple choice options.
Subsequently, a more detailed thematic analysis41 of the qualitative data was conducted. NVivo 10 was used
to facilitate coding of the data. From the 60 staff interviews, 28 interviews were sampled using maximum
variation sampling to ensure variation of units and experience of being involved with renal patients. Fifteen
interviews were analysed in the first instance using thematic analysis by IO.41 ST-C independently coded 10
of the 15 interviews. These interviews were selected from four units, which were the first participants
recruited to the study. This sample was selected to ensure variation in units, staff roles and their experience
of being involved with renal patients. Researchers reread the interview transcripts in order to identify
emerging codes and to develop an initial coding framework. A further 13 interviews were selected to ensure
variation of units and experience of being involved with renal patients; they were then coded by IO, ST-C
and a third researcher, CE, using the preliminary framework, which was refined and further developed
into the final thematic framework. Discrepancies were discussed and resolved by consensus. Data from
the remaining 32 transcripts also added to the final thematic framework and facilitated saturation of the
themes, which was achieved when no new codes or themes emerged from the data.
Results
Participant characteristics
Sixty renal staff members were interviewed between February 2012 and November 2012. Table 5
summarises characteristics of all those interviewed and of the 28 staff whose interviews were analysed
using in-depth thematic analysis.
Qualitative findings
Three themes emerged from the detailed analysis of 28 interviews and the analysis of the remaining
32 interviews.
Theme 1: providing conservative kidney management to patients
Many staff discussed how they provided CKM, including what services CKM involved and the resources
available for the delivery of CKM. They also talked about how they viewed CKM and how it could be
improved in their units.
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Staff views about providing conservative kidney management as a treatment option
A variety of terms were used by participants to refer to CKM, such as ‘conservative care’, ‘maximum
supportive care’, ‘non-dialysis care’ and ‘renal palliative care’. For example, the term ‘maximum supportive
care’ was used at unit 8, which had a developed CKM programme with dedicated staff, CKM clinics,
CKM guidelines and CKM funding, whereas unit 3, with a less developed CKM programme, used terms
such as ‘non-dialysis care’.
Consultant nephrologist, unit 8, participant 47: We call it maximum supportive care and I’m sure one
of the things that you’re coming across is that people have all kinds of different names for this.
Interviewer: So do I call it non-dialysis care or conservative kidney management?
Consultant nephrologist, unit 3, participant 13: Well you know, we probably . . . we probably use it . . .
we probably use non-dialysis care. I think perhaps everywhere . . . I think we may change with the rest
of the world where everybody calls it conservative kidney management.
Conservative kidney management was generally accepted by renal HCPs as a treatment option. Many renal
staff described CKM as a valuable option for some patients, particularly for those with multiple comorbidities,
and recognised it as an active treatment, managing the symptoms of kidney failure without using RRT. Some
staff said that not dialysing someone used to be thought of as a failure by medical staff, and talked about
how HCPs had recently started to realise that dialysis was not suitable for everyone. Having CKM as an
established care pathway also helped staff, as they described how they were able to provide something to
patients rather than just not providing dialysis.
When you are dialysing [patients] you know you are doing the most you can, but now because we
have got an active conservative management programme my colleagues feel you know although the
patient is elderly we can still offer them something. So you know, you feel that you can do
something proactive.
Consultant nephrologist, unit 1, participant 1
TABLE 5 Participants’ characteristics
Characteristic 60 participants interviewed
28 participants whose interviews
were analysed in depth
Gender (n)
Male 13 7
Female 47 21
Age (years)
Median 49 47
Range 28–67 36–67
Job title (n)
Nephrologist 22 14
Nurse 25 9
Palliative care consultant 1 0
Allied health professional 12 5
Time at current unit
Median 9 years 10 years
Range 9 months to 40 years 10 months to 31 years
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While many described CKM as a valuable alternative treatment to dialysis, there was one nephrologist who
did not hold this view.
There are amazingly few [CKM] patients [in our unit], whereas most people’s conservative care clinic is
filled with people who do not currently need dialysis, who may or may not need dialysis at some point
in the future, but it has been decided that they will not get dialysis, at that point in the future. And so
these are the same people that we are treating in our nephrology clinics for chronic kidney disease,
Stage 4 and 5 [. . .] We remain unconvinced that this is a useful concept for – for managing people
with kidney disease. It doesn’t add anything to what we do at the moment.
Consultant nephrologist, unit 4, participant 23
Many interviewees recognised that there were some patients who unexpectedly responded well to dialysis,
while others did not respond well and experienced complications as a direct consequence of the
treatment. Some staff reported that they sometimes found it difficult to assess whether patients were
suitable for RRT or CKM and wondered if they had given their patients the right treatment for them.
I think most of the nephrologists will find it very tricky when a GP sends you a 90-year-old lady with
multiple comorbidities, with a GFR [glomerular filtrations rate] of 10 – how do you approach that? Do
you say – well you are going to die – without dialysis; you are probably going to die with dialysis – and
on dialysis and you’re probably going to have worse quality of life; I really don’t know.
Consultant nephrologist, unit 4, participant 22
Resources available for conservative kidney management vary
Resources available for delivering CKM varied across the units. For instance, only unit 8 had funding
dedicated to providing CKM. Some of the units without such funding used alternative funding to develop
general CKD services, which partly contributed to the delivery of CKM.
We won a bit of money and what we used that to do was to set up the Cause for Concern Register,
the two renal resource days and also communications, so myself and [nurse’s name] have done the
advanced communication course, but we want to now – for the whole of the renal services so every
consultant, every specialist nurse will do the enhanced communication training. So that’s going to
happen in the next year; so that’s what we use our funding for.
Consultant nephrologist, unit 7, participant 42
Many staff did not have allocated time for CKM patients, and their time for CKM was integrated into their
normal workload. Some units did have dedicated CKM staff and stressed the importance of having staff
who had dedicated time to treat CKM patients. Unit 8 had a dedicated palliative care nurse treating CKM
patients as part of CKD patients approaching end of life.
We have a palliative care nurse. I mean one of the things that stops people doing [CKM] is that they
know that if they sit down and have a conservative care conversation with someone, that takes an
hour. One of the things that’s helped us to do [CKM] over the last couple of years is that we
have a dedicated palliative care nurse who can spend all that time having those conversations.
We have a dedicated palliative care nurse who can then do all the set ups to the hospice and get all
the home care organised.
Consultant nephrologist, unit 8, participant 47
Some units provided their staff with training, which was perceived to improve staff’s confidence to deal
with patients who were approaching the end of life, including CKM patients.
We have undergone quite an intensive staff education programme, communication skills mainly; we’ve
done it across the board from clerical staff to doctors, right the way across nursing staff, and it really
just helps patients. It’s dealing with a distressed patient, so say, somebody on dialysis says – I’m fed up
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with this, I really don’t want to carry on, I’m quite certain some of our nurses beforehand would have
said . . . , I don’t know what to say, so I’ll pretend I didn’t hear it. Now they feel more empowered.
So we have champions in each area now, who do feel competent in discussing end of life or death
and dying.
Consultant nephrologist, unit 8, participant 47
Many staff reported that patients’ CKM decisions were recorded in their medical notes or database. Some
also pointed out that having a clear record of the CKM decision not only within the renal unit but also in
the primary care record was very important. Adequate recording was thought to minimise inappropriate
hospital admissions and/or dialysis.
I think one of the most important things we do is make a clear record of the decision about dialysis in
the hospital and in the primary care records . . . certainly in my letters it says please make it very clear
for the out-of-hours doctors, that if they become unwell they would rather not be admitted to hospital
and rather not be, you know, started on dialysis.
Consultant nephrologist, unit 5, participant 32
Service components of conservative kidney management
All staff mentioned that CKM offered assessment and management of symptoms caused by CKD.
However, the way CKM patients were seen and what service they received varied between the units.
At some units, especially those without CKM clinics, CKM patients have the same pathway as pre-dialysis
patients until they reached the point when they would have started dialysis if it had been their
chosen treatment.
[Patients on] conservative care do all the same [as dialysis patients] up to this point; counselled,
chosen, coming back to clinic on anaemia treatment, [GFR] 8 to 10 they start getting symptomatic,
then the nurses start visiting. They don’t start doing anything between [GFR] 15 and 8–10, they are
not sort of having a different pathway at that point from anybody else, so they have got the same
symptoms as the people that would start dialysis. They are not different at that point.
Consultant nephrologist, unit 6, participant 36
Unit 5 also did not have CKM clinics and a consultant nephrologist reported that they saw their CKM
patients less often than in a hospital with CKM clinics and that they mainly monitor patients rather than
actively manage them.
[At (a hospital name)] it looks like they see [CKM patients] much more often, they see people as if it is
an active treatment. For us, we bring people back in 4 months and do a blood test, there is not a lot
you can do every 4 months when you are seeing somebody and it sends out the message that well,
we are just monitoring things.
Consultant nephrologist, unit 5, participants 32
There were units that had a multidisciplinary approach towards CKM patients. Unit 9 had dedicated CKM
clinics and a nurse explained that they provided not only medical but also social care to patients.
If they come to the [CKM] clinic and we ask them very generic things about their social life, how
things are going, do you need any more carers putting in, how is the carer, are you managing –
mum’s not well, she had a fall. We do all that and then [nurse’s name] does a medical assessment;
so they get a social assessment if you like, dietetic assessment and a medical assessment, all in one
clinic. And then we’ve got our helpline, our phone as well.
Nurse, unit 9, participant 54
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All staff discussed that patients on CKM received palliative/supportive care when they started to approach
end of life. Some units mentioned the importance of providing patients with a smooth and timely
transition to end-of-life care, which usually happened in the community or at a hospice. Staff from unit 2
reported that they monitored CKM patients carefully so that they could plan the end-of-life care for
patients proactively.
We do our RAG [red–amber–green] rating, so we have red–amber–green rating for patients who are
on conservative management. We are trying to identify those that would you be surprised if they
are here in 3 months? [. . .] When the liaison nurses see one of the conservative management patients
in clinic, they attend the clinic visit with them, do their RAG rating and come and readjust it on the
supportive care register, and then raise those patients that are flagging up and moving and changing
on the register, so you’re becoming more concerned about them. You would raise them at that
[quality assurance] meeting and then at that point the liaison nurse should not only have highlighted
the increasing need but have actioned it. For example, they would have said, ‘We are thinking of
introducing them to the hospice’, ‘I’ve been in touch with the community nurses’, ‘I might have had a
conversation with the GP’. We have started an advanced care plan, a social worker would often go
out and arrange another home visit to see if there was a carer problem.
Consultant nephrologist, unit 2, participant 7
Staff views about organisation of conservative kidney management
Units 1, 8, and 9 had dedicated CKM clinics. Staff in units without dedicated CKM clinics saw CKM
patients in low-clearance or general nephrology clinics. Some units had a small number of CKM patients,
and staff discussed not needing dedicated clinics because of this.
[CKM patients] aren’t seen separately. We don’t have a non-dialysis care clinic. I suppose in the future,
depending on numbers isn’t it, because what will happen to non-dialysis care patients is they will die
off. You know so that the numbers don’t grow huge.
Consultant nephrologist, unit 3, participant 13
In contrast, some talked about the need for such clinics, as they would be likely to help provide better
quality of care.
We do feel that it is important for us to develop some sort of service which would be dedicated to the
conservative care and that’s one of the driving forces for us to probably think that we should have
some sort of dedicated clinic. And one of the advantages of having a dedicated clinic for the
conservative care, would be that we could at least spend a bit more time [with patients].
Consultant nephrologist, unit 6, participant 38
Some said that setting up dedicated CKM clinics would not be supported by consultants because they
would then lose any continuity of care.
They want to see their patients through, whether they’re dialysis patients or conservative patients, or
transplant patients. They want to be able to deal with the whole group of patients rather than . . . as
soon as they make the decision then another consultant looks after them.
Nurse, unit 5, participant 30
Conservative kidney management patients were also seen by GPs and the community team towards the
end of life, and this was mostly as a result of the patient’s preference. The size of geographical area a unit
covered also affected how the unit cared for CKM patients. For example, unit 7 encouraged patients
to be cared for by primary care teams once patients had chosen CKM, and they cared for patients in
collaboration with GPs and community teams. This is mainly because the unit covered a large geographical
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area and many of their patients needed to travel a long way to come to the renal unit. Consultants
from the unit questioned if it was fair to bring CKM patients, who were usually old and frail, to the clinic
when the same care could, in theory, be given in the community.
[CKM] patients want to be followed up in the community and I think that suits them. [Patients] are
enjoying what life they have and they are more likely to die at home, rather than coming into hospital
and relatives having to take days off just for me to check a blood pressure. I don’t add any value at
that point and I know some units tend to bring them back and I don’t approve, I don’t agree with
that; I think it’s not fair.
Consultant nephrologist, unit 7, participant 42
This approach was not supported by all, as other staff had doubts about the quality of care delivered by
units that mainly saw CKM patients remotely.
When we started we learnt a lot from [other unit]. You know I think [other unit] had a good [CKM]
programme on paper but when the nurse actually went there, they were doing things by remote
access if you know what I mean? Sort of phoning the GP and saying do the bloods, it’s not the same
as seeing to the patient. So on paper you could have a lovely conservative management programme
but how much of that is . . .
Consultant nephrologist, unit 1, participant 1
How to improve conservative kidney management within units
Many members of staff mentioned that they would need more involvement from primary care and
palliative care teams in order to improve the current way of providing CKM in their units. Some described
that they needed a more formal process to support GPs by providing information about renal management.
Interviewer: Do you give any sort of notes about symptom control to the GPs?
Consultant nephrologist, unit 7, participant 42: To be honest, we haven’t got a formal process but the
[name] strategy has developed a conservative managed pathway and on that they’ve got a lot of work
on symptom control. [. . .] We are in the process of doing our own renal LCP [low clearance pathway].
So I think once the [name] strategy has been agreed, then we can sort of disseminate that or put that
on to the PCT [primary care trust] drug website. [. . .] But you’re right, I think we need to perhaps
formalise that and get that [name] strategy conservative management out there, more locally and
regionally – which is the plan really.
Staff perceived that more resources were needed to improve CKM in their unit. Some mentioned that they
would need more nurse time, and others talked about the importance of having a psychologist or a
counsellor available. There was also an issue regarding the Payment by Results tariff system, as it was
difficult to see CKM patients under the current payment system because CKM patients might require
longer consultations than other CKD patients.
I’d like to have a psychologist on board. [. . .] Give a counselling type of psychological service. I’ve
heard of a project that one hospital is doing where they have got funding to support a day a week or
a day a month at one of the local hospices for, specifically for, renal patients, for conservatively
managed patients, to go to.
Nurse, unit 1, participant 6
The hospital gets paid by the number of patients it sees. So if I’ve got a 4-hour clinic – my follow-up
slots are 15 minutes each, so I can see about 16 kidney disease patients and 15 minutes for a kidney
disease patient is enough. So my manager is very happy because I maximise my income. If I’m seeing
conservative care patients, then the whole thing takes a bit longer and the chatting and planning for
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this is what will happen and involving the palliative care team etc., I may not be able to see 16 patients,
I might be able to see only 10. So I get paid the same salary, whether I see 15 patients or 10 patients,
so the manager will be wondering why am I paying you more and you are earning less. So the current
way – at least in England – the way the tariff system works is that it doesn’t differentiate between the
needs of the patient.
Consultant nephrologist, unit 5, participant 27
Theme 2: discussing management options to patients
Informed choice and open discussion with patients were discussed as key issues for treatment decision-making.
Many staff also described the involvement of family in decision-making as very important especially at an early
stage so that patients and family members have enough time to think about treatment options. Some staff
pointed out that deciding whether to have dialysis or CKM could be difficult for some patients; similarly
explaining CKM could be difficult for some staff. Staff also recognised that there were patients who later
changed their minds to have dialysis after opting for CKM.
Supporting patient informed choice
Most staff said that they discussed CKM as an option with all patients, although some staff explained that
discussions about CKM options with patients depended on the consultant’s preference for CKM.
From my point of view, conservative management is very dependent on the consultant in this unit.
And some of the consultants will do very good teaching on different options or help the right patients
make very good decisions not to have dialysis.
Nurse, unit 5, participant 30
All staff members talked about the importance of informed choice and open discussion with patients,
and stressed that if patients wanted to choose CKM they should be fully informed and understand what
it involved.
I would have a very open discussion with [patients who chose CKM], just making sure that they
understand what they are saying, because you get the odd patient says – oh – I don’t want
dialysis – but what they mean is – I don’t want it now, but maybe later. So we want really for
them to be sure that they are understanding what they are saying.
Consultant nephrologist, unit 9, participant 57
All staff also acknowledged the importance of patient choice in deciding whether or not to opt for CKM.
They feel that they are having the treatment to please us as much as anything. Important that they
know it’s got to be a choice, a choice they have. [If dialysis is] just too much for them then that’s got
to be their choice.
Nurse, unit 3, participant 15
Staff explained that they would try to take a neutral stance when discussing treatment options with
patients so that patients could make their own choice.
The way that a patient will decide is obviously critically influenced by what we tell them. So it’s very
important that we portray things in a neutral way initially because if we start the conversation by
saying – you’re very ill, I don’t think dialysis would help you very much – and do you want to have
[dialysis]? You are kind of creating a self-fulfilling answer in a sense. So [nurse’s name] spends a
lot of time talking about the risks of dialysis as well as the benefits and then brings in the effect of
comorbidity on the overall success of things.
Consultant nephrologist, unit 7, participant 46
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Other staff, however, explained how they would provide a more guided explanation to help patients
make a decision. This usually happened when it was obvious that patients would not benefit medically
from dialysis.
[Patients] have numerous comorbidities and you often think, from a medical assessment, what would
dialysis offer these patients? I think it’s only over the past few years, maybe, that we are getting more
honest with these patients and we are actually saying by having dialysis it might actually shorten your
life span, because you’ve already got these problems. And then we talk about quality of life and how
dialysis will impinge on what they do now, and all those things are talked about over a period of time
and then patients say – it’s not for me. I think some of them are guided by us being honest about
their medical condition.
Nurse, unit 9, participant 54
Some staff showed a more flexible approach, changing their stance depending on the situation. For example,
the above-mentioned consultant (participant 46) also described how he tailored information for patients
who he thought would not medically benefit from dialysis.
If it’s somebody that I think might not benefit from dialysis and might wish to make a conservative
decision, once they understand things, I’ll usually say to them something along the lines of – there are
some situations and combinations of problems where dialysis isn’t always as successful as in other
patients, some sort of fairly soft introduction to it like that – and then say to them we should talk to
you more about what dialysis will and will not do for you.
Consultant nephrologist, unit 7, participant 46
Family involvement in decision-making
Interviewees recognised the important role family and carers could play in decision-making, but patients’
wishes were construed as the most important. Many staff mentioned that it was important to discuss
treatment options with patients early on in their pathway, giving patients, their family and their carers time
to think about the treatment options available.
There are situations where families near the end come and say – I want my father to have
dialysis – and you have to say, well, your father has got capacity and it’s what your father wants that
guides us, not what you want, because it’s natural that you don’t want to lose people. But that
discussion does have to happen sometimes that families can’t demand that their elderly, frail parent
gets dialysed against our wishes and the parent’s wishes; you have to explain to them that – and
that’s one of the reasons that having a discussion early is so important.
Consultant nephrologist, unit 7, participant 46
Difficulties that staff experienced in discussing treatment options with patients
Many staff reported that there were some patients who had not discounted dialysis as a future available
treatment option although they had decided not to have dialysis currently. Staff emphasised that it was
very important to distinguish these patients from those who actively chose CKM.
[Patients] don’t want dialysis but actually when you talk to them more they say they don’t want
dialysis and then they say some phrase like, ‘But if it came to it I’d consider it,’ and you have got to be
really careful that you don’t accidentally put them in the conservative care box because actually they
are not conservative care, they are I’m not deciding until I have to box, and you have to make sure
you do keep revisiting it with them and trying and get them to understand that.
Consultant nephrologist, unit 6, participant 36
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Some staff described how they understood the difficulties that patients had in making their decision and
explained that it was also difficult for renal staff to explain CKM. This difficulty was perceived as being due
to a decision having to be made about a future treatment option.
We haven’t been very successful in putting them in positions where explaining that we are talking
about a decision for when you become symptomatic not about a decision [when you] feel fine at the
moment. It’s that abstract . . . that sort of what if, theoretical situation that [patients] might come to in
the future.
Consultant nephrologist, unit 5, participant 32
Difficulty in discussing CKM with patients could be amplified by the fact that staff would need to explain
CKM positively while making patients understand that they would consequently die of kidney disease.
It is all very well to talk about CKM as a management strategy, but the nitty gritty is [not talked
about], [CKM] is appreciated as it’s something you die of? I think that’s sometimes where it falls
down. People feel [CKM] is sort of woollily described and very supportive and sort of warm and fuzzy
but . . . at the end you must actually understand that it is ok to die from it too. I think sometimes we
try to present it in a sort of a very watered down version to make it more palatable to patients when
in fact misunderstand upfront that and then you won’t necessarily have the people suddenly changing
their minds and when it comes to the point of, ‘Oh am I going to die of this now, I didn’t realise?’
Consultant nephrologist, unit 2, participant 7
A lack of experience in discussing CKM was also perceived as a factor which could mean some junior staff
members struggled to discuss CKM with patients.
Some of the more junior nurses do feel very unconfident making a comment about conservative care.
They feel very unhappy about it. We’ll try and get [patients] to one of the senior doctors or [name],
our most senior nurse, because I think that we are the people who probably have most experience.
I’m not saying we are necessarily better but we have the most experience of trying to take people
through these decisions.
Consultant nephrologist, unit 8, participant 47
Interviewees reported holding many meetings and discussions between the patient and the renal staff over
a period of time to facilitate this decision-making process. Some staff described how a good relationship
with patients helped discussions about CKM and treatment options.
[Talking about CKM with patients who do not want to talk about it] is hard, because I think you have
to just be so aware and you have to be really clear about what is going on here for this person. [. . .]
Because I think that one of the things that is really important is about the relationship you have with
someone. And if you’ve been able to build a relationship then I think it enables some difficult things to
be discussed.
Clinical counsellor, unit 2, participant 9
Related to building a good relationship with patients, interpersonal continuity by the same staff was
mentioned. Unit 9 conducted a patient care survey, which revealed that their patients had been well
supported by being seen continuously by the same staff members.
The thing is with that clinic, what I think makes it work is they see the same nurse and the same
doctor all the time; there’s not a mixture of people. So we get to know the patients and that comes
out in the survey [we conducted with patients about care]; what came back was very positive: they felt
supported and that seeing the same people was beneficial.
Nurse, unit 9, participant 54
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Patients who change their mind about having dialysis
Many staff reported that some patients who had opted for CKM suddenly changed their minds to have
dialysis. This was not considered preferable by renal staff, as it usually involved creation of a temporary
catheter, which would increase the possibility of infection and other complications. This happened mainly
when patients became symptomatic and deteriorated significantly, or when their family wanted them to
have dialysis. The number of CKM patients who changed their mind, however, appeared to vary between
units. There were many such patients in unit 5.
Because I had a meeting last week with [name] talking about [hospital’s name] experience, and she
talks about no patients changing their mind there and I wonder whether that is, because they have a
much more standardised, consistent approach and they are much more focused on low clearance,
along with the conservative kidney management work. I do think that within our practice there are
more people changing their minds. So I’m surprised that is her finding, but my experience is that quite
a lot of people, a substantial proportion, change their minds when they become symptomatic.
Consultant nephrologist, unit 5, participant 32
One staff member from unit 9 reported that they had only six CKM patients who changed their mind over
the last 6 years. Several factors that might have helped minimise the number of such patients were
talked about.
I think education is important; I think getting the family on board is important. I think having a clinic
makes it almost like it’s a treatment, well it is a treatment and I think the thing to remember with
these patients is, most of them, if not all of them, would die of something else. They are dying of
cardiac or a stroke or of something else, so they don’t get to the point where they might need to
change their mind, because they are old and frail, and they die of something else.
Nurse, unit 9, participant 54
Once patients made a decision to opt for CKM, many staff considered it important to revisit the patients’
decision from time to time in order to check their understanding of the treatment and whether or not they
would like to change their mind.
I always revisit [patient’s CKM decision] with them, obviously not every single time they come. But,
reasonably regularly because it’s important, otherwise they’ll say ‘no one told me . . . I didn’t know I
wasn’t going to be on dialysis’ and also people change their mind, that’s the other thing once they
become more symptomatic they maybe get a bit frightened and want to think about possibly dialysis.
Or they get tipped into end stage for another reason and they then revisit their decisions. You always
have to revisit people’s decisions.
Nurse, unit 8, participant 32
Theme 3: working with other health-care professionals to provide care for
patients approaching the end of life
Once patients were identified as approaching the end of life, staff described how they then started to talk
about issues related to end-of-life and palliative care with patients. Such patients were mostly referred
back to the community and cared for by GPs and palliative care teams in collaboration with renal units.
Many staff explained their important role for the care of patients approaching end of life.
Discussing end-of-life issues with patients
Staff reported that they would discuss end-of-life issues with patients once they were identified
as deteriorating.
Most patients can probably manage till the GFR [glomerular filtration rate] is about 10 or so and when
it gets less than that, often even coming to clinic is quite hard – and it’s at that stage where the
most likely life expectancy is less than 3 to 6 months – is when we start negotiations with the local
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palliative service – community palliative service to get involved. Usually around that time we also
start talking to them about preferred place of death and have that conversation also – hospice versus
hospital, et cetera.
Consultant nephrologist, unit 5, participant 27
When asked about their experiences of discussing end-of-life issues, staff tended to relate their experiences
to patients who were withdrawing from dialysis. It was reported that discussing palliative and end-of-life
care with patients could be difficult for some renal staff. Some staff explained that, however, open
discussion and being honest was important to patients when discussing these issues.
I have to be honest, some of the doctors are still hesitant [to talk about palliative and end-of-life care
with patients] and it becomes very difficult because most doctors don’t have a formal training and it
becomes especially very difficult if somebody is on dialysis and you see in front of your eyes that they
are deteriorating and we encourage the doctors to ask the surprise question*, and then think about if
they think that the prognosis is very poor, at least to be honest to them and start planning their care
plan, so that at least things are in place.
Consultant nephrologist, unit 6, participant 38
*Would you be surprised if this patient died in the next year?
Nurse, unit 9, participant 54: We are quite open, your kidney function will start to deteriorate, we can
start to think about where you want to be, planning where you want to be – we’re not saying it’s
going to happen now. No one knows when you’re going to die but you want to make light of it if
you can, but we need to be seriously thinking, do you want to be at home, do you want to be at
a hospice.
Interviewer: They don’t get upset when you talk about [end-of-life care]?
Nurse, unit 9, participant 54: No, they don’t, I think they prefer when you’re open. I was with a chap
yesterday on the ward who wants to stop dialysis and we had this very open conversation about death
and dying.
Working with primary, community and palliative care services
All staff reported referring their CKM patients back to their GP at some point, especially towards the end
of life. Many stressed that they provided support for the primary, community and palliative care teams to
share their care with them. Patients were usually referred back to the community when they preferred
to be seen by GPs and/or when staff thought there was no value for patients in coming to the clinic
because of their physical circumstances, as GPs could provide the same care in the community.
We tend to continue seeing them in clinics while they feel well enough and able to come. But as
soon as they feel it’s just too much we are not going to force them into coming, drag them to clinic.
So they will be looked after by their GP. Some patients we’ve gone out and seen at home ourselves.
But that’s more of a keeping in touch and keeping continuity for them rather than particularly doing
anything. We rely much more on the palliative care and GP by that point.
Nurse, unit 3, participant 15
Providing education and support for other health-care providers
Many staff talked about the importance of providing primary care, community and palliative care teams
with education and support to help them care for patients with CKM and to help with the management
of ESKF. Some staff also recognised that GPs and palliative care nurses were sometimes hesitant to be
involved with renal patients. In order to improve the situation, there were units which provided GPs with
written guidelines for managing ESKF held some clinical meetings for GPs and had an exchange education
programme between renal nurses and palliative care nurses, where renal staff spent a week at a hospice
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while hospice staff stayed at the renal unit. Some staff reported that such meetings were well received and
were perceived to improve the confidence of GPs and other members of staff.
What we commonly face is once patients are diagnosed with kidney disease, then the GPs are very,
very hesitant to get involved, even with the minute amount of issues. So in order to support the GPs,
we have conducted a few clinical meetings where we’ve talked about conservative management in
those meetings as well. [. . .] It’s a GP forum where we invite all the GPs from the whole catchment
area and we do have a good attendance as well and we tend to organise that every year. We are in
the process of developing a GP leaflet as well, about symptom management in conservative care, just
to help them out.
Consultant nephrologist, unit 6, participant 38
Summary
Main findings
This is the first qualitative study in the UK exploring renal staff’s views and experiences of treating patients
who choose CKM. CKM was generally accepted by renal staff as a treatment option; however, they had
mixed views concerning CKM, which were reflected in the varied terminology that was used to describe
CKM. Most considered that CKM offered a valuable treatment option for patients, while some did not
perceive that CKM offered an alternative to standard care. Most staff commented that it was difficult to
assess whether patients were suitable for RRT or CKM, but all were very supportive of having open
discussions and of informing patients of their treatment options, and ensuring that family members were
involved in this decision-making process. While many staff considered that it was important for patients
and their family to make their own decisions based on the information that they had been given, some
had a more directed approach and would guide patients to a decision, particularly if they felt that patients
would not benefit from dialysis. Decision-making about treatment options, including about CKM, was
acknowledged as challenging for both patients and staff, as this often concerned future treatment.
Explaining CKM to patients was also found difficult because staff would need to discuss the consequence
of CKM (death) with patients while explaining the treatment positively. There were also some CKM
patients who suddenly changed their minds and opted for dialysis, and many staff emphasised the
importance of revisiting patients’ decision over time, implying that the decision-making was a process
rather than a one-off event. It was perceived that having a good relationship with the patient and
interpersonal continuity would facilitate good decision-making. Towards the end of their life, CKM patients
were often referred back to their GP, and it was vital for renal units to work in collaboration with the
primary, community and palliative care teams, often supporting them to care for CKM patients by
providing them with renal-specific education.
Comparison with existing qualitative research
Only a few qualitative studies have explored renal staff’s experiences with patients on RRT.44,50–51 None
have focused on staff’s experiences of being involved in the care of patients on CKM. Despite this
difference in focus, some of the previous literature can be related to our findings.
Much of the previous literature has explored the difficulties renal staff face when making the decision
whether or not to initiate dialysis and/or to withdraw dialysis.50,51 This may be because it was difficult to
assess whether or not dialysis would be in the patient’s best interests and good for their quality of life.
Consequently, staff members wished to have more time for careful and open discussions with patients
and their family.51 The current study also identified that staff found it difficult to assess whether patients
would be more suitable for dialysis or CKM, and many staff recognised the importance of having open
discussions with patients and family. Previous work also identified that renal staff tended to avoid
discussing prognosis and end-of-life issues, and many believed that such discussions would be interpreted
as negative and would diminish the patients’ hope.44 Discussing end of life at an early stage was also
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perceived as ‘not practical’ and challenging for renal staff, who tended to engage in such conversations
at a later stage or only when prompted by patients.44,53 Our findings concur, as renal staff held similar
views; for example, some staff might face difficulty in discussing the consequence of choosing CKM
(i.e. end-of-life issues). It was also recognised in a previous study that having an ongoing relationship
between renal staff and patients, and continuity of care was essential to good communication for
end-of-life issues,54 and renal staff in this study also held the same views. The current study also
demonstrated that the decision whether to opt for CKM or not was a decision patients had to make
for their future treatment. Staff discussed that many patients found this difficult, and some who had
opted for CKM would consequently change their minds and request dialysis when they became more
symptomatic or when their family wanted them to have dialysis. This implies that decision-making about
their treatment options is an ongoing process rather than a one-off activity, and is a product of an iterative
process of information assessment as suggested by other literature.55
In previous studies, not having dialysis was perceived as implying imminent death by both patients and
renal staff, and this perception made it difficult to discuss issues around not initiating or withdrawing
dialysis.50,51 This perception was not shared by the participants in this current study. Instead they perceived
CKM as an active treatment option that could help with the management of symptoms of kidney failure
without using RRT. Other studies have suggested that renal staff were also burdened by having sole
responsibility and by being the final decision-maker in life-or-death decisions for patients.50,51 In the current
study, however, renal staff emphasised the importance of patients’ informed decisions, which facilitated
patient choice in the decision whether to opt for CKM or not. Open discussion was seen to enable patients
to make their own choices and also alleviated the burden on the renal staff of making treatment decisions.
Strength and limitations
This is the first study to explore renal HCPs’ views and experiences with patients who opted for CKM.
The strengths of this study include the participation of a wide range of renal HCPs from units from a range
of locations and a range of CKM practices. However, as the primary aim of this qualitative study was to
explore the key issues surrounding CKM practice patterns, we recruited only HCPs who were involved in
the care of CKM patients. As a result, it is likely that only individuals with an interest in CKM were
interviewed in this study, and levels of renal staff’s keenness or willingness to provide CKM in the UK in
general may be much lower than shown in this study. A further limitation is that the researcher’s presence
during the data collection might have elicited socially desirable responses from the study participants;
however, the researcher presented as an impartial observer rather than being actively engaged with the
participants during the data collection. Furthermore, collecting data through interviews does not allow us
to open a window on events as they happened but can instead provide insights into how participants
construct their experience of the event. These findings resonate with other literature and, although
qualitative findings cannot be generalised to other populations, the data can sensitise us to important
issues and can offer transferability to other populations and to other settings.
Implications for practice
The findings of this study showed that renal staff faced challenges in discussing CKM and/or end-of-life
issues with patients. The provision of education, such as training regarding communication skills, CKM
and/or end-of-life issues for renal staff, may be beneficial. Better decision aid may also help facilitate
discussion about treatment options. Staff in our study also expressed that they sometimes found it difficult
to assess whether patients were suitable for RRT or CKM, and this may make staff feel less comfortable
discussing CKM with patients. Research which compares outcomes between patients who receive
CKM and similar patients who receive RRT will inform shared and informed decision-making when
contemplating the suitability of CKM and RRT for a patient.
Our study also demonstrated that working together with primary, community and palliative care teams
was key to the provision of care for CKM patients, emphasising the importance of communication
between renal units and those services. A clear record of the CKM decision in the primary care record will
be of benefit in minimising inappropriate hospital admissions and/or dialysis. Educational support for
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primary, community and palliative care teams regarding the care for CKM and renal patients in general
can facilitate this process. This may involve developing a formal strategy for knowledge translation that
includes better educational tools and measurement of the effectiveness of those tools.56 In this study some
units described providing educational material to other HCPs, which renal staff reported was successful;
however, the effectiveness of such education is still not clear. Research is therefore also needed to
understand the effectiveness of specific education/interventions.
Currently there is no financial payment for CKM under the Payment by Results tariff scheme and this was
pointed out as a barrier to seeing CKM patients in general nephrology clinics. The current Payment by
Results system may need to be reviewed to support the provision of CKM. There is a need to increase
opportunities for units to obtain funding dedicated to providing CKM.
There is also a need for more standardised terminology for CKM in the renal community, which will enable
accurate communication for clinical and research purposes.
Conclusions
Conservative kidney management is generally accepted by renal staff, and perceived as a valuable option
for patients who would not medically benefit from dialysis. Patient informed choice and open discussion at
an early stage of the patient illness trajectory were considered important, even though staff reported
difficulties in discussing CKM as an option with patients. Providing staff with training about communication,
CKM and/or end-of-life care would facilitate the decision-making process. A more standard terminology
for CKM is needed, as different terminology may lead to different conceptualisations about CKM.
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Chapter 4 Conservative Kidney Management
Assessment of Practice Patterns Study survey: the
delivery of conservative kidney management in UK
renal units – a national survey
Introduction
This national survey of UK renal units addresses all the main objectives of the CKMAPPS project,
namely (1) to understand the scale and patterns of delivery of CKM; (2) to explore how decisions not
to have dialysis are made; (3) to explore clinicians’ willingness to randomise patients with CKD5 to
CKM versus dialysis; (4) to describe how renal units and primary care work in managing CKM patients;
and (5) to identify the resources involved in delivering CKM.
Only a small number of surveys on practice patterns in renal units have been conducted in the past,
and none outside the UK to our knowledge. Gunda et al.31 surveyed the pattern of provision of palliative
care for ESKF in the UK, reporting a significant variation in provision of such care across the country.
While lack of resources was identified as a major problem, they indicated that palliative care might
be given a low priority in some geographical areas. In order to provide a more adequate service for ESKF,
existing palliative care services would need to be made available also to non-cancer patients.31 Another
national survey of renal units in the UK surveyed services for CKD patients in 2004, and found that
the organisation and delivery of pre-ESKF care were variable across the units. It also identified some
barriers to the development of services for CKD patients, which included lack of a full complement of
multiskilled renal team (MSRT) in many units, problems of geographical accessibility to pre-ESKF care and
lack of sociopsychological support.57
These studies provide insights into the practice patterns of provision of services for CKD patients and for
those who need palliative care in UK renal units. Their data were, however, published in 2005 and in
2006, and since then CKM has been established as a treatment option in many UK renal units. CKM is
one of the fastest-changing areas of renal medicine,58 and there is a need to understand how it
is delivered nationally.
Methods
Survey development and distribution
The content of the survey was developed based on existing literature and findings from the staff
qualitative study and feedback from the steering group.
Based on the staff qualitative study, the following main themes were identified as areas to investigate:
how CKM is provided (service components, resources available for CKM, future improvement); how CKM
is discussed with patients; and roles of primary care and palliative care services. Using the staff interview
guide, interview questions regarding the above areas were selected and revised to make them more
suitable for the survey questions. Data from the qualitative study also helped to organise multiple-choice
options under each question.
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The draft survey was piloted using cognitive interviews with three nephrologists and one renal nurse
specialist. Two forms (web-based and postal) of the survey were used. The survey focused mainly on the
management of patients aged 75 years and over with ESKF (CKD5) who did not or had opted not to have
dialysis (i.e. who were on CKM). In order to supplement the renal unit data publicly available from the UK
Renal Registry, the survey also included general questions regarding the management of patients with
CKD (see Appendix 3 for the survey).
Contact details of clinical directors from all 71 UK renal units were obtained from the UK Renal Registry,
and both versions of the survey were sent to them in March 2013. Telephone and e-mail follow-ups were
conducted after the first mailing in April and May 2013.
Data analysis
Data analysis was conducted using basic statistics. Cross-tabulation was conducted to explore the relationship
between practice patterns and selected key factors which we hypothesised might lead to differences in
such patterns. These were factors related to the general unit organisation for patients with CKD; the size
of units in terms of numbers of CKM patients; and resources available for CKM (e.g. funding). Closed-ended
questions related to the above factors in the survey were selected for the analysis (see Appendix 4). Units
were categorised into two groups, larger and smaller, based on responses to questions on numbers of CKM
patients and numbers of symptomatic CKM patients (see Appendix 5 for details). We related unit size to
the number of patients aged 75 years and over on RRT derived from UK Renal Registry data on prevalent
RRT in 2012.
We tested for associations using these categorical variables using χ2 and Fishers exact test; given the
potential for multiple testing and false positives we report only associations that were significant at
p< 0.01. We report some descriptive comparisons of interest in order to measure how much time renal
staff were involved in CKM, full-time equivalent (FTE) time was asked. A FTE of 1.0 indicates that a person
is equivalent to a full-time worker, or two persons working half-time.
In order to analyse resources and cost to provide services for CKM patients, the following questions from
the survey were used.
l Question 35. Of those, how many were on conservative care and followed up in your unit?
l (This question was under Q34. In calendar year 2012, approximately how many CKD5 patients aged 75
and over were cared for by your renal service?)
l Question 37. In 2012, how many patients aged 75 and over in your unit chose to have conservative
care, became symptomatic of advanced CKD and did not have dialysis?
l Question 39. How much time do the following staff have specifically allocated for CKD 5 patients on
conservative care? Please enter number of fulltime equivalent (FTE) hours for each discipline.
l Question 47. How much annual funding was dedicated to providing conservative care in the 2011/12
financial year (April 2011–March 2012)?
Results
Of the 71 renal units in the UK, 67 (94%) responded (50 of 52 units in England, five of five in Wales,
eight of nine in Scotland and four of five in Northern Ireland). Thirty-seven units completed the web-based
survey and 30 completed the paper one. Of the 67 units, two did not fully complete the survey, and
one unit did not have any patients with CKD5 who made an active decision not to undergo dialysis, so
most of the survey questions were not applicable for this unit. Therefore the total number of responses
was 64 for many questions. Some questions were not answered by all the 64 units so the number of
responses varied by question (Appendix 6 shows the full survey results).
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Services for chronic kidney disease patients
Almost all responding units (66 of 67, 99%) had an MSRT and, of those, 58 of 66 (87%) had regular MSRT
meetings. Half of these teams (33 of 58) met once a week and in 14 units, teams met once a month.
When asked which staff members either were involved in their MSRT or usually attended the MSRT
meeting, most had a dietitian (51 of 58, 88%) and a pre-dialysis education provider (46 of 58, 79%),
but only 18 (31%) and 16 (27%) of responding units had a psychologist and a counsellor respectively (Table 6).
In addition to clinics at their renal unit, the majority of units (59 of 67, 88%) also ran clinics for CKD
patients in neighbouring hospitals. The number of neighbouring hospitals they served ranged from one to
12 per unit, with a median of three.
Many units (56 of 67, 84%) had a formal ‘pre-dialysis’ clinic (or equivalent) for managing patients
approaching RRT. Of those, however, 15 units responded that not all consultants who had CKD patients
used the pre-dialysis clinic. Reasons for this varied: three reported that it was because some consultants
thought that long-term continuity of care by the same consultant was more important, while another three
said it was because some consultants’ clinics were at neighbouring hospitals but the pre-dialysis clinic was
in the main hospital and they wanted their patients to avoid additional travel. Two respondents indicated
that both of these factors were important factors and seven gave other reasons: for example, because
consultants had different clinics; there were different models across their geographical area; and MSRT
members could not support all pre-dialysis patients.
TABLE 6 Staff involved in MSRT or usually attending MSRT meetings
Staff
Staff involved in MSRT or usually
attending MSRT meetings (%)
Consultant nephrologists 100
Renal nurses 97
Dietitians 88
Pre-dialysis education providers 79
Anaemia nurses 77
Renal registrars 76
Vascular access co-ordinators 72
Pharmacists 59
Social workers 53
Palliative care consultants 36
Renal palliative care clinical nurse specialists 34
Surgeons 33
Psychologists 31
Counsellors 27
Specialty and associate specialist grade doctors 26
Occupational therapists 12
Physiotherapists 10
Palliative care registrars 7
Diabetes nurses 3
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The majority of units (54 of 67, 81%) had a pre-dialysis education day (a group session with other
pre-dialysis patients). During the education day, many responding units reported that they covered topics
such as transplantation (53 of 53 responding units covered), dietary restrictions (53 of 53), types of dialysis
(52 of 53), fluid balance (47 of 53), medicines (46 of 53), side effects (45 of 53), CKD-related anaemia
(45 of 53) and psychological support (42 of 53). However, some topics, such as sexual matters (20 of 53),
cardiovascular risk factors (35 of 53), and renal bone disease (39 of 53) were less commonly covered.
Conservative care was included in most (45 of 53).
How consultants shared responsibility of patients with each other varied between the units: 18 of 66
(27%) units shared responsibility, whereas in 19 units (29%) consultants took sole responsibility for
individual patients. Twenty units (30%) indicated that they shared responsibility for most patients but took
a lead role for individual patients with particular needs. Nine units (14%) had more a mixed approach:
for example, they shared inpatients but not outpatients; and consultants had both dedicated patient
caseloads and shared patient caseloads.
Services for patients who chose conservative kidney management
Sixty-six of 67 renal units (99%) had patients with ESKF who made an active decision not to undergo
dialysis even when they were symptomatic. The unit without such patients reported that their patients
were well informed of the possible limitations and side effects of RRT, and RRT was still their choice.
When asked what was the most commonly used word in their unit to refer to CKM, respondents reported
a variety of terms: ‘conservative management’ (30 of 65, 46%), ‘conservative care management’ (8 of 65,
12%), ‘supportive care’ (5 of 65, 8%) and ‘conservative kidney management’ (3 of 65, 5%). Eleven out of
65 units (17%) reported they used more than one term to refer to CKM.
Fifty-one out of 66 units (77%) reported that all consultant nephrologists followed the same practice
regarding CKM patients. The remaining units indicated that some consultants acted differently, their
practice differing only slightly (10 of 15) or moderately (5 of 15) from one another.
Number of conservative kidney management patients
Thirty-five of 67 units (52%) reported the approximate number of CKM patients aged 75 years and over in
their renal unit in 2012. Numbers ranged from 4 to 152 with a median of 45 [interquartile range (IQR),
20.0–83.0] patients per unit.
Thirty-three respondents (49%) provided data on the number of symptomatic patients over 75 years old who
received CKM. Numbers ranged from 1 to 50 patients with a median of 8 (IQR 4.5–22.0). Respondents
who did not provide data reported that it was difficult to obtain numbers for such patients specifically aged
75 years and over, and they did not collect data on whether CKM patients were symptomatic or not.
Following the unit categorisation criteria shown in Box 1 (see Appendix 5 for more details), 24 and 23 units
were categorised as larger and smaller respectively and 20 were unclassifiable because of missing data.
The larger CKM units had more patients aged 75 years and over (median 161, IQR 121–200) than
the smaller ones (median 54, IQR 44–110); those with missing CKM data were intermediate in
size (median 95, IQR 65–164).
The implementation of conservative kidney management
About a third of 66 respondents (23, 35%) had a written guideline (other than a palliative care or
symptom control guideline) on how to manage CKM patients. Eighteen (27%) respondents were
preparing such a guideline.
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Two-thirds (43 of 65, 66%) of units had a single person or small team primarily responsible for CKM. All
staff responsible were consultant nephrologists and/or renal nurses. In two units palliative care consultants
were also involved.
Only 15 of 65 units (23%) reported having clinics exclusively for CKM patients. Only a minority of the
smaller units had CKM clinics (4 of 23), while 10 of 24 larger units had such clinics. Half of the units with
dedicated CKM clinics (7 of 15) ran these once a week in their renal unit. Six units ran CKM clinics outside
the main renal unit but less frequently (once a fortnight/month). Of the units without dedicated CKM
clinics, 22 of 49 most commonly saw CKM patients in pre-dialysis clinics, and 11 in general nephrology
clinics. Patients were also seen at home by their GP or a community team (4 of 49) and by the renal team
(3 of 49). There was no unit whose CKM patients were followed up solely by primary care or
community services.
The availability of dedicated CKM clinics was closely related to whether or not units had staff primarily
responsible for CKM (p< 0.001): units without staff responsible for CKM appeared not to have dedicated
CKM clinics; however, 64% of the units who had staff responsible for CKM practised CKM without
dedicated clinics (Table 7).
A higher proportion of units (18 of 43, 42%) with staff responsible for CKM had a written guideline for
CKM than those that did not have such staff (4 of 22, 18%).
Symptomatic patients were seen more frequently: 34 of 61 (56%) units said they saw symptomatic
patients monthly, while 43 of 63 (69%) units saw asymptomatic patients every 3 months. Nine units
indicated that patients were seen as required.
TABLE 7 Cross-tabulation of relationship between availability of CKM clinics and availability of staff responsible
for CKM
Availability of staff responsible for CKM n
Availability of CKM clinics
Yes (%) No (%)
Yes 43 36 64
No 22 0 100
Total 65 23 77
p< 0.001.
BOX 1 Conservative kidney management size categorisation process
Conservative kidney management size categorisation
Units were divided into two categories based on their responses to the survey questions regarding the number
of CKM patients aged 75 years and over in calendar year 2012 (Question 2.5.1) and the number of patients
aged 75 years and over who stayed on CKM after they became symptomatic in the same year (Question 2.6).
Units that had ≥ 25 CKM patients and/or ≥ 20 symptomatic CKM patients were categorised as units with a
larger size of CKM (24 units), and the rest of the units were categorised as those with a smaller size of
CKM (23 units). (This resulted in including three units that had ≥ 25 CKM patients but had fewer than
20 symptomatic patients in the ‘large’ group.)
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Resources and conservative kidney management funding
Components of conservative kidney management
All units (65 of 65) responded that they provided EPO and iron therapy, and symptom assessment and
management. Most units also provided dietary advice (64 of 65, 99%), prescription of medication for renal
symptoms (63 of 65, 97%), and clinic consultations (61 of 65, 93%) The four units that did not have clinic
consultations provided home visits instead. Seventeen units (26%) reported that an occupational therapist
attached to the renal unit or hospital provided advice on the patient’s home environment, just over half of
units provided some form of psychological support to patients (38 of 65, 59%) and 36 units (55%) provided
home visits by renal staff (Table 8).
Staff resources
About half of the units (28 of 65, 45%) reported that they had staff whose time was specifically allocated
for CKD5 patients who were on a CKM pathway. The larger units were more likely to have such staff
(15 of 24) than the smaller units (8 of 23) (Table 9).
TABLE 8 Key components of conservative care provided to patients in renal unit
Key components of conservative care % (n)
Provision of EPO and iron therapy 100 (65)
Symptom assessment and management 100 (65)
Dietary advice 99 (64)
Prescription of medication for renal symptoms (fluid retention, itching, etc.) 97 (63)
Clinic consultations 93 (61)
Blood results review 91 (59)
Telephone support for patients 88 (57)
Communication with primary care team for Gold Standards Framework approach 80 (52)
Telephone support for carers 79 (51)
ACP 77 (50)
Social circumstances review by social workers attached to the renal unit or hospital 63 (41)
Psychological support 59 (38)
Home visits by renal staff 55 (36)
Advice on home environment by occupational therapist attached to the renal unit or hospital 26 (17)
Other 11 (7)
TABLE 9 Cross-tabulation of the relationship between CKM size and the availability of staff whose time is
dedicated to CKM
CKM size n
Availability of staff whose time is dedicated to CKM
Yes (%) No (%)
Larger 24 63 37
Smaller 23 35 65
No response 18 28 72
Total 65 43 57
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Twenty-four of the 28 units provided data on how much time each staff member had specifically allocated
for CKM patients (see Table 10). Sixteen units had renal nurses whose time was specifically allocated for such
patients. A median FTE of these 16 units was 0.9 (IQR 0.5–1.0). Twelve units responded that consultant
nephrologists had allocated time for CKM patients with a median FTE of 0.2 (IQR 0.1–0.2). Nine units had
either pre-dialysis education providers or dietitians whose time was allocated for CKM patients. These units
had median FTEs of 0.4 (IQR 0.18–1.0) and 0.2 (IQR 0.1–0.35) respectively. The relationship between number
of CKM patients and total staff time dedicated to CKM is shown in Figure 2. Renal registrars, occupational
therapists, pharmacists, counsellors and management staff were reported by up to three units for each.
Twenty-two of 28 units (79%) with staff whose time was specifically allocated for CKM patients had staff
primarily responsible for CKM, whereas 54% of the units (20 of 37) without such dedicated staff had
staff primarily responsible for CKM. Half of the units with dedicated staff (14 of 28) had a written
guideline for CKM, whereas fewer than a quarter of the other units (9 of 37) had a guideline. Units with
dedicated staff were more likely to have dedicated CKM clinics (10 of 28) than those without (5 of 37).
Many units with dedicated staff provided staff with formal training about CKM (20 of 28), whereas only
one-third of other units had such training (13 of 37) (p= 0.009). Twenty-one out of 28 units with
dedicated staff had a written guideline for renal end-of-life care, whereas only fewer than half of the other
units (15 of 37) had such a guideline.
Specific funding
Only 10 of 65 units (15%) had funding dedicated to providing CKM in their renal service. Of those,
seven units reported that it came as part of routine NHS income, while one answered that it came from
non-NHS sources, and two received funding from both NHS and non-NHS sources. Only 5 of 10 units
that had CKM funding were able to provide the total amount; the median amount was £40,000
(range £3942–£101,300).
Funding availability was significantly related to whether or not there were staff whose time was specifically
allocated for CKM patients and to the number of CKM patients. Units without such funding were
significantly less likely to have staff with dedicated time for CKM (p= 0.002), and the proportion of units that
had such funding was significantly higher in units with a larger CKM patient population than in smaller units
(p= 0.009). However, 68% of units that had dedicated staff did not have any CKM funding (Table 11).
TABLE 10 The number of FTE hours dedicated to caring for patients with CKM
Staff n Median Minimum Maximum
Percentiles
25 75
Consultant nephrologists 12 0.20 0.05 1.00 0.10 0.20
Renal nurses 16 0.90 0.30 2.60 0.50 1.00
Social workers 7 0.20 0.05 1.00 0.05 0.20
Dietitians 9 0.20 0.10 1.00 0.10 0.35
Psychologists 5 0.10 0.05 0.20 0.08 0.20
Pre-dialysis education providers 9 0.40 0.10 1.00 0.18 1.00
Anaemia nurses 6 0.15 0.10 1.00 0.10 0.44
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FIGURE 2 The relationship between total staff hours dedicated to CKM and the number of CKM patients
aged ≥ 75 years per unit.
TABLE 11 Cross-tabulation of the relationship between availability of funding and CKM size, and the availability of
staff whose time is dedicated to CKM
Unit characteristic n
Availability of funding
Yes (%) No (%)
CKM sizea
Larger 24 29 71
Smaller 23 0 100
No response 20 17 83
Total 67 15 85
Staff whose time is dedicated to CKMb
Yes 28 32 68
No 37 3 97
Total 65 15 85
a p= 0.009.
b p= 0.002.
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Staff training
Half of the units (33 of 66) provided renal staff with formal training or education regarding CKM,
and 12 (18%) of 66 units were developing such training. One-third (21 of 63) did not provide their
staff with formal training; common reasons for this were lack of time (11 of 21) and lack of funding
(8 of 21). Five units also reported that staff did not need formal training, as CKM was an ingrained
culture in the unit.
Development of conservative kidney management
The key influences on the reported development of CKM in units were nurses’ attitudes (57 of 64, 89%),
nephrologists’ attitudes (51 of 64, 80%) and patients’/families’ attitudes towards CKM (45 of 65, 69%).
Two units (2 of 62, 3%) indicated that the Payment by Results tariff system for dialysis negatively
influenced the development of CKM. Both such units were in England.
Most units (43 of 61, 70%) indicated that frequency of late referrals did not affect the development of
the CKM programme. Just over half of the units (35 of 64, 55%) reported that the availability of funding
specifically for CKM had no influence, while 14 (22%) and 15 (23%) of 65 units respectively indicated
that it positively and negatively influenced the development of CKM.
Discussing conservative care with patients and assessing suitability
The majority of units (56 of 65, 86%) reported that they discussed the option of CKM with all CKD5
patients aged 75 years and over. The other nine units reported that consultant nephrologists tended to
decide whether or not to discuss CKM with such patients. There was no unit which only discussed the
CKM option if a patient or carer asked about the alternative to dialysis.
Various factors influenced staff when they contemplated the suitability of conservative care for a patient
(Figure 3). All 65 respondents reported that patients’ preference for CKM influenced staff strongly or
very strongly when considering the suitability of conservative care. This factor was followed by the extent
and severity of comorbidities (61 of 65, 94%), frailty (58 of 65, 89%), functional status (52 of 65, 80%),
patient’s current quality of life (50 of 65, 77%) and cognitive status (48 of 65, 74%). In addition,
12 of 64 (19%) and 11 of 65 (17%) units respectively reported that carer and consultant preferences for
CKM strongly or very strongly influenced them. The distance from the dialysis unit to a patient’s home
had the least influence on decisions about the suitability of conservative care (2 of 64, 3%). Uraemic
symptoms and rate of decline in kidney function did not have a major influence.
About half of the units (37 of 65, 57%) indicated that the option of CKM was most commonly first
raised with a patient when they were referred to the pre-dialysis clinic. Fifteen of 65 units (23%) reported
that CKM was first raised when a patient’s eGFR reached a certain level: 10 units when eGFR reached
20ml/minute/1.73m2, two units at eGFR level 19ml/minute/1.73 m2 and three units at eGFR level
15ml/minute/1.73m2. In six units (9%) the option of CKM was usually first raised with patients at a
specific time before the anticipated start of dialysis (from 3 to 12 months with a median of 9 months).
Family involvement
Family/carers were reported to be actively involved in decision-making about CKM. Almost all units
(62 of 65, 95%) encouraged family to attend clinics, and 50 units (77%) involved family in the discussions
to review patients’ CKM decision. Patients’ family/carers were also invited to patient education days
(44 of 65, 68%), and involved when patients were visited at home (42 of 65, 65%).
Decision aids
The majority of units (54 of 65, 83%) used decision aids when discussing the option of CKM with patients.
Forty-four of these units (82%) used booklets or handouts from national organisations; 33 units (61%)
used booklets or handouts written by their own renal unit staff; and 22 units (41%) used DVDs from
national organisations. The recently developed NHS Right Care Patient Decision Aid was being used
by 16 units (30%).
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Recording a conservative kidney management decision
All responding units recorded a CKM decision: medical notes were used most commonly. Sixty-one of
65 units (94%) used medical notes in conjunction with other databases and two used medical notes alone.
Twenty-two of 65 units (34%) used medical notes and a renal database; 16 units (25%) used medical
notes, a renal database and a GP database; six units (9%) used medical notes, a renal database, a GP
database and an out-of-hours database.
Reviewing treatment decisions
All 65 respondents indicated that once patients decided not to have dialysis their decision was reviewed
by renal staff, and two-thirds of units (43 of 64, 67%) reviewed the decision during each clinic visit.
The patient’s decision was also reviewed on their request (9 of 64, 14%) and when they became
symptomatic (4 of 64, 6%).
All of the units (63/63) indicated that they had had patients who changed their mind after deciding not to
have dialysis. The commonest reason for this was because a patient’s family wanted them to have dialysis
(47 of 62 units, 72% – occasionally, frequently or very frequently). Thirty-seven of 62 (60%) units also
indicated that they had patients who changed their mind after having had longer to think about their
decision (occasionally or frequently). On the other hand, patients’ CKM choice was rarely changed because
they were unconscious on hospital admission and they did not have their wishes in writing and the family
insisted on dialysis (52 of 61 units, 85% – rarely; very rarely; or never).
Only a minority of units (10 of 65, 15%) reported having any CKM patients who had vascular access
created. The main reason provided for CKM patients having vascular access was that they had previously
chosen dialysis and then changed their mind to CKM after access had been created (7 of 10 units).
Only three units reported that access was made in case a CKM patient changed their mind and later
decided to have dialysis; one of them reported that it happened very occasionally.
Working with primary care and general practitioners
No unit reported referring all CKM patients aged 75 years and over back to GPs to be cared for under
primary care only. Some units referred patients back to GPs but GPs shared care of patients with the
renal unit (12 of 65, 19%), whereas in some units patients were primarily cared for by the renal unit
with little GP involvement (7 of 65, 11%). More than half of the units (40 of 65, 62%) indicated
that GPs’ involvement was varied in line with the three options above. Thirty-one units indicated that
this decision varied by patient/carer preference and nine units indicated that the decision varied by
nephrologist preference.
When asked about the role of GPs in the management of CKD5 patients receiving CKM, a majority
(59 of 65, 91%) of units reported that GPs liaised with the renal unit for specialist support. Forty-four of
65 units (68%) also reported that GPs and primary care staff were involved by providing/organising
palliative care support at the end of life. Half of the units (34 of 65, 52%) reported that GPs also
checked patient medication and arranged blood tests for patients but liaised with the renal unit for their
interpretation. A minority of units indicated that GPs assessed patients regularly/routinely (not on demand)
in the GP surgery (9 of 65, 14%) or via home visits (13 of 65, 20%).
A majority (57 of 65, 88%) of units provided GPs and/or their practice team with information or advice
regarding the treatment of CKD5 patients receiving conservative care. Information given to GPs and/or
their practice team was mainly written advice/guidelines (55 of 57, 97%) and verbal advice (46 of 57,
81%). One-third (18 of 57, 32%) of units held educational meetings to provide information to GPs.
Among the units that did not provide any information/advice to GPs, four of eight units said it was for lack
of time and/or funding. One unit reported lack of time and funding as well as the opinions of consultants
as a precluding factor.
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End-of-life care
Just over half (36 of 65, 55%) of units had a written guideline for renal end-of-life care, and 11 units
(18%) were preparing such a document. Thirty-six of 65 units (55%) used a register to identify CKM
patients approaching the end of life. The following factors were indicated as influencing very strongly or
strongly their decision whether or not to add a patient to the register: frailty (31 of 35, 89%), frequent
hospitalisation (30 of 35, 86%), symptoms (28 of 35, 80%), comorbidities (27 of 35, 77%), quality of
life (27 of 35, 77%), and the ‘surprise’ question of survival of less than 12 months (26 of 35, 74%).
Of those units without a register (29 units), three indicated that they were in the process of developing a
register; 11 units used their medical notes or database instead; and other units identified CKM patients
approaching end of life based on individual assessment, clinical judgement and discussion with other
health professionals, GPs or family.
Fifty-one (79%) of 65 units used ACP in end-of-life care; those who were involved in ACP were mainly
consultant nephrologists and nurses (13 units). Eight units indicated that they also had palliative care
specialists involved in ACP, and six units had social workers and counsellors as well.
In terms of staff training in palliative/end-of-life care for renal patients, a majority of responding units
(57 of 64, 89%) indicated that their staff had had such training; however, 39 of 64 (61%) said only a
small number of the staff had received training. Only two units (3%) reported that all staff had had such
training, and seven (11%) reported the majority of the staff had.
All 65 responding units appeared to liaise with some services to provide care for patients receiving CKM
and approaching the end of life. Specialist palliative care services within the hospital were used most
commonly (59 of 65, 91%), followed by a primary care team (58 of 65, 89%). Almost all units (62 of 65,
95%) used more than one service; for instance, 38 of 65 units (58%) liaised with specialist palliative
care services within the hospital, those from a local hospice, those in the community and the primary care
team. Patients received these services mainly at home (59 of 65, 91%), at a hospice (55 of 65, 85%) or
within the hospital as an inpatient (53 of 65, 82%). About half of the units provided specialist palliative
care services within the hospital to outpatients (38 of 65, 59%) and at the GP practice (33 of 65, 51%).
The major services that specialist palliative care services provided for renal patients on CKM were
symptom management at the end of life (61 of 62, 94%), followed by patient support at home out of
hours (54 of 62, 83%) and admission to the hospice, when required (52 of 62, 80%).
More than half of the units (42 of 65, 65%) provided palliative care specialists with training or advice
regarding the management of renal patients. Verbal advice was most commonly given (35 of 42, 83%),
followed by written advice or guidelines (24 of 42, 57%) and educational meetings (22 of 42, 52%).
Evaluation and future provision of conservative care
Fewer than half (25 of 65, 39%) of responding units reported that the quality of CKM provided in their
unit was regularly evaluated. Place of death was most commonly used as information when evaluating
CKM (22 of 25 units), followed by symptoms (19 of 25), survival (16 of 25) and quality of life (16 of 25).
When asked about factors that could help improve the provision of CKM in their unit, 52 of 64 units (81%)
strongly or very strongly agreed that both providing renal staff members with more CKM education/training
and increasing communication/involvement with GPs could help this. These were followed by providing
GPs with more education/training regarding CKM (51 of 64, 80%); increasing communication/involvement
with community teams (50 of 64, 78%); increasing communication/involvement with palliative care teams
(49 of 64, 77%); improving computer systems by integrating primary care data with renal data (48 of 64,
75%); and more funding to develop CKM within the unit (48 of 64, 75%). Forty-two of 63 (67%) units also
strongly or very strongly agreed that having funding models specifically designed to reimburse the cost of
delivering CKM could help improve the provision of CKM. Fifty-one units (80%) also supported better evidence
of the comparative outcomes between patients who receive CKM and those who receive dialysis (Figure 4).
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In terms of actual reported plans to improve CKM services, over half of the responding units (36 of 63,
57%) planned to provide renal staff members with more CKM education/training, and to provide better
end-of-life care by implementing ACP (33 of 63, 52%). Half of the units (32 of 63, 51%) planned to
increase communication/involvement with GPs, 25 units with palliative care teams (40%) and 24 units
(38%) with community teams. Other plans were to improve computer systems by integrating primary care
data with renal data (21 of 63, 33%), and to establish a system for evaluating the provision of CKM
(21 of 63, 33%). Only a quarter of units (16 of 63) planned to increase the number of staff dedicated
to CKM (including nine units with dedicated staff and seven without such staff) and to implement a
written up CKM policy (only 6 of 25 units without CKM policy planned to have a written policy). Fewer
than 20% of units were planning to have dedicated CKM clinics (12 of 63, 19%) and to obtain funding
to develop CKM (10 of 63, 16%) (Figure 5).
Future research
Participants were presented with theoretical descriptions for a randomised clinical trial (RCT) and an
observational study, which could compare conservative care with dialysis (see Appendix 3).
When asked if their unit would consider entering a patient aged 75 years or over with CKD5 into an RCT
comparing conservative care with dialysis, more than half of respondents (42 of 65, 65%) indicated that
they would consider it for some patients. Of those, 18 units said that their unit would definitely be willing
to participate in such a trial, and 20 units said they might consider doing so. Only one unit reported they
would be unwilling to participate in such a trial.
When asked if they would consider entering CKD5 patients aged 75 years and over into a prospective
multicentre observational study to compare conservative care and dialysis, a majority of units (60 of 65,
92%) said they would consider it for some patients; of those, 28 units indicated that they would definitely
be willing to participate in such a study, and another 28 units might like to do so. No unit said it would
not be willing to participate.
There was no significant relationship between the factors such as size of CKM patient population,
availability of staff primarily responsible for CKM, or availability of staff whose time was specifically
allocated for CKM patients and whether or not units would consider entering their patients into an RCT
or an observational study (Table 12).
Summary
Main findings
This national survey had a very high response rate and, using a detailed structured questionnaire, it
provided a robust assessment of the state of CKM in the UK for older patients with CKD5. Several
important findings emerged.
All but one unit had a pathway alternative to dialysis. There was no agreed terminology to describe this
pathway, although ‘conservative management’ was most frequently used. The lack of agreed terminology
means that there is no standard definition for CKM. Although data about numbers of CKM patients were
obtained in this survey, the lack of definition for CKM hampered evaluation of such data. CKM is used to
characterise a future treatment option as well as non-dialysis care for ESKF (i.e. a disease state equivalent
to being on dialysis); the number of patients in the latter group on CKM was relatively small (median 8,
IQR 4.5–22) in the units that responded to this question.
In order to assess suitability for CKM for a patient, similar criteria were used across the units, foremost
among them being patients’ preference for CKM. The CKM decision-making process was also similar
across units: most reported that they undertook informed decision-making with CKD5 patients aged
75 years and over by presenting treatment options including CKM to all such patients, and decision aids
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were widely used when discussing the options. Not only patients but also family/carers were actively
involved in decision-making about CKM. After the initial CKM decision-making, their decision was always
reviewed at clinic visits. Family members were often involved when a decision was reviewed. All units had
patients who had changed their mind after deciding not to have dialysis; however, from our survey we
could not quantify numbers of such patients.
Conservative kidney management practice patterns varied across units; some showed considerable
investment of staff time (both nursing and medical) and consequent processes with evidence of dedicated
clinics, a written CKM guideline and staff training initiatives. There was also some evidence that having
staff responsible for CKM was associated with some of these practice patterns, such as having a dedicated
CKM clinics and a CKM guideline. The number of patients was related to the number of patients aged
75 years and over on RRT. The components of CKM varied, for example provision of EPO and iron
therapy, and symptom assessment and management were uniform, whereas formal psychological support
and use of home visits was more varied. Only a minority of units had funding dedicated to providing CKM.
Whether they had funding or not was associated with numbers of CKM patients; however, our survey
could not identify whether they had more CKM patients as a result of receiving funding or units with the
larger number of CKM patients had more opportunities to apply for and/or to receive such funding.
Only a quarter of units had clinics exclusively for CKM patients, and this was closely related to availability
of staff responsible for CKM. Again, we could not identify whether they had CKM clinics because they had
responsible staff or vice versa.
All responding units worked collaboratively with primary care and palliative care teams, indicating their
vital role in the care for patients receiving CKM especially at the end of life. For instance, many units
provided GPs and their practice team with information or advice regarding the treatment of CKD5 patients
receiving CKM, and all responding units appeared to liaise with some palliative care services in order to
provide care for patients receiving CKM and approaching the end of life. Some units involved patients and
families in the decision regarding sharing care for CKM with the primary care team.
In relation to palliative care, almost all units appeared to have staff who had training in palliative/end-of-life
care for renal patients. There was, however, variation in the proportion of such staff: from two units with
all staff trained to 39 with very small proportions of such staff. This may be related to a lack of resources,
but may also be because higher priority is given to involving palliative care specialists in providing care to
ESKF patients rather than developing the skills of renal staff.
TABLE 12 Cross-tabulation of relationships between (1) CKM size, staff responsible for CKM and staff time
dedicated to CKM and (2) whether or not units would consider entering their patients into a RCT or an
observational study
Unit characteristic n
RCT Observational study
Yes (%) No (%) Yes (%) No (%)
CKM size Larger 24 67 33 92 8
Smaller 23 65 35 91 9
No response 20 61 39 94 6
Total 67 65 35 92 8
Staff responsible for CKM Yes 43 62 38 95 5
No 22 67 33 86 14
Total 65 64 36 92 8
Staff whose time is dedicated to CKM Yes 28 68 32 93 7
No 37 61 39 92 8
Total 65 64 36 92 8
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To improve the provision of CKM in future, increasing communication/involvement with GPs, community
teams and palliative care teams were thought to be very important by many units. For better collaborative
working, information sharing was also thought to be vital, which could be facilitated by the integration of
primary care and renal computer-based data. Many units reported that providing more education and
training regarding CKM was important not only for renal staff but also for primary care and palliative care
teams. However, it was also clear that lack of funding and time was a big issue for many units. Although
many units thought that more funding could help develop CKM in their units, only a minority were
actually planning to apply for funding. This may indicate that either it is difficult to obtain such funding, or
that funding to cover CKM may not be widely available. Moreover, currently there is no financial payment
for CKM under the Payment by Results tariff scheme. There is a need for a better understanding of the
resources and costs of CKM to improve the commissioning of CKM. In terms of planned changes
regarding the provision of CKM, increasing the number of staff dedicated to CKM and setting up
dedicated CKM clinics were not prioritised as much as other items. This may be also because of a lack of
funding; however, many units delivered CKM without receiving funding. It would be useful to understand
how units without funding currently manage this provision.
Comparison with existing research
This is the second national survey to explore the practice patterns of renal units regarding care for older
adults who choose not to have dialysis. Our survey showed similar variation in practice patterns to those
found by the previous national surveys of the provision of CKD and of palliative care provision to renal
patients in UK renal units.31,57
The previous study regarding CKD practice patterns in the UK demonstrated that the most common
perceived staff shortages in the care were of counsellors and psychologists: only 33% and 25% of units
respectively had such staff in their MSRT.57 Figures are similar in the current study. This suggests that
formal emotional and psychological support is still considered to be a low priority in many units.
The proportion of units with a pre-dialysis clinic has increased from 50 of 70 (71%) to 56 of 67 (84%).57
Similarly, regarding geographical accessibility to pre-ESKF care, the proportion of units that run clinics for
CKD patients in neighbouring hospitals has increased from 49 of 70 (70%) to 59 of 67 (88%). The
previous research showed that, even in units where outreach clinics were already set up, some patients
were not receiving the same MSRT input as those being followed up in the main unit57 because these
MSRT personnel were not funded to work outside the remit of the employing hospital. Our survey did not
investigate whether CKD patients in the neighbouring hospitals could access to MSRT services or not;
therefore, the quality of care in neighbouring hospitals remains unclear.
Many units that had a pre-dialysis education day covered CKM and psychological support as topics.
From this survey, however, it is not possible to find to what extent they were discussed during such
programmes. Compared with the previous study,57 psychological support was more commonly reported.
Many renal units first raised the option of CKM with patients either when they were referred to the
pre-dialysis clinics or when their eGFR level was about 20ml/minute/1.73 m2. Our survey was not set to
explore if the timing of referral to pre-dialysis was governed by eGFR or timing before the expected start
of dialysis. According to an Australian study conducted by Morton et al.,59 84% of patients received
information about treatment options when their eGFR was< 15ml/minute/1.73 m2. They suggested that
education on treatment was probably best commenced in stage 4 (eGFR< 30ml/minute/1.73 m2) rather
than CKD5. Although our survey did not collect actual patients’ eGFR values at the time of the first
discussion on treatment, our results may indicate that many UK renal units provide patients with such
information earlier, as suggested by Morton et al.59 Only a minority of units used timing rather than
eGFR level in order to decide when to raise the CKM option with a patient. Many CKD patients have
a non-linear eGFR trajectory or a prolonged period of non-progression in contrast to the traditional
notion of steady eGFR progression over time.60 This suggests that careful assessment of kidney disease
progression is needed to decide when to discuss CKM with patients rather than solely using an eGFR level.
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In the past, UK renal units did not have ready access to palliative care services, although most were willing
to provide ongoing care in terms of outpatient follow-up.31 Our survey, however, showed that all units
liaised with specialist palliative care service for CKM patients approaching the end of life. Many liaised with
such services not only within the hospital but also from a local hospice. Access to palliative care used to be
restricted to patients with malignant disease, and specialist palliative care services were involved only in the
minority of ESKF patients’ care.31 However, data from the more recent study undertaken by Hobson et al.61
demonstrated that specialist palliative care services accepted more referrals of ESKF patients than before.
In our survey, precise figures related to referrals were not collected; however, this survey may support
Hobson’s data, suggesting that palliative care services are now more widely available to patients with
ESKF. Similarly, the current study showed that a larger number of renal units had more standardised care
for renal end-of-life care than before: currently over a half of responding units had a written renal
end-of-life care protocol compared with only 20% at the time of the past study.31
Strengths and limitations
Although we achieved an excellent response rate, some limitations need to be addressed. First, the survey
responses were self-reported; therefore, we could not check their validity and they were predominantly
completed by clinical directors. Some of these data were necessarily estimates, such as the number of
CKM patients aged 75 years and over, and the number who were symptomatic. Such estimates should be
regarded with caution. Our division of units into larger and smaller categories was arbitrary and for
exploratory purposes. This survey focused on CKM patients aged 75 years and over. There are patients on
CKM aged under 75 years;62 therefore, the results do not fully address all CKM patients. While we
examined if some selected factors were associated with the use of certain practices regarding CKM,
we were unable to determine causal relationships. Furthermore, most questions in the survey were
multiple-choice questions where respondents were asked to select the best possible answer (or answers)
out of the choices from a list. This may have limited their responses, although a selection of ‘other’ was
provided in case the respondent could not find any appropriate items in the list. Finally, these findings
represent a current snapshot of CKM practices in the UK, which is one of the fastest-changing areas
among the renal community.
Implications for research and practice
There is a need for a standard terminology and more precise definition for CKM, since a non-uniform
terminology and definition may lead to both conceptual errors and misinterpretation of data. Our study
highlighted a vital role of primary care and palliative care teams, which emphasises the importance of
communication between renal units and those services. Improving computer systems by integrating renal
data with primary care and out-of-hours databases is essential in order to ensure good continuity of care
across different care providers. Lack of resources was seen as a big problem. More opportunities for
funding dedicated to providing CKM will be needed, and the current Payment by Results tariff scheme
and renal commissioning may need to be revised in order to support CKM. Resources available
for delivering CKM varied between the units; however, the value of resources such as dedicated staff and
dedicated CKM clinics in terms of quality of service is still not clear. There is a need to quantify the value of
such services in order to facilitate development of CKM services.
Having identified the individual components comprising CKM in renal units around the UK, there is an
urgent need to establish the most cost-effective combination of these components in a CKM service and
indeed the optimal way to organise a CKM service across primary and secondary care.
At this stage, an observational approach is likely to be the most appropriate next step to achieve this.
With practice patterns now defined and measurable, provision/receipt of these individual components of
CKM could be captured at a unit level/individual patient level, and novel statistics such as propensity
score matching, instrumental variable analysis or marginal structural modelling used to deal with the
confounding due to treatment by indication bias. The UK Renal Registry, which has recently had its Section
251 approval extended to pre-dialysis CKD, could provide a very cost-effective infrastructure for obtaining
some of these data.
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The present study has also highlighted the importance of measuring patient quality of life and satisfaction
with treatment when comparing the outcomes achieved with CKM and dialysis, and addressing carer and
family burden. Given the age, comorbidity and cognitive function of the patients for whom there is likely
to be equipoise for this decision, such matters will be particularly important to consider when planning and
designing future observational or interventional studies.
While an observational study may provide high-quality comparative effectiveness evidence for CKM versus
dialysis, the gold standard is likely to remain a RCT. Although 65% of centres indicated willingness to
participate in such a study, some serious doubts persist among clinicians about whether such a study is
really possible or not. A previous attempt to undertake a RCT comparing the outcomes of HD and
peritoneal dialysis was unsuccessful because of the limited number of patients who were uncertain over
their therapy choice and willing to participate.63 A feasibility study exploring the willingness of clinicians
and patients to be randomised to CKM versus dialysis, with embedded qualitative research to identify
recruitment, would likely be a necessary first step.64 Data from the observational work described above
would also be very useful for refining both the hypothesis and the intervention for such a study.
Conclusion
Conservative kidney management is widely practised in UK renal units. Provision and organisation of CKM
varies in many ways, such as availability of CKM funding, dedicated clinics, staff whose time is especially
allocated to CKM patients, written CKM policy and availability of staff training. Our survey also highlighted
the vital role of primary and palliative care teams for the provision of CKM. Palliative care services for renal
patients approaching the end of life are more widely available than previously reported. In order to
improve the provision of CKM, better understanding is needed of the comparative outcomes and costs
between CKM and RRT.
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Chapter 5 General practitioner interview study:
managing patients with advanced chronic kidney
disease in primary care – a qualitative study with
general practitioners
Introduction
This study set out to address objective 4 of the CKMAPPS project by exploring GPs’ views and experiences
of managing patients with CKD4 and 5.
National Institute for Health and Care Excellence guidelines on the management of CKD and recommendations
on CKD in the Quality and Outcomes Framework (QOF) provide GPs with guidelines on how to monitor and
treat patients with CKD and, where necessary, refer them to a nephrologist.2,65 The introduction of these
recommendations in 2006 highlights that CKD is a relatively new condition for general practice. Awareness of
how to treat CKD has subsequently increased among GPs.65
Previous quantitative studies have identified that CKD can easily be detected in primary care electronic
records,66 offering opportunities for better health promotion behaviours and disease prevention. Others
have identified the positive effects of CKD recommendations on patient care and referral rates.67 Although
these benefits exist, other literature has identified that primary care patients may not always be aware of a
CKD diagnosis and that GPs may have difficulties discussing the diagnosis with patients, thereby limiting
the opportunity for self-management and health promotion.68–71
Qualitative studies with GPs can help to explore approaches to the management of CKD in primary care
and identify barriers which GPs may experience when discussing the diagnosis or treatment with patients.
Few such studies have been carried out to date. Studies in the UK and the USA have identified that GPs
have varied views on CKD and its treatment, indicating that GPs may be sceptical about guidance and
whether or not CKD can be classified as a disease.66,72,73 GPs also stress the difficulties of diagnosing CKD,
particularly in older adults, and explaining a diagnosis to patients.66,71,72 Other studies have identified how
the organisation of primary care influenced these factors, concluding that general practice was probably
missing opportunities for health promotion and prevention of disease progression and/or complications
such as acute kidney injury.71,74
To date, few studies have explored GPs’ experiences of managing patients with CKD, particularly in its
more advanced stages. This study aimed to explore GPs’ views and experiences of managing patients
with CKD4 and 5 and in particular GPs’ decisions to refer such patients to secondary care renal services.
A secondary aim was to identify the proportion of older adults with CKD5 not known to a local renal unit
by examining laboratory data.
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Methods
Design and setting
This was a mixed-methods study involving quantitative data collection from UK renal units and semistructured
interviews with GPs. The same nine English renal units were included as in the staff and patient studies.
GPs were identified from general practices which were in the catchment area of four of the nine renal units
(King’s College, London; Southmead, Bristol; Heartlands, Birmingham; and Lister, Stevenage).
Data linkage
Nine renal units were contacted to identify an information technology (IT) professional who could obtain
patient data. Two data sets were required, renal unit data and clinical biochemistry data from their local
laboratory. Renal unit data included any patients who were known to the renal unit at the time of the
laboratory data extract. Laboratory data included patients, aged 75 years or older, with two eGFR
results< 15ml/minute/1.73 m2 for the first time on record between January 2010 and June 2011. These
individuals were therefore new cases of CKD5. Specific data were required in each data set as detailed in
Appendix 7. IT professionals sent secure versions of the data to the UK Renal Registry. Approval was
obtained from the National Information Governance Board. Laboratory data provided the number of
patients with new CKD5 in the 18-month period (as determined by eGFR blood results). Renal unit data
provided information on all patients known to a renal unit; in some units, such patients included those
who had received phone advice only. Laboratory data were matched with data from renal units to identify
patients with new CKD5 who were and were not known to a renal unit.
Participants and interviews
The original approach for identifying GPs to take part in the qualitative section of the study involved
inviting the GPs of patients identified through the quantitative data collection. Patients of interest were
those who were identified as having new CKD5, but who were not known to local renal units. As only a
small number of patients were identified from the quantitative data, an alternative approach was adopted
in order to recruit GPs. This approach aimed to invite any GP working in the catchment area of four of the
nine renal units of interest. Additional ethical approval was granted for this.
Primary care trusts (PCTs) in the catchment area of the four renal units of interest were identified. General
practices within each PCT were identified through the QOF database. One GP in each practice was invited
to take part in the study by post. If a GP did not respond or declined to take part, a second GP from the
same practice was invited. GPs returned a reply slip and a signed consent form by post to indicate they
were happy to take part in the study. GPs were then contacted by telephone or e-mail to arrange a time
for interview. Interviews were carried out by telephone by ST-C, an experienced qualitative researcher.
Interviews followed a semistructured interview guide which asked about GPs’ previous experience of
managing patients with CKD, referring CKD patients to secondary care and providing palliative care to
end-of-life CKD patients (see Appendix 8). GPs were reimbursed for their time to take part in interviews
at £40 per interview. Interviews were audio-recorded and transcribed verbatim by an independent
transcriptionist. Interview transcripts were checked by ST-C.
Qualitative data analysis
Data analysis was carried out using an inductive thematic approach in order to allow results to be driven by
the data.41 This approach minimised the influence of the researchers’ preconceptions or existing knowledge
on analysis. Transcripts were analysed once they had been checked and reread by ST-C. Line-by-line coding
was used to produce basic codes, and new codes were added as more transcripts were analysed. NVivo 9
was used to organise data and facilitate coding. ST-C independently coded 10 interviews and developed an
initial set of themes. Themes were developed by comparing codes and grouping them into similar categories
to produce themes and subthemes. Themes and supporting quotes were discussed with MS and revised to
produce a consensus framework. This framework was used to code the remaining transcripts. Any new
codes were incorporated into the existing framework, which was amended if necessary. Final themes were
developed by ST-C and MS and discussed with the wider research team until a consensus was achieved.
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Results
Data linkage
Data were linked for only three of the nine pairs of renal units and laboratories (Table 13). In all three,
renal units were aware of the majority of CKD5 patients; however, there were patients in all areas who
were not known to the local renal unit.
In the remaining units, four contacts reported that it was not possible to obtain the data required. This was
most often because of the computer systems used by the various units and laboratories and the ability to
search for the required data. For two units, it was not possible to identify an appropriate IT contact whom
we could liaise with, and in one, the CKD5 patients were not broken down by age.
Participant characteristics
A total of 353 GPs were invited to the study across the four areas. Twenty-five GPs responded to say that
they were interested in taking part in the study. Other than two responses from GPs who replied to
say they did not want to take part, no response was received from any of the other GPs. The overall
response rate was 7%, although this varied between areas, with a response rate of 4% in London and
13% in Bristol. It was not possible to obtain characteristics of non-respondents.
Nineteen GPs were interviewed, with three to six GPs being interviewed in each of the four regions.
Six GPs who had initially indicated they would like to take part were unavailable to be interviewed.
GPs were mostly male (63%), had a mean age of 46 years, a mean of 16 years in practice and worked in
practices with five doctors on average. Three GPs worked in inner-city practices, five in rural areas and the
remaining 11 in suburban areas. Nine of the GPs said they had no special interest in kidney disease or
other associated conditions; the remaining 10 GPs indicated that they were interested in diabetes,
palliative care and/or care of the elderly, so there was some selection effect.
Qualitative findings
Five themes were identified from the analysis of transcripts. All themes were relevant to all interviews but
GPs occasionally reported different views and behaviours within themes depending on the context in
which they worked and their experience.
Theme 1: managing chronic kidney disease in primary care
General practitioners reported that they commonly identified patients with stage 3–5 CKD through regular
monitoring for other chronic conditions. Some GPs felt that it was hard to reach a firm diagnosis of CKD
because of the difficulty of having to check repeated blood results.
Well, generally as a GP we routinely check people with hypertension, high blood pressure and
diabetes for their renal function, so we do that at least once a year.
GP7, Bristol, rural location, 20 years in practice
TABLE 13 Results of the data linkage from three units identifying the number of CKD5 patients not known to the
renal unit
Unit
Number of CKD5 patients
identified from laboratory data
Number of patients identified in
laboratory data but not on renal unit
database (unknown to renal unit)
% of CKD5 patients
unknown to renal unit
5 152 1 1
1 55 5 9
7 45 8 18
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It is quite hard to actually make the diagnosis [of CKD] and you’ll find that you will get two or three
tests with an eGFR of less than 60, and then all of a sudden you get some normal ones when you
have done absolutely nothing. So actually making the diagnosis can be difficult.
GP14, London, suburban location, 32 years in practice
While all GPs reported that they had several patients diagnosed with stage 3 chronic kidney disease
(CKD3), most reported that they rarely saw patients with CKD4 or 5 and thus had little experience
of treating the later stages of kidney disease.
I know some Birmingham areas they have a lot of patients on dialysis because they are from some
different [ethnic] backgrounds, so we don’t have that, we have one or two maximum on dialysis in our
practice. So it’s not that frequent to go into that stage.
GP8, Birmingham, suburban location, 10 years in practice
General practitioners stressed how new the concept of CKD was to general practice, following the
introduction of NICE guidelines in 2008 and QOF targets in 2006. Most GPs reported that they did not
feel confident about managing patients who had stage 4 or 5 CKD without input from specialists or
colleagues with more experience.
Interviewer: What about when you are referring someone, what sort of stage would you want to
refer them?
GP3, Bristol inner city location, 13 years in practice: Ooo again I probably would look it up. I think that
. . . no, I’m not going to answer that because I would look it up to be honest because I’m so unfamiliar
at the moment that I wouldn’t guess.
In contrast, a few GPs had a particular interest in renal disease or associated conditions (e.g. diabetes) and
therefore felt they knew more than the average GP about managing CKD. In addition, GPs with an older
population, who saw CKD more often, also reported that they were confident in managing patients
with CKD4.
I’ve got an older population. Nine per cent of my population have got an eGFR below 60. That’s nine
per cent. Which is why it’s an area, shall I say, I do quite a lot of work in.
GP1, Bristol, rural location, 32 years in practice
Theme 2: explaining chronic kidney disease to patients
Most GPs made reference to the asymptomatic nature of CKD. Many felt it was difficult to explain a
diagnosis of CKD to patients because they did not feel unwell and were not familiar with kidney disease
as a condition.
I think [patients] don’t understand what [CKD] actually means. Especially those who don’t really have
symptoms, there are lots of people with CKD5 that don’t have symptoms . . . it’s ‘life’s all fine, how
can my kidneys be failing? I feel fine’ . . . I think because they don’t have symptoms often they don’t
really understand the importance of it.
GP4, Stevenage, suburban location, 10 years in practice
It is tough because [patients] don’t feel it . . . and I think that is where the biggest problem is. If you
knew your heart was failing you can feel you heart failing, you are becoming more short of breath,
but with your kidneys if your kidneys are failing you don’t feel it until literally the last moment.
GP12, Stevenage, suburban location, 13 years in practice
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General practitioners stressed that they tried to prevent their patients from becoming distressed or anxious
about their diagnosis. Most explained the diagnosis when patients were at CKD3. Some mentioned
how they gave information about CKD over several consultations in order not to overwhelm patients
with information. Most GPs said that they did not use the terminology ‘CKD’ or ‘kidney failure’ when
explaining a diagnosis to patients but instead most explained to patients that their kidneys were not
‘working as well as they should be’ or that their kidneys were ‘ageing faster than you’.
It’s like other things, if you use the word ‘kidney failure’ or ‘heart failure’ people instantly think ‘oh my
goodness, I’m going to drop dead tomorrow’.
GP2, Bristol, inner city location, 3 years in practice
I mean if you start talking about renal impairment or kidney disease [patients] sometimes panic. So it’s
trying to alleviate the communication gap, it’s just saying that the kidneys are just slightly more leaky
than normal which means that they are losing a bit of protein from the body and that can cause
problems in the future. It doesn’t mean that the kidneys aren’t working properly; they are just
showing signs maybe of a bit of wear and tear.
GP10, Birmingham, suburban location, 19 years in practice
General practitioners reported that all CKD patients who were at stage 4 or 5 would know of their
diagnosis but those diagnosed with stage 3 might not always know. This was usually because patients
were older, their kidney function was stable and their eGFR indicated they had CKD3a rather than CKD3b.
When making a referral to secondary care, GPs told patients that it would be beneficial to get an expert
opinion about their kidneys. GPs reported that patients were generally happy to be referred and understood
the need for a referral. All GPs said that they avoided talking about dialysis and left patients to discuss
treatments with specialists.
If they are stage 4, I would tell them that their kidney is behaving like a kidney for an eighty-year-old
person . . . but at the level that it is at a specialist input is necessary.
GP5, Stevenage, suburban location, 12 years in practice
Theme 3: getting advice on managing chronic kidney disease
All GPs contacted their local renal unit for advice about how to manage patients with CKD4 and 5.
Most GPs felt communication with secondary care was good although a minority reported that there were
sometimes delays in responding to queries. Some suggested that having a dedicated phone line for renal
queries may be a way to improve communication.
I think the nephrology service we’ve got is good, as I say, we have got a lot of liaison with them.
Easy access to them.
GP11, Birmingham, suburban location, 8 years in practice
A few GPs were from practices which appeared to have very good links with their local renal unit. These
GPs reported that their local unit had provided guidelines for the management of CKD patients and some
had received education sessions run by the renal unit.
[The consultant nephrologist] has been pro-active, he’s come out and given talks to us, come to the
practice and he’s also given talks to postgraduate meetings.
GP9, Birmingham, suburban location, 8 years in practice
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General practitioners mentioned specific areas where they felt they needed guidance. This was most often
in assessing whether or not a patient needed to be referred to nephrology and how to manage CKD4 or
5 patients when they did not yet need to be referred or had been sent back from secondary care.
If you are a young person with [CKD] 4 and 5 it’s much more clear cut as to what you are treating and
how you manage it compared to an elderly person when there is all this comorbidity, you know, they
have all got diabetes, they have all got ischemic heart disease, very few of them have just got renal
disease. The care is much more complicated really.
GP14, London, suburban location, 32 years in practice
I think if they are going to discharge more and more people back to GPs there has to be clear
guidelines as to when you refer them back [to nephrology].
GP4, Stevenage, suburban location, 10 years in practice
Theme 4: referring patients with chronic kidney disease to secondary care
There appeared to be variation in when GPs referred patients to secondary care. Some reported that they
referred all CKD4 and 5 patients whereas most GPs reported that referral depended on the individual. GPs
with less experience of managing CKD tended to refer all patients. Several GPs said that they had learnt
which patients they needed to refer through having patients referred back from secondary care. Some GPs
also mentioned the tension between national guidance to refer all patients with CKD4 or 5 and believing
that their renal unit may not wish to see all these patients or may refer them straight back.
I suppose in my very GP brain I have CKD 4 means the renal unit. You know, that’s where I have
divided that in my brain.
GP13, London, suburban location, 11 years in practice
At that level [CKD4] um a specialist input is necessary . . . I don’t think I have got enough skills to say
that [dialysis] is not going to be beneficial to the patient.
GP5, Stevenage, suburban location, 12 years in practice
That is the dilemma, as an ex-colleague of mine said, you know, ‘I didn’t really want to refer all my patients
with CKD stage 4 because one of the nephrologists said ‘we’re not going to do a great deal anyway.’
So even though the guidance says refer everybody with stage 4, you know, [GPs] don’t particularly.
GP7, Bristol, rural location, 20 years in practice
Most GPs made reference to the decline in eGFR, rather than the exact value, and stressed that referral
should be based on this rather than the value alone.
I think [referral] depends on rate of decline [of eGFR], I think it depends on other features, I mean if
there are other things that we think might be causing it, particularly diabetes, difficult hypertension,
yeah, I think rate of decline.
GP6, Bristol, rural location, 20 years in practice
Several GPs talked about assessing the patient holistically when deciding whether or not they needed to
be referred. GPs were more likely to refer patients with particular management problems such as poorly
controlled hypertension or proteinuria. Some said they avoided referring very elderly patients unless there
were particular concerns about their CKD.
I mean if they are sort of over 75, over 80, I think each case is on its own merit in terms of stage 4
really, you know, have we got well controlled hypertension? Um, is it recently um sort of developed?
Is it rapidly declining? And if there is a lot of proteinuria as well we would refer that particular stage
four, but otherwise some stage 4s in the quite elderly we might just be sort of keeping an eye on.
GP9, Birmingham, suburban location, 27 years in practice
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Interviewees gave several reasons for trying not to refer unless absolutely necessary. There appeared to be
a general feeling among GPs that it was better for patients to be treated in primary care for as long as
possible where appropriate. A few GPs working in rural locations also considered how far patients lived
from their closest renal unit and delayed referral where possible to avoid patients having to travel.
In addition, GPs commented on the importance of not overloading secondary care services with
unnecessary referrals.
[Our] kidney service is fine but it’s a pressurised service. And I don’t like sending people we could have
managed better in the community or managed better locally, down to a service which is pushed. But
at the same time if needs do, hey, I work with them.
GP1, Bristol, rural location, 32 years in practice
We’ve communicated fairly closely with the [hospital trust] and we’ve been encouraged to be relatively
sort of independent and managing as much as possible within the practice . . . mainly [for] the
stage 4s.
GP9, Birmingham, suburban location, 27 years in practice
One GP reported that his/her practice preferred not to refer older patients with CKD to secondary care
because they had other comorbidities which were being actively treated which might conflict with the
management of their CKD.
Well to be honest we don’t send the older [patients] because, as I say, it is all about their other
morbidities. [later in interview] Because usually [elderly patients] have got something else, they have
got a coronary disease or something else which kind of overrides what is happening in their kidneys
. . . what will frequently happen is the cardiologist will start the medication that makes the renal
function deteriorate but the cardiologist will say, ‘never mind the renal function, take it.’ They then get
to the renal physicians who say, ‘absolutely not, they can’t be taking this’, and they stop it. And so
you’ve gone round in a big circle and um nobody has benefitted. That frequently happens.
GP14, London, suburban location, 32 years in practice
Theme 5: managing conservative kidney management patients and patients
for palliative care
Once patients were being seen by a nephrologist, GPs reported that they had little involvement in
managing CKD patients who were pre-dialysis or who had started dialysis. GPs did, however, continue to
care for patients with CKD4 and 5 who had not been referred and, less commonly, patients who had
opted for CKM.
General practitioners identified patients who would not be referred as those whom they would not expect
to benefit from dialysis. Most often GPs mentioned patients receiving palliative care, patients with
dementia and/or patients who were in nursing homes. In most cases, GPs said they would not alert
nephrology to such patients, although GPs differed in this decision, with some wanting to check their
non-referral decision with specialists.
GP12, Stevenage, suburban location, 13 years in practice: [I wouldn’t refer a] palliative care patient,
with cancer, or a patient who is in a nursing home, or who has severe dementia and therefore is in a
nursing home.
Interviewer: Ok. And what would your reasons be for not referring those?
GP12, Stevenage, suburban location, 13 years in practice: Purely what quality of life would they have?
Because they are not mobile and it’s not fair.
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If there is still a possibility that [the patient] may well be palliative for several months or so then we
may consider [referring], but if it’s going to be a matter of weeks or whatever then I think it would just
be a matter of just keeping them comfortable.
GP10, Birmingham, suburban location, 19 years in practice
Generally GPs did not appear to be familiar with the idea of CKM and few had experience of caring for
such patients. GPs felt comfortable with the idea of conservative management of CKD if patients could be
treated as a palliative care patient, although some worried about patients changing their mind and
wanting dialysis in the future.
GP10, Birmingham, suburban location, 19 years in practice: We have had [CKM patients]. I’m not sure
whether they are still with us or not. But, yes, there have been situations where they have
declined dialysis.
Interviewer: And how do you feel about managing those patients?
GP10, Birmingham, suburban location, 19 years in practice: Well, again I suppose it is trying to do it as
best you can. I mean obviously with the patients being under the care of the secondary care services
at least you feel that there is communication going on and if there is a change of heart on the side of
the patient or a deterioration then, you know, you have got someone to call on to and give you some
further advice and support.
GPs emphasised that it was very unusual to have patients at ‘end of life’ who had only renal disease.
Most CKD patients had several other conditions and when deteriorating were treated as any other
palliative care patient.
We do control, we do treat, we do pain, and families and at the end of the day it is end of life, ok,
they are not taking medication, they need some pain relief, just like any other palliative care,
end-of-life care patient.
GP8, Birmingham, suburban location, 10 years in practice
Palliative care registers helped GPs to identify patients who were approaching end of life and this
information was shared with community teams. GPs reported that renal units did not get involved in
end-of-life care unless a patient was withdrawing from dialysis, in which case the care was usually
co-ordinated by secondary care teams.
Summary
Main findings
Quantitative results indicated that the majority of patients with CKD5 were known to local renal units,
indicating that GPs were referring most patients, although it was difficult to obtain and evaluate such data,
and our data set was limited to three renal units. The qualitative analysis identified several factors which
influenced GPs’ management and referral of patients with CKD4 and 5 to help explain these numbers.
Previous experience of treating patients with CKD was a good indicator of how familiar GPs were with
guideline recommendations and when to refer. Some GPs had relatively little experience of managing
patients with CKD4 or 5 and of CKM per se and found it harder to comment about their experiences with
these patients. GPs with older patient populations felt more comfortable managing patients with CKD,
who were often older adults with comorbidities. While some GPs felt that patients with CKD3 might not
know of their diagnosis, all felt that patients diagnosed with stages 4 and 5 would be aware of their
CKD and that patients were generally happy to be referred. Most GPs reported that they had good
communication with their local renal units and particularly sought advice on when to refer patients and
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how to manage patients if they were not referred, or after they had been sent back from nephrology.
There was variation in when individual GPs said they would refer patients with CKD4. They were
influenced by the eGFR, decline in eGFR, the general well-being of the patient, the patient’s age and
comorbidities, and occasionally the distance to the renal unit. In general, GPs emphasised that it was
preferable for patients to stay under primary care where possible and to refer patients based on their
individual characteristics. Some GPs identified older adults with comorbidities as complicated cases where
referral decisions were more difficult. Finally, GPs identified patients receiving palliative care or with
advanced dementia as less likely to be referred to the renal unit and were happy to care for such patients.
Most interviewees had little experience of managing palliative care for patients with CKM those who had
were comfortable with this as long as the patient had made an informed decision in secondary care and
that this had been communicated to primary care.
Comparison with existing research
Qualitative research in this area is limited, with only a few studies having been carried out in the UK and
the USA;66,71,72,74,75 however, there were similarities between the results of the current study and such
previous research. GPs reported that they felt some anxiety about telling patients with early-stage CKD of
their diagnosis71,72 and that GPs felt patients and the public had little understanding of kidney disease.66,72
In addition, most GPs accepted that they did not know a great deal about the management of CKD4 and
5 because they had relatively few patients with these and they welcomed any guidance or additional
advice that they could get to inform their practice.75
Other studies have found that GPs can be sceptical about using the measure of eGFR to make a diagnosis
of CKD.66,76 It was interesting to note that GPs did not seem to have this concern in the current study.
Although a few GPs described using eGFR as a factor when deciding whether or not to refer, it was most
often the decline in eGFR rather than the single reading that was referred to. This may have meant that
GPs were more confident using a decline in eGFR as evidence of impaired renal function or that GPs had
had longer to get used to referring to eGFR results since the introduction of NICE guidelines.
Only one previous study mentioned GPs’ approaches to referring patients.75 Its results were similar to
the current study, showing that GPs varied in when they made a referral and on which factors a referral
was based. The study also indicated that GPs working in more rural locations tried to manage patients
themselves as much as possible to avoid unnecessary travel for patients.75
Patients who have opted for CKM are not currently identified and recorded by the UK Renal Registry or
any other national registry. While our data suggest that most are known to nephrology services, it is
likely that some are kept in primary care and are never referred. A report by Kidney Health Australia
identified the number and proportion of patients with ESKF who did not start RRT by age, based on death
certificates and registry data.77 The results identified a substantial proportion of patients who did not
receive RRT, with a higher proportion being seen in older age groups.77 More data that links prevalent
CKD cases to dialysis is needed in the UK, and linking primary care databases to the UK Renal Registry may
help with the identification of patients with CKD and an assessment of the proportion of patients treated
without dialysis.
Strengths and limitations
This was the first study to identify the proportion of CKD patients known to renal services through the
collection of laboratory data. It was difficult to obtain the data needed to identify the proportion of
patients with CKD5 not known to renal services, and only three of nine units could provide the full
information. Moreover, we accessed the clinical biochemistry laboratory of only the hospital in which the
renal unit was based; this might have led to an overestimation of the referral proportion referred. This also
meant that GPs could not be sampled based on individual patient cases and that some GPs had to talk
hypothetically in some instances because they had not treated a patient with CKD5 recently. Despite this,
GPs were able to answer all questions posed to them and there was a similarity between those who had
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specific patients in mind when answering questions and those speaking hypothetically, indicating that the
approach taken by GPs was consistent between practices and areas.
General practitioner participation was voluntary; this probably led to sampling GPs who had a particular
interest in CKD or a related specialty (half the volunteers). Data did indicate that there were differences in
GPs’ knowledge of guidelines and confidence in managing patients between groups who had a special
interest and those who did not. This may mean findings have less relevance to all the GPs in the UK.
There was a particularly low response rate from GPs invited to take part in the qualitative study.
Study materials emphasised that GPs did not have to have specialist knowledge in the management of
CKD. However, GPs may have been reluctant to participate because it was something they did not
commonly see in practice. Previous research has identified low response rates in general practice research
and the difficulties of recruiting GPs to research studies involving surveys.78 Postal invitations, FreepostTM
envelopes for replies and reimbursement for time spent taking part in the study have been shown to help
increase participation by GPs and were all used in the current study design.79
Unlike previous studies, GPs were recruited from practices in specific areas of the UK, rather than from
practices which were taking part in a larger research study.66,71 Invitations sent to individual GPs, rather
than practice managers, avoided recruiting only from those practices that were research-focused and
probably added to the relevance of findings to GPs in general.
Additional insight into primary care practice might have been obtained by including practice nurses or
district nurses in the sample. Practice nurses might have provided insights into the management of CKD
patients and discussions with CKD patients when diagnosed, and district nurses might have been able to
offer insight into palliative care for patients with CKM, although these are likely to form a small minority of
their workload. It was not possible to obtain data on nurses working in all practices and this would have
limited recruitment. In addition, nurses were less likely to have views on the decision to refer patients to
secondary care, as this was something most commonly discussed between GP and patient.
Implications for practice
General practitioners distinguished between younger and older adults with CKD, of whom many had
comorbidities. Some mentioned that there was a conflict between treatment for CKD and treatment for
another chronic condition and others felt unsure about referring older adults because of the many other
conditions they had. It appeared to be difficult for GPs to judge which condition was most detrimental
to a patient and, given contrasting advice from specialists, there may have been a preference to keep the
patient under primary care. While this approach may avoid anxiety and multiple hospital appointments
for patients, there may be missed opportunities to educate patients about their CKD and prevent further
decline. Guidelines which focus on single conditions are particularly problematic in CKD, where so many
patients have comorbidities. Further advice on managing common comorbidities would be helpful for GPs.80
General practitioners appeared to be comfortable managing patients with CKD and were confident
that they could obtain advice from renal specialists when necessary, for example about medication.
Some GPs suggested that current communication with secondary care could be improved by the provision
of a dedicated telephone helpline to answer renal queries. GPs reported that this already existed for
other conditions and that it would make it easier for them to obtain fast responses to their queries.
GPs felt patients needed to be seen by secondary care when they needed to talk about future options
for treatment.
Some GPs reported that they had already received specific input from their local renal units through local
guidelines or educational meetings. These had been positively received and appeared to have offered
clarity on issues about referral. There is potential for other renal teams to emulate such approaches and to
initiate better communication strategies with primary care professionals, which will probably improve care
for renal patients in local areas.
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General practitioners used decline in eGFR as a key factor in the decision if and when to refer to a
nephrologist. Highlighting trends in eGFR in pathology reports by clinical chemistry laboratories would aid
this decision process.81
Conclusion
General practitioners make decisions about referrals to nephrology services on an individual patient basis.
A substantial majority of CKD5 patients are known to renal units. GPs have access to guidelines on
management of CKD and, although they sometimes found it difficult to refer all patients suggested in
national guidelines, they generally felt supported by additional information from local nephrology services.
GPs may benefit from advice delivered from their local renal unit and clinical chemistry laboratory to clarify
referral criteria and additional guidance on the management of older adults with multiple comorbidities.
Most had little direct experience of managing palliative care for patients with CKM.
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Chapter 6 Discussion and conclusions
This mixed-methods study sought the views of renal unit staff, patients and GPs about the managementof ESKF in older people and the potential role of a conservative care pathway, and undertook a
national survey of renal units to identify current practice. Several important issues have emerged from the
individual study components and from triangulating the findings:
l terminology and definition
l informed decision-making in multimorbid patients
l communication, education and training
l role of primary care
l commissioning and funding.
These are considered under the five objectives.
Objective 1: to describe the differences between renal units in
the extent and nature of conservative kidney management
This was the primary objective and was met largely by the national survey, which in turn was informed
by the qualitative studies with staff and patients. The national survey had a very high response rate.
It demonstrated the widespread acceptance of a conservative pathway as an active alternative to dialysis by
UK nephrology services and the development of such a programme in virtually all renal units over the past
10 years. CKM patient numbers, practice patterns, components of care and terminology varied markedly
across units. Patient numbers were hard to obtain for some units and differed markedly for the pre-dialysis
phase of CKM and postdialysis equivalent, for the latter numbers were small with a median of only eight at
any one time, partly reflecting short survival. There was some evidence that units with larger populations
of patients aged 75 years and over on RRT had more CKM patients. Some units showed considerable
investment in staff time (both medical and nursing) and consequent processes such as dedicated clinics,
guidelines and staff training programmes, and this bore some relation to patient numbers.
A key issue underlying practice patterns is the terminology and definition of CKM. We chose the term
CKM to underpin our study. However, there was considerable variation in the terms used by different
units. An agreed terminology and definition would assist the further development of CKM.
The pathway from advanced CKD to a symptomatic state where dialysis could be offered or a supportive
conservative pathway followed is complex and unpredictable. This pathway may be described using a
staging classification which reflects its progressive nature, though individual subjects may move from stage
to stage in either direction and at variable rates.
l Early conservative care pathway option: the time before clinical manifestations of the ESKF occur;
the focus here is education, decision-making and standard CKD care, with the exception of dialysis
access and transplant work-up.
l The alternative to dialysis phase, when dialysis would have been commenced if opted for, characterised
by a low eGFR, rising serum urea, increasing uraemic symptoms and/or symptoms related to comorbidity;
the focus here is revisiting of options, clarification of pathway chosen, symptom assessment and
management and ACP. There may be periods of stability, punctuated by crisis episodes that need
intensive management, followed by a period of instability, increasing symptom burden, revisiting
decision-making and discussion about preferred place of death.
l End-of-life phase, when prognosis is short (days) and previous plans for end-of-life care need
confirming and implementing, including provision of anticipatory medicines for the end of life.
l Bereavement support.
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Most units did not report the numbers of patients receiving CKM, indicating that these data were not
captured prospectively. In units that did report a number of patients designated as receiving CKM,
the wide variation suggests that units differed in when in the course of a patient’s CKD they applied the
term. While guidance promotes early discussion with patients and decision about future conservative
care (the ‘early conservative care pathway’ option above), for many patients there may be a long period
before the decision about whether or not to opt for dialysis is faced (the ‘alternative to dialysis’ phase).
A significant proportion of patients die from their other comorbidities before reaching this later phase.32
It may be that two designations are needed to capture these key points on the pathway: (1) a decision to
opt for conservative care and not to prepare for dialysis and (2) a decision to opt for conservative care
rather than dialysis despite symptoms.
It is expected that the recent KDIGO consensus conference on renal supportive care will produce a
definitive definition, although the definition produced will need to include other elements relating to
situations in countries in which CKM is obligated by the lack of resources for RRT. Adoption of an agreed
definition has considerable implications for clinical practice, research and policy: in clinical practice, a
common understanding is necessary to aid communication with patients and carers and to share best
practice; in research, evidence can be developed only once there is recognition and an accurate definition
of this CKM population; and for policy, decisions, guidance and direction can be achieved only if the
population is clarified. Any definition must be clear for patients, and their carers and families. A clear
definition would facilitate derivation of key quality indicators.
In this study we focused on patients aged 75 years and older, as the majority of patents opting for CKM
are in this age band. However, we recognise that CKM may be a mode of choice for some patients who
are aged under 75 years.
Objective 2: to explore how decisions are made about the main
treatment options for older patients with stage 5 chronic
kidney disease
This was addressed first by the qualitative interviews with staff and patients, and then elements of the
process were quantified in the survey. Further insights were obtained from the GP interview study.
The CKM decision-making process was similar across units: most reported that they undertook shared
informed decision-making with CKD5 patients aged 75 years and over by presenting treatment options
including CKM to all such patients, and decision aids were widely used.
Stage 5 CKD patients held contrasting beliefs about what dialysis can offer in terms of survival and quality
of life, which appeared to be influenced by the information provided by renal staff. This can differ between
units, particularly in regard to CKM. Few patients reported speaking to staff about the future, in terms of
the consequences either of starting dialysis or of opting for CKM. The staff interviews identified that lack of
knowledge regarding the likely impact of dialysis on individual patient’s quality of life and survival made
discussion about prognosis difficult. Difficulty discussing poor prognosis and end-of-life issues was also
related, partly from a well-intentioned desire to maintain patients’ hope. While most renal units were
addressing treatment options including conservative care and were using a variety of resources including
decision aids, patients in some units reported not being aware of a conservative option. It was recognised
that decision-making about CKM and dialysis options is iterative and time-consuming (and hence needs to
be appropriately resourced) and may be facilitated by continuity of care. The assessment and impact of
cognitive impairment, dementia and depression, which are not uncommon in these patients, also need to
be considered.
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Better information on the benefits and risks of both dialysis and conservative care according to patient
characteristics (e.g. degree of morbidity and frailty) and including information on quality of life and carer
burden would enhance shared decision-making. The patient interviews highlighted the complex trade-offs
for patients in terms of survival and quality of life, and the importance of the latter. Renal professionals are
likely to see quality of life issues somewhat differently from patients. For instance, in accord with the work
of Morton et al.,45 we identified that transport to and from dialysis was a major concern for patients, and,
for some, strongly influenced their CKM decision. Existing and new evidence is needed to better inform
decision-making. Such data could come from a synthesis of the existing studies that have compared
dialysis and conservative care, along with future research (see below).
The fact that the initial decision to opt for the conservative pathway may often be made when patients
are asymptomatic, along with the uncertain trajectory in ESKF, would indicate that (1) more detailed and
realistic consideration of what might happen in the future is often needed and (2) regular review of the
decision is needed and flexibility over a change of course. This has implications for establishing timely
access for dialysis.
We did not specifically address the information needs of patients from ethnic minorities, who will form an
increasing proportion of the older people with ESKF given the ageing of these younger populations and
their higher rates of ESKF. Not only is language a potential barrier but so are cultural and religious
differences in attitudes to death and in the responsibility for decision-making.
It is clear from all four strands of this research project that excellent communication is a cornerstone in
delivery of high-quality care to people with advanced CKD and frailty/multiple morbidity. Of course, good
communication is essential for the delivery of much of health care, but for such patients it plays an even
more important role, supporting the patient’s understanding and perceptions of their kidney disease,
providing a solid foundation for their decision about their management pathway, and enabling their
subsequent palliative and supportive care.
One of the main findings of our work was the importance of education and training of renal professionals.
It is clear that renal unit staff need more training and resources to help them discuss conservative care with
patients with ESKF and their carers/families.
This was evident from the patient interviews, where their perceptions and understanding of their kidney
disease, as informed by renal staff, were paramount in driving the management decisions, and in the staff
interviews, where both the decision-making and the discussion of palliative and end-of-life issues were
acknowledged as highly challenging. Because of the very specific challenges entailed, renal-specific training
may be useful, such as the training in advanced communication skills tailored to advanced kidney disease
developed by Bristowe et al.82
The marked variation across the UK, both in the numbers of staff with dedicated CKM time and in the
amount of training in renal palliative care, indicates that there are a variety of models of care (who delivers
care and how), as well as variety in their training (affecting the quality of the care they deliver). There is
urgent need for consistent measurement of patient experience in clinical practice, as well as formal
research evaluations of education and training programmes, to identify both the effectiveness and the
cost-effectiveness of these approaches. This evaluation is an important prior step to sharing best practice.
If there is robust evaluation of different models and education/training methods, then there may be scope
for informal or formal local and regional networks to share best practice. This would support smaller renal
units which had fewer ESKF patients opting for CKM, and hence limited experience and dedicated
resources for CKM.
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Objective 3: to explore clinicians willingness to randomise
patients with stage 5 chronic kidney disease to conservative
kidney management versus dialysis
This was covered by a series of questions included in the survey. There was strong support from our
respondents for further evidence of the comparative benefits and costs of CKM and dialysis, and
willingness to support further prospective studies and to a lesser degree a RCT. We did not specify the
details of such studies, so these data are only preliminary indications of the scope for further research.
Work is needed to assess the feasibility of a RCT, specifically if there is wider clinician and
patient equipoise.
Objective 4: to describe the interface between renal units and
primary care in managing stage 5 chronic kidney
disease patients
The survey had a section on the primary care interface, informed by the staff interview study, and with
further information provided by the GP interview study.
In contrast to CKD3 patients, individual GPs had relatively little experience of managing patients with
CKD4 or 5 and of CKM per se, which limited the insights into GP role for CKM patients. Our limited
analysis of referral suggested that most ESKF patients were known to nephrology services, and that GPs
were making considered judgements about referral based on prognosis and morbidity, although it was
difficult to obtain and evaluate such data and our data set was limited to three renal units. More
systematic national and local data are needed on patterns of occurrence of advanced CKD and referral.
It is recognised that GPs and community teams including social care professionals have a central
co-ordinating role in the end-of-life phase but with a need for training in renal-specific elements.
The engagement of GPs in the pre-terminal palliative phase of conservative care varied between units,
partly reflecting GP experience and geographical factors. There is scope for sharing good practice and
further evaluation of different models. There is also a need for better communication between GPs and
renal units about specific patients; integrated primary and secondary care data systems would facilitate
this. Other methods such as a dedicated phone line were also suggested.
Objective 5: to identify the resources involved and potential
costs of conservative kidney management
This objective was only partly met. We were unable to undertake detailed fieldwork of processes of care
either at the level of staff or of patients to enable bottom-up costing. However, detailed analyses of the
actual resource use and cost would have been challenging. A patient-focused client inventory approach
would have had problems of recruitment of the critical CKM patients on an alternative to dialysis. From the
staff perspective we captured ‘dedicated’ staff time; a staff diary approach would have been complex
given the number of potential contacts a CKM patient would have had. Analysis of routine unit data on
CKM resources and treatments received would be limited by the under-recording of the CKM pathway
decision. In essence, the first stage of the CKM pathway in most units generally seems similar to pre-ESKF
care without the vascular access; the second stage, after the dialysis decision, will be considerable cheaper
than the costs of dialysis.
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We were able to identify from the survey the variation in resources reported to be dedicated to CKM patients
and, from some units, details of funding sources. Most units had few patients under the ‘post-dialysis
equivalent’ and more intensive phase of CKM. Some did have dedicated staff, largely nurses and to
a lesser extent medical staff, and only a minority reported receiving funding, which was modest in amount
(median £40,000). Most CKM care is subsumed into the overall renal unit budget.
In England, preparation for RRT (or ‘renal assessment’) and RRT per se are commissioned as specialist
services and there are specific Payment by Results tariffs. However, CKM (or supportive care, the term used
in Payment by Results service specification) is mentioned within the renal assessment pathway but it is
commissioned locally. This is based on the rationale that CKM does not need RRT infrastructure, and
services should be available locally. However, CKM care can last from months to even a few years
(i.e. it is not just end-of-life care), and we were unable to distinguish the resources and costs for CKM for
the pre- and postdialysis equivalent phases. In some units the former pathway is equivalent to advanced
CKD care before dialysis (other than access formation).
Most units reported no dedicated funding for conservative care. The lack of a tariff for conservative care
under Payment by Results was seen as a barrier to developing these services. It remains to be seen if
the inclusion of the renal multiprofessional tariff will effectively reimburse at least some of the work
undertaken within the CKM pathway. More evidence is needed to compare the effectiveness, acceptability
and cost-effectiveness of different approaches to delivering conservative care, and also to understand the
comparative benefits and costs between different pathways. This is not, as discussed earlier, in order to
ration dialysis but rather to better inform rational or appropriate approach to maximise benefit for
resource utilisation.
Once CKM definitions are clarified, there needs to be a consensus about what resource elements should
be included. In the early phases of the conservative pathway the input is similar to other ESKF pre-dialysis
patients other than the provision of vascular access. The end-of-life component of conservative care also
applies to the larger pool of patients undergoing RRT. Detailed costing analysis of CKM pathway in a
variety of units would be valuable. The second stage, after the dialysis decision, will be considerably
cheaper than the costs of dialysis.
Summary of study strengths and limitations
The study used mixed methods and had several complementary components. The multicentre qualitative
phase using a purposive sample of renal units was robust. We were able to obtain multidisciplinary
perspectives by interviewing a range of relevant HCPs. For patients, the interviews were cross-sectional
rather than sequential within individuals over the CKM pathway and, as alluded to, there were problems
with recruiting later-stage CKM patients, and patients from ethnic minorities.
The survey had a very high response rate and a high question completion rate, though with a single
respondent at each unit and focusing only on patients aged over 75 years. Determining the size of the
CKM population was, however, difficult given variation in definition and recording. Our definition of size
of CKM programme was arbitrary.
We had problems linking laboratory biochemistry data on CKM5 referral, and GPs’ limited experience of
managing such cases meant that they had less to say about their care of such patients. An alternative
strategy of identifying older CKD5 patients who were referred, and contacting their GP, might have been
more illuminating. Recruiting GPs to such an interview study was difficult. Our major shortfall was in the
expertise and resource required to undertake detailed costing studies using patient and/or staff diaries,
as discussed above.
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Summary
Clinical/service implications
l Conservative kidney management is widely recognised and delivered across the UK, but through
differing models of care and sizes of CKM programmes.
l An agreed terminology and definition of CKM are needed to enable future evaluation. The designation
of a patient as having CKM must recognise the two key points on the CKM pathway: (1) stating a
preference or intention to opt for conservative care rather than have dialysis in the future, made at an
unspecified level of kidney function and an unspecified time before dialysis is indicated – ‘the early
conservative care pathway’ – and (2) a decision to opt for CKM made at a level of kidney function or
despite symptoms that would otherwise justify starting dialysis – the ‘alternative to dialysis pathway’.
The systematic routine recording of the CKM pathway within renal data systems would provide a
foundation for evaluation of CKM patterns and outcomes.
l Communication and information given to patients with ESKF who are older and or multimorbid
needs to (1) support patients’ understanding and perceptions of their kidney disease and their other
comorbidities; (2) routinely include details of the CKM pathway, settings of care and codependencies
with other pathways of care that individuals are receiving; (3) include realistic discussions (according to
preferences) of what is likely to happen in the future; (4) recognise that shared decision-making in
this setting is a process rather than an event and that decisions made need to be periodically reviewed;
(5) recognise the importance of identifying and where possible ameliorating cognitive impairment and
ensuring that plans are in the best interests of individuals.
l In order to address the challenging nature of decision-making, and communication about end-of-life
issues, renal staff need education and training in (1) advanced communication skills, adapted to include
the specific issues around dialysis decision-making, and (2) how to discuss and address palliative and
supportive care needs, including end-of-life care.
l Better communication and information sharing is needed with primary care teams and training in the
renal-specific elements of CKM care.
l End-stage kidney failure is a unique kind of organ system failure in that a replacement therapy is
potentially available for the majority. As a consequence, planning for care occurs earlier than in other
conditions, such as heart failure. However, a better understanding of patient and their carers’ wishes,
needs and values in advancing CKD and of the optimum service for CKM is likely to have wide interest
across the health-care system. This is, first, because multimorbidity, frailty and functional decline in
those with long-term conditions is a major system challenge, and, second, because the appropriate
balance between advanced technology and palliative care is also relevant for other conditions.
Research implications
Research is required to measure the benefits and costs of CKM and dialysis and to inform decision-making
by staff, patients and their families. There is some support in principle for a randomised trial, which would
be the most robust method in terms of internal validity given the problem of selection bias in observational
designs. A feasibility study exploring the willingness of clinicians and patients to be randomised to CKM
versus dialysis is likely to be needed before embarking on a definitive interventional study. Data from such
observational research would be very useful for refining both the hypothesis and the intervention for
such an interventional study.
l An alternative would be a prospective observational study, and there was strong support for that
approach. The fact that there is variation in the scale of conservative care between units suggests
that similar patients are being treated by these two approaches across the UK, so it should be possible
to undertake such a study.
l Nested within the CKM versus dialysis question is the need to establish the most cost-effective
combination of various components in a CKM service and the optimal way to organise a CKM service
across primary and secondary care. An observational approach could capture the provision/receipt of
individual components of CKM at a unit level/individual patient level.
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l In observational studies, propensity score matching, instrumental variable analysis or marginal structural
modelling could be used to deal with the confounding caused by treatment indication bias.
l Given the age, comorbidity and cognitive function of patients for whom there is likely to be equipoise
with regard to CKM versus dialysis, patient and carer quality of life and satisfaction with treatment will
need to be carefully measured in studies comparing outcomes.
l Given the underascertainment of non-English speakers, a focused qualitative study is needed looking
specifically at this population.
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Appendix 1 The semistructured interview guide
followed during patient interviews
Part one: you and your illness – a brief biography
1. Please could you tell me briefly about your kidney disease?
Probe: when were you diagnosed?
i. How was your kidney disease diagnosed?
ii. Can you tell me what you think caused your kidney disease?
iii. What impact does your kidney disease have on your life now?
iv. How do you think your kidney disease may impact on your life in the future?
2. Where are you now with your kidney disease in terms of its management?
Probe: CKM versus wait for RRT or on RRT.
i. How long since CKM decision or since RRT start?
Part two: how decisions were made about management and
views on pathway
3. How were the options for the management of your kidney disease presented to you?
Probe: who discussed the options with you?
i. How did you feel about this discussion?
ii. When were the options discussed with you?
iii. How did you feel about the timing of this discussion?
iv. What information was shared with you/were you given?
– How did you feel about the information you were given?
– What sort of questions did you have about your options for management?
4. Who made the decision about whether or not to have dialysis?
Probe: when was the decision made?
i. How much time was spent thinking about the decision?
– By you? By your doctor?
– What factors influenced your final choice of management?
– Have you changed your initial choice?
– Do you think you will change your choice in the future?
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5a. [For those who chose CKM] What did choosing CKM mean to you?
Probe: what were the reasons you chose CKM?
i. What did you think the benefits might be?
ii. What other implications did you think there would be?
– Have you experienced anything which you did not expect since starting on the CKM pathway?
iii. What do you think the benefits of CKM are now?
iv. Who do you think CKM is most appropriate for?
5b. [For those who chose dialysis but not yet started] What did choosing dialysis mean to you?
Probe: what were the reasons you chose to have dialysis in the future?
i. What do you think the benefits might be?
ii. What other implications do you think there will be?
iii. Who do you think dialysis is most appropriate for?
5c. [For those already on dialysis] What did choosing dialysis mean to you?
Probe: what were the reasons you chose to have dialysis?
i. What did you think the benefits might be?
ii. What other implications did you think there would be?
– Have you experienced anything which you did not expect since starting dialysis?
iii. What do you think the benefits of dialysis are now?
iv. Who do you think dialysis is most appropriate for?
6. Can you tell me about any concerns that you had when the decision about your kidney disease
management was made?
Probe: were there any challenges that you anticipated?
i. Were there any opportunities that you thought you may miss out on?
ii. Do you feel you understood fully what was being agreed?
7. Can you tell me about any concerns that you have now about the decision that was made?
Probe: how well do you feel you understood the consequences at the time?
i. How well do you feel you understood what was involved at the time?
ii. Did you feel you were involved enough in the decision?
iii. Do you feel you had enough clinical input from the doctors?
8. Overall, how do you feel about the way the decision was managed?
Probe: how did you feel about the amount of time you were given to think about the decision?
i. Did you feel you were able to ask questions?
– Did you feel your family/significant others were able to contribute to the decision?
ii. How do you think the decision-making process could be improved?
iii. Should anything be changed about the decision-making process?
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Conclusion
1. Are there any other relevant issues we haven’t covered that you would like to mention?
2. Are there any questions you that would like to ask me?
Your demographic information
1. Gender.
2. Age.
3. Ethnicity.
4. Occupation prior to retirement.
5. Marital status.
6. Religion.
7. Living arrangements.
Thank you very much for taking the time to speak with me.
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Appendix 2 The semistructured interview guide
followed during staff interviews
Part one: your role and experience
1. Could you tell me more about your role and your responsibilities within your unit?
2. Could you tell me what conservative management means in your renal unit?
i. What acronym or name do you use for conservative management?
3. How much time in your role is spent with CKM patients?
i. Is your role dedicated to CKM patients only?
4. Can you tell me what training you have had about assessing and addressing palliative and supportive
needs of kidney patients?
i. If none, do you feel the need to receive such training? Why?
ii. If some, how do you feel about this training?
5. Can you tell me about any communication skills training you have had?
i. If none, do you feel the need to receive such training? Why?
ii. If some, how do you feel about this training?
Part two: your views on CKM in general
1. Could you tell me your views on the value of CKM in general?
Prompts:
i. Advantages?
ii. Disadvantages?
iii. Reasons why?
2. In your view what are the components of CKM that are likely to make a difference to outcome?
Prompts:
i. Psychological.
ii. Physical.
3. For which types of patient do you think CKM is most appropriate?
Prompts:
i. Dilemmas.
ii. Comorbidity number and severity, age, other.
iii. Social circumstances.
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4. In general, how would you describe the key barriers and facilitators to the implementation of CKM?
Prompts:
i. Late referral.
ii. Family/carer expectation.
iii. Family/patient lack of knowledge.
iv. Expectation of clinical staff.
v. Lack of experience of CKM.
vi. Lack of resources.
Part three: how decisions are made about chronic
kidney management
1. How do you identify patients who have advanced kidney disease in your unit?
Prompts:
i. Do you encourage referrals in any way?
ii. Do you identify patients from their laboratory biochemistry reports?
2. Does your nephrology team also take part in the general/acute medicine service in your hospital?
Prompts:
i. How does this affect your access to patients with advanced kidney disease?
3. Are you aware of any specific guidelines on shared decision-making and withdrawal from dialysis?
(e.g. NHS kidney care)
i. If you are, do you refer to these when making decisions?
4. In your unit how is the decision made to raise the issue of CKM with a patient?
Prompts:
Roles of:
i. Renal consultant?
ii. MDT [multidisciplinary team] meeting? Participants?
iii. Patient/carer?
5. Is a decision to consider CKM typically ‘distributed’ or ‘shared’ by a number of people?
6. What factors are likely to influence a consideration of CKM?
Prompts:
i. Frailty?
ii. Extent and severity of comorbidities?
iii. Social support?
iv. Cognitive function?
v. Patient/carer preference?
vi. Use of the ‘surprise’ question?
vii. Consultant preference?
viii. Age of patient?
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7. At what point in a patient’s illness trajectory will a decision for CKM typically be made?
Prompts:
i. eGFR level (for stable patients in the clinic).
ii. Iterative nature of decision-making.
iii. What about patients presenting unwell and as an emergency?
8. Once a decision is made to follow CKM pathway, what does a typical patient pathway look like?
i. How does this differ from pre-dialysis and dialysis patients?
9. During the CKM pathway, is there any phase where patients are symptomatic and difficult
to manage?
i. To what extent do they differ from dialysis patients? (e.g., a longer symptomatic phase for
CKM patients?)
10. Are you involved in discussing CKM with patients and families?
i. If yes, on the basis of your clinical training, how well prepared do you feel to do so?
11. Do you use any decision aids when discussing CKM with a patient?
Prompts:
i. Pamphlets? Videos? Web-based tools?
12. How do you feel patients find making the decision about CKM?
Prompts:
i. How much time do patients spend thinking about the decision to have CKM?
ii. Do you ever ‘double-check’ patients’ decisions about CKM?
– If yes, why? At what point? How often?
iii. Do patients ever change their mind and opt for dialysis?
– If yes, why? At what point?
iv. Do you find there are any differences in those patients who change their mind?
– Patients with families who want them to have dialysis.
– Patients from an ethnic minority background.
– Patients who were scared of the idea of dialysis/were less well informed.
13. How do you feel patients find making the decision to have dialysis?
i. How much time do patients spend thinking about the decision?
ii. Do patients ever change their mind?
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iii. How do patients find dialysis once they’ve started?
– Is there anything which you think surprises patients or that they don’t expect?
– Is there anything which patients struggle with?
– Are there any other benefits of having dialysis aside from the medical benefits?
iv. What happens if patients don’t do well on dialysis?
14. Do any of CKM patients have access ready for dialysis (i.e. fistula)? If so, to what extent does this
‘access’ decision determine whether they remain CKM or not?
15. If CKM patients change their mind and have dialysis when they become symptomatic, what kind of
problems would this cause?
16. How does your renal service link up with general medical teams and general practices in the medical
care of elderly patients (> 75 years) with CKD5 for whom dialysis is not considered appropriate?
Prompts:
i. Do you keep them under your care?
ii. Do you discharge them?
iii. Do you share follow up in any way?
iv. How do you decide whether to keep or discharge them?
17. What is the role of GP regarding CKM patients?
Part four: end-of-life care
1. Could you define what the term ‘Palliative care/end-of-life care’ means to you?
2. How do you identify patients approaching end of life?
i. Do you use a register of these patients within your unit to facilitate delivery of palliative and
supportive care?
ii. What are the criteria used for identification for the register?
3. Do you use advance care planning to provide end-of-life care sensitive to an individual’s requirements?
i. If YES, what is the component of ACP?
4. How do you support patient’s family and carers?
i. Through end of life and beyond?
5. Do any of your staff have specialist training in the delivery of palliative care for patients with end
stage disease?
6. What end of life services does your unit typically liaise with for CKM, and how?
Prompts:
i. End-of-life/bereavement care?
ii. Specialist palliative care services within or outside the hospital?
iii. Hospices?
iv. What is the role of the GP regarding patients at the end of life?
7. Are there any palliative care specialists involved in your unit? Role?
8. Are there any Macmillan Nurses involved in your unit? Role?
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Part five: the development of chronic kidney management in
your unit
1. Is there a policy for CKM?
Prompts:
i. Do you have anything written?
ii. Who was responsible for drawing up the policy?
iii. Who is responsible for its implementation?
iv. What are the key components?
v. Strengths/weakness/problems?
2. Can you describe how CKM has developed in your unit? (e.g. relationships with GPs, other practitioners).
i. Any key players in developing CKM in your unit?
ii. Any barriers to overcome in developing CKM in your unit?
Part six: chronic kidney management resources
1. What is the size of the CKM programme in your unit?
i. Patients on dialysis versus CKM.
ii. Number of CKM patients who would have started dialysis by now if chosen.
2. Approximately what percentage of patients aged > 75 years with progressive CKD5 opt for CKM in
your unit?
3. Do you have staff dedicated to CKM patients?
Prompts:
i. If yes, ask FULL time or PART time.
ii. How many and who they are?
4. How much time do non-dedicated staff spend on CKM patients?
5. In your unit who tends to get involved in the care of patients treated conservatively?
6. Do you have dedicated clinic space for CKM patients in your unit?
7. How often do CKM patients come to your unit?
8. Can you tell us in particular about the key service components in relation to CKM?
Prompts:
i. Clinic consultations – follow ups?
ii. Blood result review [specifically haemoglobin, potassium, calcium, phosphate, bicarbonate
(acidosis), albumin]?
iii. EPO and Fe [iron] (what percentage require?)
iv. Multidisciplinary meetings?
v. Liaison with GPs? Links to 4.6.
vi. Telephone support for patients?
vii. Home visits?
viii. Liaison with other non-renal palliative care services or hospices?
ix. Training/educating staff and patients/careers?
9. Do you record CKM decisions? If so, how/where is this information recorded?
10. How is CKM funded? Funded separately or as part of renal unit budget?
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Part seven: future of chronic kidney management in your unit
1. Is implementation of your unit’s CKM policy evaluated/audited/monitored?
i. How?
ii. Details?
2. What are the good things about having the CKM pathway in your unit?
3. How could the CKM pathway be improved in your unit?
4. How has the development of your unit influenced the growth in numbers of staff resources (and the
number of CKM patients)?
5. Can you tell me about what changes are planned in your unit?
i. Why are these happening? Why are there no changes?
For renal clinicians and senior nurses to answer: willingness to randomise
There is a lack of high quality evidence for patients and clinicians to consider when deciding whether to
have dialysis or CKM.
1. Would you consider it appropriate to enter any patients aged > 75 years with progressive CKD5 into a
RCT of CKM versus dialysis?
Prompts:
i. More detail on types of patient that might be considered?
ii. Reasons against/for a trial?
iii. Would your unit be willing to participate in such a trial?
If no, willingness to enter into a prospective observational non-randomised study comparing outcomes of
patients with CKM with similar patients starting RRT.
Part eight: conclusion
1. Are there any other relevant issues we haven’t covered that you would like to mention?
2. Are there any questions that you would like to ask me?
Your demographic information
1. Gender.
2. Age.
3. Ethnicity.
4. Profession/grade/specific post (e.g. Consultant Nephrologist).
5. How many years of experience do you have in your current role?
6. How many years have you worked within this unit?
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Appendix 3 Conservative Kidney Management
Assessment of Practice Patterns Study national survey
Page 1
Thank you for completing this survey 
 
This questionnaire asks about how you treat patients in your unit aged 75 years and over with advanced chronic 
kidney disease who do not have dialysis.  
 
Many of the questions address practice patterns that may vary among staff members in your unit. Please try to give 
the answer that is most representative of the unit as a whole (i.e. the whole renal service including satellite units). 
 
In order to complete this questionnaire, you may want to consult other members of the renal team or to delegate this 
task to a more appropriate person who has responsibility for such patients (e.g. you will be asked who has received 
CKM training; how many full time equivalent hours are allocated to CKM for your staff). For some questions, you will 
need to retrieve unit data (e.g. you will be asked the number of patients aged 75 years and over on CKM; the amount 
of funding your unit received for CKM in the last financial year). The questionnaire will take about 40 minutes to fill in. 
You may find the survey is rather lengthy; however, we tried to limit the number of questions as much as possible.  
 
Instructions for completing the questionnaire 
• Please answer each question by ticking the box. 
• In most cases you will only have to tick one box  
but please read the directions carefully, as occasionally you may need to tick more than one box. 
• By clicking the 'next' or 'done' button your answers will be saved automatically. You can leave the survey and 
resume it later. You can also edit your survey at any time even after you click the 'done' button. 
• The survey can be completed by multiple respondents. If you would like someone else to continue to fill in the 
survey, you can forward the web link to the next person. However, the survey should not be opened and filled in by 
more than one person simultaneously. Please also note that you will still have only a single response registered per 
unit even if it is completed by multiple respondents.  
 
We would be very grateful if you could complete the survey by Friday 19th April. 
 
Prof Paul Roderick (Chief investigator) Professor of Public Health, University of Southampton 
Dr Hugh Rayner Consultant Nephrologist, Heart of England NHS Foundation Trust 
 
If you have any queries regarding this questionnaire, please contact: 
Sarah Tonkin-Crine on 023 8024 1080, S.K.Tonkin-Crine@soton.ac.uk 
or 
Dr Ikumi Okamoto on 023 8079 5734, io@soton.ac.uk 
 
This survey has been developed with the support of CKMAPPS steering committee group members. 
  
Professor Julia Addington-Hall 
Dr Fergus Caskey 
Dr Rob Elias 
Professor Ken Farrington 
Dr Richard Fluck 
Dr Roger Greenwood 
Dr Geraldine Leydon 
Fiona Loud 
Beverley Matthews 
Dr Natasha McIntyre 
Emma Murphy 
Dr Fliss Murtagh 
Dr Donal O’Donoghue 
Dr Charlie Tomson 
Dr Ian Wilkinson 
 
Instruction
 
Questions regarding CKD in your unit
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Page 2
Before asking questions regarding conservative care in your unit, we would like to know how your unit is organised 
with regard to patients with CKD in general. 
 
In order to supplement the data publicly available from the UK Renal Registry, please answer the following questions. 
1. Please choose your centre from one of the renal centres listed below in 
alphabetical order
2. How many FTE (full time equivalent) consultants (including CKD, dialysis and 
transplant) do you have working in nephrology in your unit?  
_ _._ FTE
 
(e.g. 60% clinical work with no academic/research activity and no general medicine responsibility = 0.6 FTE) 
3. Do you have a Multi-Skilled Renal Team (MSRT) available to manage patients 
approaching RRT in your unit?
5. If yes, how often do you have the meetings?
*
Renal centre
*
 
Questions regarding CKD in your unit
4. Do you have regular MSRT meetings?
 
Questions regarding CKD in your unit
 
Questions regarding CKD in your unit
Yes
 
No
 
Yes
 
No
 
Once a week
 
Once a fortnight
 
Once a month
 
Other (please specify)
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6. Which of the following staff members are involved in your MSRT and usually 
attend the MSRT meeting? 
 
Please tick all that apply in each column below 
7. Do you run clinics for CKD patients in neighbouring hospitals?
8. How many neighbouring hospitals do you serve?
9. In how many of the neighbouring hospitals do you have renal clinics?
*
Staff involved in MSRT Staff who usually attend MSRT meeting
Consultant nephrologists
Renal registrars
Renal nurses
Palliative care consultants
Palliative care registrars
Renal palliative care 
clinical nurse specialists
Surgeons
SAS grade doctors
Diabetes nurses
Social workers
Occupational therapists
Physiotherapists
Dieticians
Pharmacists
Psychologists
Pre-dialysis education 
providers
Anaemia nurses
Vascular access 
coordinators
Counsellors
Other
*
 
Questions regarding CKD in your unit
Please enter number
Please enter number
Please specify 
Yes
 
No
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10. Do you have a pre-dialysis clinic or equivalent for managing patients approaching 
RRT?
11. Do all consultants who have CKD patients use the pre-dialysis clinic?
12. Why don’t all consultants who have CKD patients use the pre-dialysis clinic? 
Please tick one
13. What percentage of the outpatients under follow up in your renal clinic, who are 
approaching dialysis, receive the following?
*
 
Questions regarding CKD in your unit
*
 
Questions regarding CKD in your unit
≤25% 26-50% 51-75% 76-100%
Nurse-led education
Home visit
Trained 
counsellor/psychologist 
input
OT and/or social work 
input
 
Questions regarding CKD in your unit
Yes
 
No
 
No, but we are planning to set up similar clinics
 
Yes
 
No
 
Because some consultants think that long-term continuity of care by the same consultant is more important.
 
Because some consultants’ clinics are at one of a neighbouring hospitals and the pre-dialysis clinic is in the main hospital. They 
don’t want their patients to travel to the main hospital. 
Other (Please specify)
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14. How is pre-dialysis education delivered in your unit? 
Please tick all that apply
15. Do you have a pre-dialysis education day*? 
 
*Group session with other pre-dialysis patients 
*
 
Questions regarding CKD in your unit
Consultant/registrar consultation
 
DVD education materials to take home
 
Written material to take home
 
Translated (if appropriate) written material (except Welsh)
 
Computer-based education programme
 
Group session with other pre-dialysis patients
 
Talk from a patient on conservative care
 
Talk from a patient on centre HD
 
Talk from a patient on home HD
 
Talk from a patient on PD
 
Talk from a patient with functioning transplant
 
Cultural/language-matched nurse educators
 
Flexibility to allow extra education time for those who need it
 
Visit to an HD unit
 
Formal case-by-case MSRT discussion
 
Other (please specify)
 
 
Yes
 
No
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16. Which of the following topics are usually covered during the pre-dialysis education 
day? 
Please tick all that apply
17. Do your consultants share responsibility for patients with each other? 
Please tick one
The following questions ask you about conservative care in your unit 
18. Does your unit ever have patients with CKD5* where an active decision is made 
not to dialyse even when they are symptomatic?
*CKD5 is an eGFR less than 15 ml/min for at least 3 months (established kidney failure) 
*
 
Availability of an alternative to dialysis
*
 
Types of dialysis
 
Transplantation
 
Conservative care
 
Side effects
 
Medicines
 
Dietary restrictions
 
Fluid balance
 
CKD-related anaemia
 
Renal bone disease
 
Cardiovascular risk factors
 
Sexual matters
 
Psychological support
 
Other (please specify)
 
 
Yes, they share responsibility for all patients
 
No, they work on a named-patient basis
 
They share responsibility for most patients but take a lead role for individual patients with particular needs
 
Other (Please specify)
 
 
Yes
 
No
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19. How does your unit follow up patients with CKD5 where a decision is made not to 
dialyse?  
Please indicate the approximate percentages followed up as specified below. Totals do 
NOT need to add up to 100%. 
20. What words do you most commonly use in your unit when referring to the care of 
patients with CKD5 where a decision is made not to dialyse? 
Please tick one.
21. Do all consultant nephrologists follow the same practice regarding patients with 
CKD5 where a decision is made not to dialyse?
Availability of an alternative to dialysis
*
≤25% 26-50% 51-75% 76-100% N/A
In a dedicated programme 
with its own clinic for those 
patients
In a pre-dialysis clinic/low 
clearance clinic
In a general nephrology 
clinic
Patients are referred back 
to primary care and unit 
provides care in 
collaboration with GPs
Other
*
 
(Please specify and indicate percentage ) 
Conservative kidney management
 
Conservative management
 
Conservative care management
 
Maximum conservative management
 
Non-dialysis care
 
Supportive care
 
Palliative care
 
Other (Please specify)
 
 
Yes
 
No
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22. How much do they differ? 
Please tick one
23. How do they differ?
 
24. Please explain why you always offer RRT to patients irrespective of their 
comorbidities.
 
25. Please add any additional thoughts on care for patients with CKD5 where a 
decision is made not to dialyse.
 
In the following questions, the term ‘conservative care’ will be used to describe the situation where a decision is made 
not to dialyse. Although different terminology may be used in your unit, please answer the questions with this patient 
group in mind. 
Availability of an alternative to dialysis
*
 
Availability of an alternative to dialysis
*
*
 
The development and implementation of conservative care in your unit
Slightly
 
Moderately
 
Greatly
 
Other (Please specify how)
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26. Is there a written guideline for how to manage patients on conservative care (other 
than a palliative care/symptom control guideline)?
27. Which staff member(s) predominantly led the development of this policy? 
Please tick all that apply
28. Is there a single person or team primarily responsible for conservative care in your 
unit?
29. What is their position? 
Please tick all that apply
 
The development and implementation of conservative care in your unit
 
The development and implementation of conservative care in your unit
Yes
 
No, but in preparation
 
No
 
Consultant nephrologist
 
Consultant in palliative care
 
Renal nurse
 
Palliative care nurse within the renal unit
 
Palliative care nurse from community team/other hospital department
 
Other (Please specify)
 
 
Yes
 
No
 
Consultant nephrologist(s)
 
Palliative care consultant(s)
 
Nurse(s)
 
Other (Please specify)
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30. Does your unit provide renal staff with formal training or education regarding 
conservative care?
31. Approximately what percentage of the following staff members have received the 
training?
*
 
The development and implementation of conservative care in your unit
≤25% 26-50% 51-75% 76-100% N/A
Consultant nephrologists
Renal registrars
Renal nurses
Diabetes nurses
Social workers
Occupational therapists
Physiotherapists
Dieticians
Pharmacists
Psychologists
Pre-dialysis education 
providers
Anaemia nurses
Vascular access 
coordinators
Counsellors
Management/administrative
staff
Other
 
The development and implementation of conservative care in your unit
Yes
 
No, in preparation
 
No
 
(Please specify and indicate percentage) 
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32. Why is formal training or education regarding conservative care not provided for 
your staff? 
Please tick all that apply
 
The development and implementation of conservative care in your unit
Lack of funding
 
Lack of time
 
Lack of appropriate person to organise the training
 
Consultants’ lack of interest in the training
 
Clinical director’s lack of interest in the training
 
Other staff members’ lack of interest in the training
 
We do not need formal training as conservative care is an ingrained culture in the unit
 
Other (Please specify)
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33. How did each of the factors listed below influence the development of the 
conservative care programme in your unit?  
Please indicate if each of the factors below positively or negatively influenced the 
development of the conservative care programme. 
34. In calendar year 2012, approximately how many CKD5 patients aged 75 and over 
were cared for by your renal service? 
(Please exclude patients with a failing kidney transplant) 
35. Of those, how many were on conservative care and followed up in your unit? 
If you don't know the number, please answer the next question instead.
*
Positively influenced Negatively influenced No effect
Frequency of late referrals
Nephrologists’ attitudes 
towards conservative care
Nurses’ attitudes towards 
conservative care
Other unit staff’s attitudes 
towards conservative care
Patient/family/carers’ 
attitudes towards 
conservative care
Attitudes of people from 
different ethnicity/culture 
towards conservative care
Availability of staff 
experienced in 
conservative care
Availability of funding 
specifically for 
conservative care
Payment-by-Results tariff 
for dialysis
Other
*
Please enter number
Please enter number
(Please specify) 
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36. Of those, approximately what % were on conservative care and followed up in your 
unit?
37. In 2012, how many patients aged 75 and over in your unit chose to have 
conservative care, became symptomatic of advanced CKD and did not have dialysis? 
38. Does your unit have staff whose time is specifically allocated for CKD 5 patients 
on conservative care?
*
Please enter number
If you don't know, please 
tell us why not.
*
 
The development and implementation of conservative care in your unit
0%
 
1-9%
 
10-19%
 
20-29%
 
30-39%
 
40-49%
 
50-59%
 
60-69%
 
70-79%
 
80-89%
 
90-99%
 
100%
 
Don't know. (please tell us why not)
 
 
Yes
 
No
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39. How much time do the following staff have specifically allocated for CKD 5 patients 
on conservative care? 
Please enter number of full-time equivalent (FTE) hours for each discipline.  
(e.g. If you have two nurses with 0.5 FTE, enter 1.0) 
40. Do you have clinics exclusively for CKD 5 conservative care patients?
41. How often do you run conservative care clinics in your renal unit and outside the 
main renal unit? 
Please tick one for each row
Consultant nephrologists
Renal registrars
Renal nurses
Diabetes nurses
Social workers
Occupational therapists
Dieticians
Pharmacists
Psychologists
Pre-dialysis education 
providers
Anaemia nurses
Vascular access 
coordinators
Counsellors
Management/administratie 
staff
Other (Please specify and 
enter number of FTE hours)
*
 
The development and implementation of conservative care in your unit
Once a week Once a fortnight Once a month Other N/A
In your renal unit
Outside the main renal 
unit
 
The development and implementation of conservative care in your unit
Yes
 
No
 
If other is chosen please give details 
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42. Where are CKD 5 patients receiving conservative care most commonly seen or 
followed-up by clinical staff? 
Please tick one 
43. How often are your CKD 5 conservative care patients most commonly seen?  
Please tick one for each row 
 
The development and implementation of conservative care in your unit
Weekly Monthly 3 monthly 6 monthly Other
Symptomatic patients
Asymptomatic patients
In a general nephrology clinic
 
In a pre-dialysis clinic/low clearance clinic
 
In own home by renal team
 
In own home by GP/community team
 
At GP surgery
 
Telephone clinics run by renal unit
 
Other (Please specify)
 
 
If other is chosen please give details 
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44. What are the key components of conservative care provided to patients in your 
renal service?  
Please tick all that apply
45. Do you have any funding dedicated to providing conservative care in your renal 
service? 
46. Is the funding part of routine NHS income or from non-NHS sources?  
Please tick one 
*
*
 
The development and implementation of conservative care in your unit
Clinic consultations
 
Blood results review
 
The provision of EPO (erythropoietin) and iron therapy
 
Symptom assessment and management
 
Prescription of medication for renal symptoms (fluid retention, itching, etc)
 
Telephone support for patients
 
Telephone support for carers
 
Home visits by renal staff
 
Dietary advice
 
Social circumstances review by social workers attached to the renal unit or hospital
 
Advice on home environment by occupational therapist attached to the renal unit or hospital
 
Advanced care planning
 
Communication with primary care team for Gold Standards Framework approach
 
Psychological support
 
Other (Please specify)
 
 
Yes
 
No
 
Routine NHS income
 
Non-NHS sources
 
Both
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47. How much annual funding was dedicated to providing conservative care in the 
2011/12 financial year (April 2011 – March 2012)?  
Please enter number
48. In your unit, is the option of conservative care discussed with all CKD 5 patients 
aged 75 years and over? (excluding emergency patients)
49. If the option of conservative care is not discussed with all CKD 5 patients aged 75 
years and over, please tell us how the decision is made whether or not to discuss 
conservative care with a patient? 
Please tick all that apply
Overall 
£
If you 
don't 
know, 
please 
tell us 
why 
not.
 
Discussing conservative care with patients
*
 
Discussing conservative care with patients
*
Yes
 
No
 
I don't know (Please tell us why not)
 
 
Consultant nephrologist in charge of patient decides alone
 
Consultant nephrologist in charge of patient decides with input from other consultants
 
Consultant nephrologist in charge of patient decides with input from other professionals during an MSRT meeting
 
Clinical nurse specialist/consultant nurse in charge of patient decides alone
 
Clinical nurse specialist/consultant nurse in charge of patient decides with input from consultants
 
Clinical nurse specialist/consultant nurse in charge of patient decides with input from other professionals during an MSRT meeting
 
The decision-making is a reactive process during the consultation
 
Only if patient/carer asks about alternatives to dialysis
 
Other (Please specify)
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50. Which of the following factors are likely to influence staff when contemplating the 
suitability of conservative care for a patient? 
Please indicate how strongly each would influence a decision to discuss conservative 
care with a patient/carer. Please answer on behalf of all staff members.
* “Would I be surprised if this patient died in the next year?” 
51. When is the option of conservative care most commonly first raised with a 
patient?  
Please tick one
*
Not at all Very little Little Somewhat Strongly Very strongly
Response to the ‘surprise’ 
question*
Frailty
Extent and severity of co-
morbidities
Cognitive status
Functional status
Uraemic symptoms
Rate of decline of kidney 
function
Social support
Distance from dialysis unit 
to home
Patient’s current quality of 
life
Patient preference for 
conservative care
Carer preference for 
conservative care
Consultant preference for 
conservative care
Other
*
(Please specify and rate) 
When estimated GFR reaches a certain level
 
When they are referred to the pre-dialysis/low clearance clinic
 
When dialysis access needs to be performed
 
When symptoms start
 
At a specific time prior to the anticipated start of dialysis
 
Other (Please specify)
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52. Please specify estimated GFR
53. Please specify when
54. How are patients’ family/carers involved in decision making about conservative 
care? 
Please tick all that apply 
55. Do any renal staff members use practical tools (see below for examples) when 
discussing the option of conservative care with a patient?
Examples 
Booklets / hand outs from national organisation(s) 
Booklets / hand outs written by own renal unit staff 
DVDs from national organisations(s) 
NHS Right Care Patient Decision Aid 
 
Discussing conservative care with patients
eGFR
 
Discussing conservative care with patients
Months
 
Discussing conservative care with patients
 
Discussing conservative care with patients
They are invited to patient education day
 
They are encouraged to attend clinics with patient
 
They are involved in home visits
 
They are involved when patient is revisited regarding conservative care decision
 
Other (please specify)
 
 
Yes
 
No
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56. What do they use when discussing the option of conservative care with a patient?  
Please tick all that apply  
57. If a decision is made not to have dialysis, where is this information recorded? 
Please tick all that apply 
58. If a decision is made not to have dialysis, is this decision reviewed at any time? 
59. When is the decision reviewed? 
 
60. Do patients who decide not to have dialysis ever change their mind and start 
dialysis?
 
Discussing conservative care with patients
*
 
Discussing conservative care with patients
Booklets / hand outs from national organisation(s)
 
Booklets / hand outs written by own renal unit staff
 
DVDs from national organisations(s)
 
NHS Right Care Patient Decision Aid
 
Other (Please specify)
 
 
Medical notes
 
Renal database
 
GP database
 
Out of hours (ambulance service) database
 
Other (Please specify)
 
 
Yes
 
No
 
Yes
 
No
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61. How frequently is the change of mind due to the following reasons? 
Please indicate how frequently each of the reasons listed below cause the change of 
mind. 
62. Is vascular access ever created for patients who have opted for conservative care?
63. Please tell us why vascular access is created.
 
Never Very rarely Rarely Occasionally Frequently Very Frequently
Because patients change 
their mind after having 
had longer to think about 
their decision
Because a patient’s family 
wants them to have 
dialysis and a patient 
agrees
Because patients are 
acutely admitted to 
hospital and dialysis is 
started without time for a 
full discussion between 
family and clinical team
Because patients present 
unconscious without 
having recorded their 
wishes in writing and the 
family insist on dialysis
Because patients have 
symptoms that cannot be 
controlled with 
conservative treatment
Other
 
Discussing conservative care with patients
 
Working with primary care and general practitioners
(Please specify) 
Yes
 
No
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64. Once a decision has been made that a patient aged 75 years and over with CKD5 
will not have dialysis, how are GPs involved in their care?  
Please tick one 
65. What is the role of GPs in the management of CKD 5 patients receiving conservative 
care? 
Please tick all that apply 
*ACP is a voluntary process of discussion about future care between an individual and their care providers, and their family and friends if the 
individual wishes. An ACP discussion might include: the individual’s concerns and wishes, their important values or personal goals for care, 
their understanding about their illness and prognosis, and their preferences and wishes for types of care or treatment that may be beneficial in 
the future and the availability of these.  
66. Do you provide GPs and/or their practice team with information or advice 
regarding the treatment of CKD5 patients receiving conservative care?
*
*
 
Working with primary care and general practitioners
Patients are primarily kept under the care of the renal unit with little GP involvement
 
Patients are referred back to GPs but care of patients is shared between GPs and the renal unit (e.g. patients are seen by GPs who 
liaise with the renal unit regarding renal symptom control) 
Patients are referred back to GPs and cared for under primary care only
 
Mix of all three as it varies between nephrologists
 
Mix of all three as it varies by patient/patient preference
 
Other (Please specify)
 
 
GPs liaise with the renal unit for specialist support
 
GPs arrange and interpret blood tests
 
GPs arrange blood tests but liaise with renal unit for their interpretation
 
GPs check patients’ medication
 
GPs regularly (not on demand) assess patients in the GP surgery
 
GPs regularly (not on demand) assess patients via home visits
 
GPs/primary care staff provide/organise palliative care support at the end of life
 
GPs discuss advance care planning (ACP*) with patients
 
Other (Please specify)
 
 
Yes
 
No
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67. What do you provide to GPs regarding the treatment of CKD5 patients receiving 
conservative care? 
Please tick all that apply
68. Please tell us why information/advice regarding conservative care is not provided to 
GPs and/or their practice team. 
Please tick all that apply 
69. Please use the space below to tell us any other thoughts on the role of primary care 
in the provision of conservative care for renal patients.
 
 
Working with primary care and general practitioners
 
Working with primary care and general practitioners
 
End of life care
Verbal advice
 
Written advice / guidelines
 
Educational meetings
 
Other (Please specify)
 
 
Lack of time
 
Lack of funding
 
Opinion of consultants
 
Opinion of clinical directors
 
Opinion of other staff members
 
GPs do not wish to have any information/advice from the renal unit
 
Other (Please specify)
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70. Does your unit have a written guideline for renal end of life care?
71. Do you identify conservative care patients approaching end of life through use of 
a register?
72. How likely are the following factors to influence a decision to add a patient to the 
end of life register? 
Please indicate how strongly each of the factors listed below influence this decision 
*
 
End of life care
*
Not at all Very little Little Somewhat Strongly Very strongly
Surprise question
Estimated GFR level
Measured GFR level
Comorbidities
Frailty
Unexpected weight loss
Quality of Life
Symptoms
Frequent hospitalisation
Other
 
End of life care
Yes
 
No, but in preparation
 
No
 
Yes
 
No
 
(Please specify and rate) 
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73. If you do not use a register, how do you identify conservative care patients 
approaching end of life?
 
74. Is advance care planning (ACP*) used in end of life care by renal staff? 
*ACP is a voluntary process of discussion about future care between an individual and their care providers, and their family and friends if the 
individual wishes. An ACP discussion might include: the individual’s concerns and wishes, their important values or personal goals for care, 
their understanding about their illness and prognosis, and their preferences and wishes for types of care or treatment that may be beneficial in 
the future and the availability of these. 
75. Who is involved in advance care planning in your unit? 
Please tick all that apply 
76. Have any of your staff had any training in palliative/end of life care specifically for 
renal patients? 
Please tick one 
*
 
End of life care
 
End of life care
Yes
 
No
 
Consultant nephrologist(s)
 
Nurse(s)
 
Palliative care specialist(s)
 
Social worker(s)
 
Counsellor(s)/psychologist(s)
 
Other (Please specify)
 
 
Yes, everyone has
 
Yes, the majority of the staff have
 
Yes, about half of the staff have
 
Yes, but only the small number of the staff have
 
No
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77. With which services does your unit liaise for patients receiving conservative care 
approaching end of life?  
Please tick all that apply 
78. You have chosen 'none' in the previous question. Please tell us why your unit 
does not liaise with any services for patients receiving conservative care approaching 
end of life.
 
79. Where do patients receive these services? 
Please tick all that apply 
*
 
End of life care
*
 
End of life care
Specialist palliative care services within the hospital
 
Specialist palliative care services from local hospice
 
Specialist palliative care services in the community (e.g. Macmillan nurses)
 
Primary care team
 
None
 
Other (please specify)
 
 
Within the hospital as in-patients
 
Within the hospital as out-patients
 
At home
 
At hospice where patient is admitted at end of life
 
At GP practice
 
Other (Please specify)
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80. What services do they provide for renal patients receiving conservative care in your 
unit?  
Please tick all that apply 
81. Do you provide palliative care specialists with training or advice regarding the 
management of renal patients?
82. What do you provide? 
Tick all that apply
83. Is the quality of conservative care provided in your unit regularly evaluated?
 
End of life care
*
 
 
Evaluation of the provision of conservative care in your unit
*
 
Evaluation of the provision of conservative care in your unit
They help to write guidelines on how to treat patients receiving conservative care
 
They provide symptom management at the end of life
 
They support patients at home out of hours
 
They discuss ACP with patients
 
Admission to the hospice as required
 
Other (Please specify)
 
 
Yes
 
No
 
Verbal advice
 
Written advice / guidelines
 
Educational meetings
 
Other (please specify)
 
 
Yes
 
No
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84. What measures or information do you use?  
Please tick all that apply 
Symptoms
 
Survival
 
Hospitalisation
 
Quality of life
 
Carer burden
 
Place of death
 
Survey with patients/carers about their experience of conservative care
 
Other (please specify)
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85. Which factors do you think could help improve the provision of conservative care 
in your unit? 
Please indicate how strongly you agree or disagree with each of the following 
*
Strongly agree Agree
Neither agree nor 
disagree
Disagree Strongly disagree
Increasing the number of 
staff dedicated to 
conservative care
Increasing the number of 
times conservative care 
patients are seen by staff
Increasing clinic time
Providing better end of life 
care by implementing ACP
Improving computer systems 
by integrating primary care 
data with renal data
Increasing involvement of 
allied healthcare 
professionals (e.g. social 
worker) in treatment 
decision-making
Increasing 
communication/involvement 
with GPs
Increasing 
communication/involvement 
with community teams
Increasing 
communication/involvement 
with other hospitals
Increasing 
communication/involvement 
with palliative care teams
Providing renal staff 
members with more 
education/training regarding 
conservative care
Providing GPs with more 
education/training regarding 
conservative care
Providing palliative care 
teams with more 
education/training regarding 
renal conservative care
Providing patients with 
better decision aids about 
conservative care
More funding to develop 
conservative care within unit
Having funding models 
specifically designed to 
reimburse the costs of 
delivering CKM
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Having a written 
conservative care policy
Having dedicated 
conservative care clinics
Establishing a system for 
evaluating the provision of 
conservative care
Having better evidence of 
the comparative outcomes 
between patients who 
receive conservative care 
and those who receive 
dialysis
Having better evidence of 
the comparative costs 
between patients who 
receive conservative care 
and those who receive 
dialysis
Other
(Please specify and rate) 
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86. What, if any, of the following changes are planned in your unit regarding the 
provision of conservative care?  
Please tick all that apply 
87. You have chosen 'none planned' in the previous question. Please indicate why 
no change is planned in your unit regarding the provision of conservative care.
 
*
 
Evaluation of the provision of conservative care in your unit
*
Increasing the number of staff dedicated to conservative care
 
Increasing the number of times conservative care patients are seen by staff
 
Increasing clinic time
 
Providing better end of life care by implementing ACP
 
Improving computer systems by integrating primary care data with renal data
 
Increasing involvement of allied healthcare professionals (i.e. social worker) in treatment decision-making
 
Increasing communication/involvement with GPs
 
Increasing communication/involvement with community teams
 
Increasing communication/involvement with other hospitals
 
Increasing communication/involvement with palliative care teams
 
Providing renal staff members with more education/training regarding conservative care
 
Providing GPs with more education/training regarding conservative care
 
Providing palliative care teams with more education/training regarding renal conservative care
 
Providing patients with better decision aids about conservative care
 
Obtaining funding to develop conservative care
 
Writing up a conservative care policy
 
Having dedicated conservative care clinics
 
Establishing a system for evaluating the provision of conservative care
 
None planned
 
Other (Please specify)
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88. If you would like to make any further comments on conservative care, please use 
the space below.
 
There is a lack of high quality evidence on the outcomes of conservative care for patients and clinicians to consider 
when deciding whether to have dialysis or conservative care, and for commissioners and providers on the cost 
effectiveness of such care. We are keen to address this evidence gap by building on this current research.  
89. Would your unit consider it appropriate to enter a patient aged 75 and over with 
CKD5 into a randomised clinical trial comparing conservative care versus dialysis?  
(An abstract of the proposed design is provided below) 
 
Future research
*
Yes, for some patients
 
No, never
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The following is an abstract of the proposed research described above. The study will be informed by the findings from this national survey 
and called CKMAPPS 2. 
 
CKMAPPS (2): a multicentre study to compare the efficacy and effectiveness of conservative kidney management (CKM) and dialysis. 
 
Rationale  
The UK has been at the forefront of developing alternative pathways to dialysis as an option for older patients with end-stage renal failure. 
Limited research to date suggests that in elderly dependent patients with high co-morbidity, dialysis confers only a small survival advantage in 
terms of hospital-free days.  
 
However all studies have been single centred, retrospective and observational, and have not fully addressed the problem of bias by indication. 
In addition there are little data comparing quality of life on conservative kidney management (CKM) and dialysis, or a health economic 
evaluation. 
 
To facilitate patient choice and to inform commissioning decisions, information on quality of life, prognosis and health care resource use in 
comparable patients on CKM and dialysis is required. We are planning a multicentre study to compare the effects of CKM and dialysis on 
outcomes for patients and their carers, and associated resource use and costs for NHS and social care. 
 
The study design could be a randomised controlled trial or a prospective observational study. Although an RCT would be scientifically more 
rigorous, it would raise ethical and practical issues. We compare these alternatives below: 
 
RCT  
- Patients aged 75+ with progressive ESRF in whom there is uncertainty of the benefits and risks of dialysis vs CKM. 
- Patients would be approached and asked whether they would be willing to be randomised on an intention to treat basis to CKM or dialysis. 
- Patients would be followed for up to 3 years to capture: Hospitalisation, Mortality, Cause and place of death, Quality of life (repeated 
assessments, 6 monthly) e.g. EQ5D, KDQoL, POS , NHS and social care resource use (GP and OP visits, medication, IP days ), Care r burden 
and quality of life. 
 
Advantages 
- Most robust design to overcome selection effects  
 
Disadvantages  
- Units would require CKM pathway and capacity to provide both modes as required over course of the study  
- Low patient recruitment given likely patient preferences and lack of clinician uncertainty  
 
Prospective observational study 
- Patients aged 75+ with progressive ESRF who reach eGFR of 15ml/min/1.73m2 would be recruited and followed up for 3 years with similar 
data collection as in the RCT.  
- This is a complex design given the very strong selection effects for CKM.  
- Potential methods for adjusting for this are to use: 
i) the Instrumental variable (IV) approach at Renal Unit level as used in DOPPS [the current CKMAPPS survey would provide data for this]  
i i) Marginal structural models allowing for time varying start of RRT (and CKM) and time varying covariates such as comorbidity  
i i i) Propensity scoring to adjust for confounding where socio-demographic and clinical factors associated with starting CKM are used to derive a 
score which is used to match patients who start dialysis 
 
Advantages 
- Higher patient recruitment 
- Can include units with and without CKM pathway 
 
Disadvantages 
- Bias because of the selection effects. 
- Number of units needed for IV approach (20+) 
 
  
Future research
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90. Would your unit be willing to participate in such a trial?
91. Would your unit consider entering CKD5 patients aged 75 and over into a 
prospective multicentre observational study to compare conservative care and dialysis, 
which addresses the major selection bias?  
(The same abstract shown previsously is provided below again) 
 
*
*
Yes, definitely
 
Maybe
 
No
 
Other (Please specify)
 
 
Yes, for some patients
 
No, never
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The following is an abstract of the proposed research described above. The study will be informed by the findings from this national survey 
and called CKMAPPS 2. 
 
CKMAPPS (2): a multicentre study to compare the efficacy and effectiveness of conservative kidney management (CKM) and dialysis. 
 
Rationale  
The UK has been at the forefront of developing alternative pathways to dialysis as an option for older patients with end-stage renal failure. 
Limited research to date suggests that in elderly dependent patients with high co-morbidity, dialysis confers only a small survival advantage in 
terms of hospital-free days.  
 
However all studies have been single centred, retrospective and observational, and have not fully addressed the problem of bias by indication. 
In addition there are little data comparing quality of life on conservative kidney management (CKM) and dialysis, or a health economic 
evaluation. 
 
To facilitate patient choice and to inform commissioning decisions, information on quality of life, prognosis and health care resource use in 
comparable patients on CKM and dialysis is required. We are planning a multicentre study to compare the effects of CKM and dialysis on 
outcomes for patients and their carers, and associated resource use and costs for NHS and social care. 
 
The study design could be a randomised controlled trial or a prospective observational study. Although an RCT would be scientifically more 
rigorous, it would raise ethical and practical issues. We compare these alternatives below: 
 
RCT  
- Patients aged 75+ with progressive ESRF in whom there is uncertainty of the benefits and risks of dialysis vs CKM. 
- Patients would be approached and asked whether they would be willing to be randomised on an intention to treat basis to CKM or dialysis. 
- Patients would be followed for up to 3 years to capture: Hospitalisation, Mortality, Cause and place of death, Quality of life (repeated 
assessments, 6 monthly) e.g. EQ5D, KDQoL, POS , NHS and social care resource use (GP and OP visits, medication, IP days ), Care r burden 
and quality of life. 
 
Advantages 
- Most robust design to overcome selection effects  
 
Disadvantages  
- Units would require CKM pathway and capacity to provide both modes as required over course of the study  
- Low patient recruitment given likely patient preferences and lack of clinician uncertainty  
 
Prospective observational study 
- Patients aged 75+ with progressive ESRF who reach eGFR of 15ml/min/1.73m2 would be recruited and followed up for 3 years with similar 
data collection as in the RCT.  
- This is a complex design given the very strong selection effects for CKM.  
- Potential methods for adjusting for this are to use: 
i) the Instrumental variable (IV) approach at Renal Unit level as used in DOPPS [the current CKMAPPS survey would provide data for this]  
ii) Marginal structural models allowing for time varying start of RRT (and CKM) and time varying covariates such as comorbidity  
iii) Propensity scoring to adjust for confounding where socio-demographic and clinical factors associated with starting CKM are used to derive a 
score which is used to match patients who start dialysis 
 
Advantages 
- Higher patient recruitment 
- Can include units with and without CKM pathway 
 
Disadvantages 
- Bias because of the selection effects. 
- Number of units needed for IV approach (20+) 
  
Future research
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Page 36
92. Would your unit be willing to participate in such a study?
93. Please give your role in renal unit.
 
94. If someone else helped you complete this questionnaire, please give their role in 
renal unit.
 
95. Please provide your contact details* in case we need to contact you.  
*This information will not be used in any research reports 
*
 
Details of person completing the questionnaire
*
*
*
Name:
Email Address:
Phone Number:
Yes, definitely
 
Maybe
 
No
 
Other (Please specify)
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Appendix 4 Factors used in analysis
Group 1: factors related to chronic kidney management
resources/size
CKM size (small or large).
Availability of staff responsible for CKM.
Availability of staff whose time is specifically allocated for CKM patients.
Group 2: factors related to the general unit organisation for
patients with chronic kidney disease
Whether or not to have regular MSRT meetings.
Availability of pre-dialysis clinics.
Availability of pre-dialysis education day.
Whether or not consultants share responsibility for patients with each other.
Group 3: factors related to chronic kidney management practices
Whether or not same practice regarding CKM is provided.
Availability of written CKM guideline.
Availability of dedicated CKM clinics.
Group 4: factors related to chronic kidney management resources
Availability of funding for CKM.
Group 5: factors related to chronic kidney management
decision-making
Whether or not CKM is discussed with all CKD5 patients aged 75 years and over.
Use of decision aids.
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Group 6: factors related to training
Provision of formal CKM training to renal staff.
Training in palliative/end-of-life care for renal patients for staff.
Provision of training about management of renal patients to palliative care specialists.
Group 7: factors related to general practitioner involvement
How are GPs involved with CKM patients.
Provision of information/advice regarding treatment of CKM patients to GPs.
Group 8: factors related to end-of-life care
Availability of written guideline for renal end-of-life care.
Use of register to identify CKM patients approaching end of life.
Use of advance care planning.
Group 9: factors related to future research
Whether or not to consider RCT for CKD5 patients.
Whether or not to consider observational study for CKD5 patients.
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Appendix 5 Conservative kidney management
unit size
Renal unit
Q2.5.1a: no. of CKD5 patients
aged 75 years and over on CKM
Q2.6a: no. of patients aged
75 years and over who became
symptomatic and still on CKM CKM size used in the reportb
1 – – No response
2 – 11 Small
3 9 – Small
4 11 3 Small
5 – – No response
6 50 25 Large
7 – 30 Large
8 – – No response
9 – – No response
10 47 – Large
11 35 – Large
12 152 – Large
13 70 – Large
14 57 – Large
15 – – No response
16 – 5 Small
17 – 5 Small
18 112 – Large
19 60 6 Large
20 45 – Large
21 – – No response
22 6 6 Small
23 – – No response
24 117 – Large
25 – – No response
26 25 5 Small
27 – – No response
28 – 6 Small
29 4 1 Small
30 – 4 Small
31 5 2 Small
32 – – No response
33 100 – Large
34 – – No response
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Renal unit
Q2.5.1a: no. of CKD5 patients
aged 75 years and over on CKM
Q2.6a: no. of patients aged
75 years and over who became
symptomatic and still on CKM CKM size used in the reportb
35 – – No response
36 54 29 Large
37 70 14 Large
38 83 28 Large
39 127 – Large
40 35 20 Large
41 – – No response
42 25 24 Large
43 – – No response
44 86 – Large
45 – – No response
46 – – No response
47 – – No response
48 – 2 Small
49 26 26 Large
50 – – No response
51 20 – Small
52 52 40 Large
53 – 3 Small
54 18 2 Small
55 128 15 Large
56 150 50 Large
57 – 20 Large
58 12 5 Small
59 20 8 Small
60 20 – Small
61 – – No response
62 – – No response
63 – 10 Small
64 5 3 Small
65 – 15 Small
66 25 5 Small
67 – 13 Small
a See below for question wording.
b Units were characterised using the combination of data from Q2.5.1 and Q2.6. (See below for categorisation process.)
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Questions in the survey
Question 2.5.1. Of those, how many were on conservative care and followed up in your unit? If you don’t
know the number, please answer the next question instead.
Question 2.6. In 2012, how many patients aged 75 and over in your unit chose to have conservative care,
became symptomatic of advanced CKD and did not have dialysis?
Chronic kidney management size categorisation process
Units were divided into two categories based on their responses to the survey questions regarding the
number of CKM patients aged 75 years and over in calendar year 2012 (Question 2.5.1) and the number
of patients aged 75 years and over who stayed on CKM after they became symptomatic in the same
year (Question 2.6).
Units that had ≥ 25 CKM patients and/or ≥ 20 symptomatic CKM patients were categorised as units
with a larger size of CKM (24 units), and the rest of the units were categorised as those with a smaller
size of CKM (23 units). (This resulted in including three units that had ≥ 25 CKM patients but had fewer
than 20 symptomatic patients in the ‘large’ group.)
Twelve units that provided only the number of symptomatic CKM patients were looked at; two units
with ≥ 20 symptomatic CKM patients were added to the large category, and the rest were added to the
small category, which made the total numbers of units with ‘large’ CKM and ‘small’ CKM 24 and 23
respectively. (There was no response from 20 units.)
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Appendix 6 Conservative Kidney Management
Assessment of Practice Patterns Study survey:
results tables
Questions regarding chronic kidney disease in your unit
1. How many FTE (full time equivalent) consultants (including CKD, dialysis and transplant) do you have
working in nephrology in your unit? ___ FTE
Statistics
n Valid 65
Missing 2
Mean 7.35
Median 6.60
Range 39
Minimum 1
Maximum 40
Percentiles 25 3.50
50 6.60
75 9.20
2. Do you have a Multi-Skilled Renal Team (MSRT) available to manage patients approaching RRT in your unit?
Answer options Response per cent Response count
Yes 98.5 66
No 1.5 1
Answered question 67
Skipped question 0
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2.1. Do you have regular MSRT meetings?
Answer options Response per cent Response count
Yes 87.9 58
No 12.1 8
Answered question 66
Skipped question 1
2.1.1. If yes, how often do you have the meetings?
Answer options Response per cent Response count
Once a week 56.9 33
Once a fortnight 8.6 5
Once a month 24.1 14
Other (please specify) 10.4 6
Answered question 58
Skipped question 9
Other
l Only meetings for patients attending low clearance in [unit].
l Every 3 months meeting of full team: but weekly discussions of individual patients.
l Twice a week.
l Joint clinic and specialist nursing staff for this patient cohort.
l Transplant and advanced kidney care twice weekly.
l Pre low clearance clinic generally weekly.
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2.2. Which of the following staff members are involved in your MSRT and usually attend the MSRT meeting?
Please tick all that apply in each column below
Answer options Staff involved in MSRT
Staff who usually
attend MSRT meeting Response count
Consultant nephrologists 52 45 58
Renal registrars 40 30 44
Renal nurses 51 43 56
Palliative care consultants 20 5 21
Palliative care registrars 3 1 4
Renal palliative care clinical nurse specialists 19 10 20
Surgeons 19 3 19
SAS grade doctors 15 8 15
Diabetes nurses 2 1 2
Social workers 27 18 31
Occupational therapists 7 2 7
Physiotherapists 5 2 6
Dietitians 46 31 51
Pharmacists 30 14 34
Psychologists 15 9 18
Pre-dialysis education providers 44 29 46
Anaemia nurses 43 27 45
Vascular access coordinators 42 24 42
Counsellors 16 7 16
Other 4 2 5
Please specify 9
Answered question 58
Skipped question 9
Other
l Haemodialysis and Home therapies nurses.
l Spiritual team.
l Transplant recipient coordinator and live donor coordinators.
l Renal managers.
l F1,ST2.
l Meeting supported by clerical team.
l Renal Technicians.
l Renal gp.
l Ward nurses.
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3. Do you run clinics for CKD patients in neighbouring hospitals?
Answer options Response per cent Response count
Yes 88.1 59
No 11.9 8
Answered question 67
Skipped question 0
Statistics
3.1. How many neighbouring
hospitals do you serve?
3.2. In how many of the neighbouring
hospitals do you have renal clinics?
n
Valid 58 58
Missing 9 9
Median 3.00 3.00
Standard deviation 2.4 2.1
Range 11 10
Minimum 1 1
Maximum 12 11
Percentiles
25 1.00 1.00
50 3.00 3.00
75 5.00 4.25
4. Do you have a pre-dialysis clinic or equivalent for managing patients approaching RRT?
Answer options Response per cent Response count
Yes 83.6 56
No 10.4 7
No, but we are planning
to set up similar clinics
6.0 4
Answered question 67
Skipped question 0
4.1. Do all consultants who have CKD patients use the pre-dialysis clinic?
Answer options Response per cent Response count
Yes 73.2 41
No 26.8 15
Answered question 56
Skipped question 11
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4.1.1. Why don’t all consultants who have CKD patients use the pre-dialysis clinic? Please tick one
Answer options Response per cent Response count
Because some consultants think that long-term continuity
of care by the same consultant is more important
20.0 3
Because some consultants’ clinics are at one of a
neighbouring hospitals and the pre-dialysis clinic is
in the main hospital. They don’t want their patients
to travel to the main hospital
20.0 3
Other (please specify) 60.0 9
Answered question 15
Skipped question 52
Other
l We are in the process of setting up formal pre-dialysis clinics in all areas but until this happens, there aren’t dedicated
clinics although CKD pts access and see pre-dialysis counsellors, anaemia management, vascular access/PD nurses
where appropriate and also patient counsellors when relevant.
l Patients are seen by the advanced kidney care nurses for education, anaemia management, access referral, hepatitis B
vaccination. Each AKC nurse is attached to one of the hospitals & the designated consultant(s). So patients
approaching dialysis can be seen closer to home rather than having to travel to the two pre dx clinics at [unit name]
(Covering East & West Kent). The designated clinics run weekly. Patients may return to general nephrology clinics at the
other 4 satellite units at neighbouring hospitals if they chose to be seen closer to home.
l Early CKD (up to eGFR 20ml/min) are seen in CKD or nephrology clinic under named consultants. Patients are then
referred to Advanced Kidney Care (pre-dialysis) which may then be a different named consultant for continuity of care
within pre-dialysis.
l Both the above. Also practical issues related to transport.
l There are differing models across our geographical patch.
l Both of the above selected.
l They have different clinic.
l The pre-dialysis clinics are nurse led.
l Because other members of MSRT cannot support all pre-dialysis patients attending at same clinic. Plus continuity valued.
5. What percentage of the outpatients under follow up in your renal clinic, who are approaching dialysis,
receive the following?
Answer options ≤ 25% 26–50% 51–75% 76–100% Response count
Nurse-led education 0 0 3 64 67
Home visit 21 10 9 24 64
Trained counsellor/psychologist input 51 10 2 2 65
Occupational therapist and/or social work input 38 16 9 2 65
Answered question 67
Skipped question 0
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6. How is pre-dialysis education delivered in your unit? Please tick all that apply
Answer options Response per cent Response count
Consultant/registrar consultation 86.6 58
DVD education materials to take home 73.1 49
Written material to take home 95.5 64
Translated (if appropriate) written material (except Welsh) 41.8 28
Computer-based education programme 31.3 21
Group session with other pre-dialysis patients 76.1 51
Talk from a patient on conservative care 13.4 9
Talk from a patient on centre HD 58.2 39
Talk from a patient on home HD 50.7 34
Talk from a patient on peritoneal dialysis 61.2 41
Talk from a patient with functioning transplant 50.7 34
Cultural/language-matched nurse educators 16.4 11
Flexibility to allow extra education time for those who need it 76.1 51
Visit to an HD unit 95.5 64
Formal case-by-case MSRT discussion 41.8 28
Other (please specify) 32.8 22
Answered question 67
Skipped question 0
Others
l Working on translated information Formal case MSRT discussion for selected patients.
l All patients plus families/carers are offered a 1 hour appt for CKD/RRT education, with our pre dx Nurse Specialist,
when all RRT options are discussed and a Kidney Care Plan offered.
l Dedicated pre-dialysis CNS [consultant nurse] team.
l Home visit by CKD nurse.
l One to one (nurse/patient) ASK clinic, a preliminary talk with an advanced kidney care nurse.
l Main education providers pre-dialysis clinical nurse specialists.
l Nurse educators.
l Just beginning to use PDA’s some home visits social worker/counsellor talks and dietician.
l Home Visits by pre-dialysis nurses and counsellors.
l Predialysis nurse education.
l One-to-one discussion/consultation with a Pre Dialysis Nurse and also follow up discussion/consultation. Appointments
arranged around and to follow clinic review with consultant where possible to minimise clinic attendances for patients.
This is not always possible due to the geographical area covered.
l First contact for pre-dialysis education is usually via a home visit when all options are discussed by the nurse.
l We have a peer support programme where patients can access other patients for support.
l Cultural and health improvement offices available.
l All patients get a home visit by educator/counsellor.
l Nurse consultation.
l 1 : 1 WITH PREDIALYSIS SPECIALIST NURSES.
l One to one education as per protocol by kidney failure support nurse. Visit to CAPD unit.
l CKD nurse specialist.
l We have formally established peer meetings if requested, though this would typically be away from the ‘medical’ clinic.
It is usually possible to match modality if requested.
l Renal unit open day 6/12ly with stands for all aspects of rrt, diet, social work, patient groups etc.
l There is a renal nurse lead Dialysis education programme covering almost 99 percent of patients.
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7. Do you have a pre-dialysis education daya?
Answer options Response per cent Response count
Yes 80.6 54
No 19.4 13
Answered question 67
Skipped question 0
a Group session with other pre-dialysis patients.
7.1. Which of the following topics are usually covered during the pre-dialysis education day? Please tick all
that applya
Answer options Response per cent Response count
Types of dialysis 98 52
Transplantation 100 53
Conservative care 85 45
Side effects 85 45
Medicines 87 46
Dietary restrictions 100 53
Fluid balance 89 47
CKD-related anaemia 85 45
Renal bone disease 74 39
Cardiovascular risk factors 66 35
Sexual matters 38 20
Psychological support 79 42
Other (please specify) 26 14
Answered question 53
Skipped question 14
a The paper survey had a Likert scale (never, rarely, occasionally, frequently, and always); however, in the web version we
simplified it to ‘tick all that apply’. Regarding responses in the paper version, only items that were ticked for either
frequently or always were counted as ticked.
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8. Do your consultants share responsibility for patients with each other? Please tick one
Answer options Response per cent Response count
Yes, they share responsibility for all patients 27.3 18
No, they work on a named-patient basis 28.8 19
They share responsibility for most patients but take
a lead role for individual patients with particular needs
30.3 20
Other (please specify) 13.6 9
Answered question 66
Skipped question 1
Other
l Consultants and CNS’s [consultant nurses] have both dedicated patients caseloads and shared patient caseloads MDT
ensures that patient cases are shared to ensure continuity of care when patients are in-patients.
l Mix-all consultants have named patients but will see others e.g. for transplant workup. there is culture of sharing care
and full MDT discussions. patients will move to a different consultant when modality changes.
l Each consultant is assigned to a satellite unit, with responsibility for HD, non dx outpatients in that unit. Consultants
also have areas of interest & are dedicated to each modality. All consultants cover inpatients on a rotational basis.
l Most CKD patients have a particular consultant. They may move to speciality consultants if nearing ESRF or
starting dialysis.
l Leads for HD, PD, LCC [low clearance clinic], Tx . . . shared gen neph, wards and on call.
l Consultant of the week cares for all in-patients, OP clinics are run on a named patient basis but Consultants do see
other colleagues patients when necessary e.g. to cover leave or on-call.
l Missing answer from paper version.
l Share as in-patient.
l Inpatients are shared (on-call person in charge). Outpatients are typically matched to a service or geographical location
e.g. in centre dialysis, or clinic at x hospital.
l Dialysis access clinic run by One consultant Transplant clinic run by one Consultant although all see some transplant pts
in their clinic.
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1. Availability of an alternative to dialysis
1.1. Does your unit ever have patients with CKD5* where an active decision is made not to dialyse even when
they are symptomatic?
Answer options Response per cent Response count
Yes 98.5 66
No 1.5 1
Answered question 67
Skipped question 0
1.1.1. How does your unit follow up patients with CKD5 where a decision is made not to dialyse? Please
indicate the approximate percentages followed up as specified below. Totals do NOT need to add up to 100%
Answer options ≤ 25% 26–50% 51–75% 76–100% N/A Response count
In a dedicated programme with its own clinic
for those patients
14 1 3 9 38 65
In a pre-dialysis clinic/low clearance clinic 9 15 4 24 13 65
In a general nephrology clinic 22 10 8 7 17 65
Patients are referred back to primary care and
unit provides care in collaboration with GPs
40 5 2 5 11 64
Other 11 1 3 3 13 32
(Please specify and indicate percentage) 16
Answered question 66
Skipped question 1
N/A, not applicable.
Other
l Of the 5 consultants, one has a monthly LCC [low clearance clinic] including CKM. I had a dedicated weekly LCC which
has recently been disbanded (into my 2 general nephrology clinics) due to my taking on a home dialysis clinic also.
Therefore, 4/5 consultants see their LCC and CKM patients in their gen neph clinics.
l Our 2 renal community nurses visit our Conservative Care patients at home regularly and liaise with GPs and DNs to
provide care.
l Shared care with primary care is common.
l 50% managed at home by Consultant Nurse in partnership with primary care where appropriate.
l Home visits.
l Referred to palliative care consultant when symptomatic.
l Currently no dedicated clinic to follow up patients who have opted for conservative management. The geographical
area covered and the resources currently available make this difficult to implement.
l Nurse specialist review at home (renal).
l Patient choice between primary care and specialist clinics.
l Dedicated clinic when e-GFR < 12.
l Community based renal palliative sister.
l Dependent on eGFR, home visits undertaken for review.
l Home visit.
l Conservative Care Nurse – Home Visits.
l A patient may not wish to attend a clinic at MRI and will be followed up at a more local OP clinic or in collaboration
with their GP.
l Home visits contribute to the regular reviews.
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1.1.2. What words do you most commonly use in your unit when referring to the care of patients with CKD5
where a decision is made not to dialyse? Please tick one
Answer options Response per cent Response count
Conservative kidney management 4.6 3
Conservative management 46.2 30
Conservative care management 12.3 8
Maximum conservative management 3.1 2
Non-dialysis care 3.1 2
Supportive care 7.7 5
Palliative care 0.0 0
Other (please specify) 23.1 15
Answered question 65
Skipped question 2
Within ‘other’, 11 units indicated they used more than one terminology.
Other
l Conservative management and supportive care.
l Conservative care management and supportive care.
l Conservative management, supportive care, maximum conservative management.
l More than one ticked (conservative kidney management, non-dialysis care, conservative management, conservative
kidney management, palliative care).
l Ticked more than one Conservative kidney management, Conservative management, Conservative care management,
Maximum conservative management, Supportive care.
l Ticked more than one non-dialysis care, conservative management, supportive care.
l 3 options ticked conservative kidney management, conservative management, supportive care.
l Conservative management (Non-dialysis) Many terms used.
l Have ticked five of the above options (Conservative kidney management, conservative management, non-dialysis care,
supportive care, palliative care).
l Three are ticked in post version (Conservative kidney management, conservative management, supportive care).
l No single term. We have as many ‘don’t knows, see when we get there’ as ‘not for dialysis’.
l Active supportive care.
l I’m not sure the terminology here is important it’s the care that is provided that is important patients may need
different care at different times and depending what other comorbidities are present i.e. may start off as max cons
management and then move to palliative care sorry I don’t feel this question is appropriate all terms can be used . . .
l Regular clinic care.
l Conservative care.
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1.1.3. Do all consultant nephrologists follow the same practice regarding patients with CKD5 where a decision is
made not to dialyse?
Answer options Response per cent Response count
Yes 77.3 51
No 22.7 15
Answered question 66
Skipped question 1
1.1.3.1. How much do they differ? Please tick one
Answer options Response per cent Response count
Slightly 66.7 10
Moderately 33.3 5
Greatly 0.0 0
Other (please specify how) 0.0 0
Answered question 15
Skipped question 52
1.1.3.2. How do they differ?
Answer options Response count
4
Answered question 4
Skipped question 63
l Some pts in whom a decision has been made for no dialysis aren’t always referred to conservative care nursing team
but this is improving with better awareness.
l Some are more likely to discharge to primary care and provide telephone advice if needed. Others will keep reviewing
CKM patients until no longer feasible/patient dies.
l Variable level of commitment to conservative care.
l Different views on treatment plans and when to classify patients, and reviewing overall condition.
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2. The development and implementation of conservative care
in your unit
2.1. Is there a written guideline for how to manage patients on conservative care (other than a palliative
care/symptom control guideline)?
Answer options Response per cent Response count
Yes 34.8 23
No, but in preparation 27.3 18
No 37.9 25
Answered question 66
Skipped question 1
2.1.1. Which staff member(s) predominantly led the development of this policy? Please tick all that apply
Answer options Response per cent Response count
Consultant nephrologist 70.0 28
Consultant in palliative care 37.5 15
Renal nurse 75.0 30
Palliative care nurse within the renal unit 15.0 6
Palliative care nurse from community
team/other hospital department
12.5 5
Other (please specify) 17.5 7
Answered question 40
Skipped question 27
Other
l Unit clinical psychologist.
l Dialysis nurses/sisters from all 3 dialysis units [unit names], social worker, counsellor, dialysis nurse educator.
l Consultant Nurse.
l Renal palliative clinical nurse specialist.
l Palliative healthcare assistant and palliative consultant nurse.
l CASTE website.
l Initially set up with dual palliative care/renal participation – now run by renal alone with good palliative care links
and support.
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2.2. Is there a single person or team primarily responsible for conservative care in your unit?
Answer options Response per cent Response count
Yes 66.2 43
No 33.8 22
Answered question 65
Skipped question 2
2.2.1. What is their position? Please tick all that apply
Answer options Response per cent Response count
Consultant nephrologist(s) 58.1 25
Palliative care consultant(s) 11.6 5
Nurse(s) 79.1 34
Other (please specify) 14.0 6
Answered question 43
Skipped question 24
Other
l McMillan Nurse Consultant.
l Team effort for any care – palliative team supportive care consultant nurse specialist and consultant for development
of . . . above plus palliative care consultant.
l We have received input from Palliative care team.
l Renal nurse specialist to add to nurses.
l Team of consultant and three nurses to add to nephrologists and nurses.
l Each area led by nephrologist and nurse specialist.
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2.3. Does your unit provide renal staff with formal training or education regarding conservative care?
Answer options Response per cent Response count
Yes 50.0 33
No, in preparation 18.2 12
No 31.8 21
Answered question 66
Skipped question 1
2.3.1. Approximately what percentage of the following staff members have received the training?
Answer options ≤ 25% 26–50% 51–75% 76–100% N/A Response count
Consultant nephrologists 9 1 10 10 0 30
Renal registrars 7 8 7 5 1 28
Renal nurses 5 11 8 7 0 31
Diabetes nurses 6 0 0 1 19 26
Social workers 6 3 3 7 9 28
Occupational therapists 6 0 0 2 19 27
Physiotherapists 7 0 1 1 18 27
Dietitians 5 3 5 6 8 27
Pharmacists 6 3 1 6 10 26
Psychologists 2 2 3 11 10 28
Pre-dialysis education providers 3 1 2 22 2 30
Anaemia nurses 3 2 2 15 8 30
Vascular access coordinators 8 1 2 5 13 29
Counsellors 3 0 2 8 14 27
Management/administrative staff 10 0 0 2 15 27
Other 1 0 1 3 5 10
(Please specify and indicate percentage) 5
Answered question 33
Skipped question 34
N/A, not applicable.
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2.3.2. Why is formal training or education regarding conservative care not provided for your staff? Please tick
all that apply
Answer options Response per cent Response count
Lack of funding 38.1 8
Lack of time 52.4 11
Lack of appropriate person to organise the training 23.8 5
Consultants’ lack of interest in the training 0.0 0
Clinical director’s lack of interest in the training 0.0 0
Other staff members’ lack of interest in the training 0.0 0
We do not need formal training as conservative
care is an ingrained culture in the unit
23.8 5
Other (please specify) 42.9 9
Answered question 21
Skipped question 46
Other
l Availability of staff to allow staff time off to attend courses (lack of time?).
l Pre-education for RRT always includes this option.
l Some individuals trained if particularly keen.
l Education to other members of the department has been provided informally by our pre dialysis nurse team. In 2010
an education project was funded by the National End of Life Care Network to provide education and training to the
renal workforce in areas of end of life care. The project was led by a specialist palliative care nurse educator.
l Nurses involved in discussing conservative care with patients have all either been to supportive care education days/
conferences or received additional training with home palliative care teams.
l This is honestly not something we have thought about until recently. We are about to set up Shared Decision Making
clinics with MDT structure along the lines of Cancer care clinics.
l Service has developed by evolution. Will likely consider formal training programme.
l We have a small team and an excellent input from palliative care.
l Not convinced we are failing these patients with our current practice – which isn’t the same as the derogatory
‘lack of interest’.
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2.4. How did each of the factors listed below influence the development of the conservative care programme in
your unit? Please indicate if each of the factors below positively or negatively influenced the development of
the conservative care programme
Answer options
Positively
influenced
Negatively
influenced No effect
Response
count
Frequency of late referrals 12 6 43 61
Nephrologists’ attitudes towards conservative care 51 5 8 64
Nurses’ attitudes towards conservative care 57 1 6 64
Other unit staff’s attitudes towards conservative care 38 2 22 62
Patient/family/carers’ attitudes towards conservative care 45 3 17 65
Attitudes of people from different ethnicity/culture towards
conservative care
14 5 44 63
Availability of staff experienced in conservative care 33 9 21 63
Availability of funding specifically for conservative care 14 15 35 64
Payment by Results tariff for dialysis 1 2 59 62
Other 0 2 11 13
(Please specify) 6
Answered question 65
Skipped question 2
Other
l Ethnic issues variable. Some positive, some negative. Not to mislead-the lack of staff availability (and funding) has
meant that development of our programme has been slower.
l Sorry but I find this question a bit odd unless I have misunderstood it. I would like to think that myself and my
colleagues treat people in a conservative manner on an individual case basis and in a shared decision manner with the
patient – patients are the influence for ‘conservative care’ in our unit . . . ?
l Inadequate resources to staff a conservative programme.
l CCG [clinical commissioning group] funding.
l The nephrologists attitude balances out, though once a decision is made it is respected. The attitude is not obviously
driven by religion, race or sex (in the nephrologist). The nurses attitudes are different. Some may exert a negative effect
as they are uncomfortable with the discussion.
l We don’t have a ‘programme’.
2.5. In calendar year 2012, approximately how many CKD5 patients aged 75 and over were cared for by your
renal service? (Please exclude patients with a failing kidney transplant)
Answer options Response average Response total Response count
Please enter number 65
Answered question 65
Skipped question 2
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2.5.1. Of those, how many were on conservative care and followed up in your unit? If you don’t know the
number, please answer the next question instead
Answer options Response average Response total Response count
Please enter number 35
Answered question 35
Skipped question 32
2.5.2. Of those, approximately what % were on conservative care and followed up in your unit?
Answer options Response per cent Response count
0% 0.0 0
1–9% 15.2 7
10–19% 17.4 8
20–29% 17.4 8
30–39% 4.3 2
40–49% 10.9 5
50–59% 8.7 4
60–69% 0.0 0
70–79% 2.2 1
80–89% 6.5 3
90–99% 2.2 1
100% 4.3 2
Don’t know, please tell us why not 10.9 5
Answered question 46
Skipped question 21
Don’t know
l Current CV IT system cannot easily give this info.
l Because having received this survey late in the day I do not have time/opportunity to access the information however,
I do know that he have a high number of patients on dialysis > 75 and using a shared decision methodology, a low
number of patients who choose conservative care or whichever term you choose to use. We also have a number of
patients that we do not ever expect to need to make that decision of whether to have dialysis or not as their kidney
function and/or symptoms do not indicate the need to start however they die of other causes . . . arguably they are
treated similarly as maximum medical management . . .
l Only can determine we had 224 patients with eGFRs < 15 in 2012 and of those 66 patients were conservative
care (30–39%).
l Conservative care not recorded on renal IT system at present.
l The number is a rough estimate. There is bias in the number on conservative care as they do not migrate. The majority
of patients on conservative care are CKD4 and they are by no means restricted to the over 75’s.
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2.6. In 2012, how many patients aged 75 and over in your unit chose to have conservative care, became
symptomatic of advanced CKD and did not have dialysis?
Answer options Response per cent Response count
Please enter number 41
If you don’t know, please tell us why not 26
Answered question 65
Skipped question 3
Don’t know
l Not recorded.
l Unknown.
l Data not collected.
l Not sure. 28 patients dies over 75 years on CKM in this timeframe.
l Difficult to obtain, but very few change to active Rx; we have published our data.
l No answer.
l Sorry again due to lateness I have not had time to look at the numbers.
l 68 died with label of cons. but most not symptomatic, we don’t have those stats.
l Patients decisions not entered on renal data base previously, new system records decisions with date.
l Not recorded.
l Have not looked at exact number over 75 yet.
l Unfortunately this information is incomplete and not accurately collected in our Proton system.
l Don’t collate this data.
l Not entered.
l Data for 2012 is not collected.
l Data not routinely collected.
l No available database.
l Unable to specify.
l Don’t have records.
l Difficult to answer. They are all symptomatic to a certain degree.
l Don’t record it.
l No dedicated data base for conservative gp of patients.
l Approx 8 – Sometimes it is a multisystem decline.
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2.7. Does your unit have staff whose time is specifically allocated for CKD5 patients on conservative care?
Answer options Response per cent Response count
Yes 45.2 28
No 54.8 37
Answered question 65
Skipped question 2
2.7.1. How much time do the following staff have specifically allocated for CKD5 patients on conservative care?
Please enter number of full-time equivalent (FTE) hours for each discipline. (e.g. If you have two nurses with
0.5 FTE, enter 1.0)
Answer options Response per cent Response count
Consultant nephrologists 52 12
Renal registrars 12 3
Renal nurses 64 16
Diabetes nurses 0 0
Social workers 32 7
Occupational therapists 12 2
Dietitians 40 9
Pharmacists 16 3
Psychologists 24 5
Pre-dialysis education providers 40 9
Anaemia nurses 4 6
Vascular access coordinators 0 0
Counsellors 12 2
Management/administrative staff 8 2
Other (please specify and enter
number of FTE hours)
12 3
Answered question 25
Skipped question 42
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2.8. Do you have clinics exclusively for CKD5 conservative care patients?
Answer options Response per cent Response count
Yes 23.1 15
No 76.9 50
Answered question 65
Skipped question 2
2.8.1. How often do you run conservative care clinics in your renal unit and outside the main renal unit? Please
tick one for each row
Answer options Once a week Once a fortnight Once a month Other N/A Response count
In your renal unit 7 1 3 2 1 14
Outside the main renal unit 0 2 3 1 6 12
If other is chosen please give details 5
Answered question 15
Skipped question 52
Other
l See text from Q15.
l Every 5 weeks.
l At two overreach sites and in patient own home by renal team.
l Every six weeks.
l In reality there is flexibility and a mixed economy. There are patients whose needs are suitable who we will return to a
local gen nephrology clinic if geographically preferable for example.
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2.8.2 Where are CKD 5 patients receiving conservative care most commonly seen or followed up by clinical
staff? Please tick one
Answer options Response per cent Response count
In a general nephrology clinic 22.4 11
In a pre-dialysis clinic/low clearance clinic 44.9 22
In own home by renal team 6.1 3
In own home by GP/community team 8.2 4
At GP surgery 0.0 0
Telephone clinics run by renal unit 0.0 0
Other (please specify) 18.4 9
Answered question 49
Skipped question 18
Other
l An equal combination of general nephrology, pre dx, & at home.
l All above.
l In a general nephrology clinic, In a pre-dialysis clinic/low clearance clinic, In own home by renal team, In own home by
GP/community team are all ticked.
l Discharged to GP. CNS [consultant nurse] joint cares for through home visits.
l All of the above.
l Ticked more than one (pre-dialysis, own home by GP/community team, follow up phone calls from LCC [low clearance
clinic] nurses).
l Ticked more than one (pre-dialysis, own home by renal team).
l Two given (in a general nephrology clinic and in own home by renal team).
l Two ticked (pre-dialysis and in own home by GP/community team).
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2.9. How often are your CKD5 conservative care patients most commonly seen? Please tick one for each row
Answer options Weekly Monthly 3-monthly 6-monthly Other Response count
Symptomatic patients 4 34 (56%) 10 0 13 61
Asymptomatic patients 0 2 43 (69%) 8 9 62
If other is chosen please give details 20
Answered question 63
Skipped question 4
Other
l Individualised.
l It depends on the individual patient needs.
l As required & care shared with GP & Hospice team.
l As required.
l As needed per individual.
l Symptomatic patients seen by palliative care weekly or daily depending on symptoms.
l Monthly appointments however regular telephone contact in between with patient/carer to monitor symptoms.
Asymptomatic pt’s two monthly.
l 2 monthly.
l Frequency will be influenced by their comorbidities and transport etc. difficulties Symptomatic patients likely seen every
2 months or so.
l Patients managed in community. Very infrequently patients come back for a single review for symptom control. Over
90% patients do not want to come back to clinic when invited.
l As required.
l 6 weekly.
l 6–8 weeks.
l If symptomatic patients reviewed in community by primary/secondary care For asymptomatic 2 monthly.
l 2 months.
l As needed by palliative care.
l If asymptomatic – seen back in standard low clearance OP clinic.
l Dependant entirely on need, frailty, symptom burden, distance etc. Weekly not uncommon in response to a change in
symptoms not uncommon.
l Depending on individual circumstances 2 to 3 monthly intervals.
l Obviously more frequently as they become symptomatic.
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2.10. What are the key components of conservative care provided to patients in your renal service? Please tick
all that apply
Answer options Response per cent Response count
Clinic consultations 93.8 61
Blood results review 90.8 59
The provision of EPO (erythropoietin) and iron therapy 100.0 65
Symptom assessment and management 100.0 65
Prescription of medication for renal symptoms
(fluid retention, itching, etc.)
96.9 63
Telephone support for patients 87.7 57
Telephone support for carers 78.5 51
Home visits by renal staff 55.4 36
Dietary advice 98.5 64
Social circumstances review by social workers
attached to the renal unit or hospital
63.1 41
Advice on home environment by occupational therapist
attached to the renal unit or hospital
26.2 17
Advanced care planning 76.9 50
Communication with primary care team for
Gold Standards Framework approach
80.0 52
Psychological support 58.5 38
Other (please specify) 10.8 7
Answered question 65
Skipped question 2
Other
l Occasional practical help provided.
l Communication with hospice or any other service/personnel as required.
l Liaison with GPs to advice when patients unable to attend clinic.
l Advanced care planning in pilot scheme at the moment Home visits not routine but could be offered if required.
l In the process of developing an advanced care planning document.
l Palliative care or community matron involvement as necessary.
l Not sure what the Gold Standards Framework is – we certainly talk to GP’s!
DOI: 10.3310/hsdr03120 HEALTH SERVICES AND DELIVERY RESEARCH 2015 VOL. 3 NO. 12
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Roderick et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
157
2.11. Do you have any funding dedicated to providing conservative care in your renal service?
Answer options Response per cent Response count
Yes 15.4 10
No 84.6 55
Answered question 65
Skipped question 2
2.11.1. Is the funding part of routine NHS income or from non-NHS sources? Please tick one
Answer options Response per cent Response count
Routine NHS income 70.0 7
Non-NHS sources 10.0 1
Both 20.0 2
Answered question 10
Skipped question 57
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2.11.2. How much annual funding was dedicated to providing conservative care in the 2011/12 financial year
(April 2011–March 2012)? Please enter number
Breakdown of the responses regarding funding
Funding sources Amount
Routine NHS income £29,464
£101,300
£69,959
£40,000
Money for 0.8 WTE nurses
No response
No response
Non-NHS sources Part of palliative care consultant’s salary
Both 0.5 band 7 nurse
£3942
Statistics
Overall £
n
Valid 5
Missing 60
Mean 48,333
Median 40,000
Standard deviation 38,050.755
Range 97,358
Minimum 3942
Maximum 101,300
Percentiles
25 15,203
50 40,000
75 85,629.50
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3. Discussing conservative care with patients
3.1. In your unit, is the option of conservative care discussed with all CKD5 patients aged 75 years and over?
(excluding emergency patients)
Answer options Response per cent Response count
Yes 86 56
No 14 9
I don’t know (please tell us why not) 0 0
Answered question 65
Skipped question 2
3.1.1. If the option of conservative care is not discussed with all CKD5 patients aged 75 years and over, please
tell us how the decision is made whether or not to discuss conservative care with a patient? Please tick all
that apply
Answer options Response per cent Response count
Consultant nephrologist in charge of patient
decides alone
33.3 3
Consultant nephrologist in charge of patient
decides with input from other consultants
33.3 3
Consultant nephrologist in charge of patient
decides with input from other professionals during
an MSRT meeting
44.4 4
Clinical nurse specialist/consultant nurse in
charge of patient decides alone
0.0 0
Clinical nurse specialist/consultant nurse in charge
of patient decides with input from consultants
22.2 2
Clinical nurse specialist/consultant nurse in charge
of patient decides with input from other professionals
during an MSRT meeting
11.1 1
The decision-making is a reactive process during
the consultation
33.3 3
Only if patient/carer asks about alternatives to dialysis 0.0 0
Other (please specify) 0.0 0
Answered question 9
Skipped question 57
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3.2. Which of the following factors are likely to influence staff when contemplating the suitability of
conservative care for a patient? Please indicate how strongly each would influence a decision to discuss
conservative care with a patient/carer. Please answer on behalf of all staff members
Answer options
Not
at all
Very
little Little Somewhat Strongly
Very
strongly
Response
count
Response to the ‘surprise’ question 5 7 8 12 23 9 64
20 12 32
Frailty 0 0 3 4 37 21 65
3 4 58
Extent and severity of comorbidities 0 0 1 3 34 27 65
1 3 61
Cognitive status 0 0 3 14 25 23 65
3 14 48
Functional status 0 0 3 10 35 17 65
3 10 52
Uraemic symptoms 13 6 16 20 9 1 65
35 20 10
Rate of decline of kidney function 14 11 14 16 8 2 65
39 16 10
Social support 10 9 20 20 5 1 65
39 20 6
Distance from dialysis unit to home 21 10 17 14 2 0 64
49 14 2
Patient’s current quality of life 0 2 2 11 35 15 65
4 11 50
Patient preference for conservative care 0 0 0 0 18 47 65
0 0 65
Carer preference for conservative care 4 8 12 28 10 2 64
24 28 12
Consultant preference for
conservative care
3 4 16 31 9 2 65
23 31 11
Other 1 0 0 0 0 2 3
(Please specify and rate) 2
Answered question 65
Skipped question 2
Other
l Sorry this is a difficult question to answer for others and it really is down to the individual pt.
l Age > 80yrs – somewhat.
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3.3. When is the option of conservative care most commonly first raised with a patient? Please tick one
Answer options Response per cent Response count
When estimated GFR reaches a certain level 23.1 15
When they are referred to the pre-dialysis/low clearance clinic 56.9 37
When dialysis access needs to be performed 1.5 1
When symptoms start 0.0 0
At a specific time prior to the anticipated start of dialysis 9.2 6
Other (please specify) 9.2 6
Answered question 65
Skipped question 2
Other
l Case by case differs Usually raised at the point of RRT education so usually at eGFR < 20–25.
l A combination of the above depending on the individual patient.
l When seen in Education Clinic to discuss RRT options.
l When assessment suggests progression to end-stage is likely. Conservative care discussed along with all modalities for
RRT with all patients.
l At the time decision is made to refer to pre-d or not (not referred if adamant they don’t want it, referred if undecided).
so 12 to 18 months pre-d.
l Not clearly one trigger. If a patient is unlike to reach esrf, then we don’t talk about it too much, on other patients we
may raise it years before when the eGFR is around 20, i.e. if there is a change of AKI putting them onto dialysis.
3.3.1. Please specify estimated GFR
Statistics
eGFR
n
Valid 15
Missing 50
Mean 18.8667
Standard error of mean 0.52433
Median 20.0000
Standard deviation 2.03072
Variance 4.12400
Minimum 15.0000
Maximum 20.0000
Percentiles
25 19.0000
50 20.0000
75 20.0000
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3.3.2. Please specify when (months)
Statistics
Months
n
Valid 6
Missing 59
Mean 8.5000
Standard error of mean 1.62788
Median 9.0000
Standard deviation 3.98748
Variance 15.900
Minimum 3.00
Maximum 12.00
Percentiles
25 5.2500
50 9.0000
75 12.0000
3.4. How are patients’ family/carers involved in decision making about conservative care? Please tick all
that apply
Answer options Response per cent Response count
They are invited to patient education day 67.7 44
They are encouraged to attend clinics with patient 95.4 62
They are involved in home visits 64.6 42
They are involved when patient is revisited regarding
conservative care decision
76.9 50
Other (please specify) 4.6 3
Answered question 65
Skipped question 2
Other
l They are involved if patient wishes them to be involved. We don’t currently invite carers/family but they are
always welcome.
l Telephone advice/information from renal specialist nurses on request.
l Encouraged to attend conservative care clinic.
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3.5. Do any renal staff members use practical tools (see below for examples) when discussing the option of
conservative care with a patient?
Answer options Response per cent Response count
Yes 83.1 54
No 16.9 11
Answered question 65
Skipped question 2
3.5.1. What do they use when discussing the option of conservative care with a patient? Please tick all
that apply
Answer options Response per cent Response count
Booklets/handouts from national organisation(s) 81.5 44
Booklets/handouts written by own renal unit staff 61.1 33
DVDs from national organisations(s) 40.7 22
NHS Right Care Patient Decision Aid 29.6 16
Other (please specify) 13.0 7
Answered question 54
Skipped question 13
Other
l They get a talk on CM at the educational evenings which includes another video about CM. They get the home visit
which is when CM is discussed. They get follow up letters which reminds them of the option of CM and asks if they
want to chat about it further. Patient decision aids just started to be used.
l Conservative care booklet under construction in unit.
l In house dvd.
l Locally produced patient decision guide.
l In-house DVD.
l Visits to dialysis units to see patients on dialysis 2. pre-dialysis workshop to see equipment i.e. mannequins with
access 3. meet with expert patients at patient education events.
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3.6. If a decision is made not to have dialysis, where is this information recorded? Please tick all that apply
Answer options Response per cent Response count
Medical notes 96.9 63
Renal database 90.8 59
GP database 47.7 31
Out of hours (ambulance service) database 16.9 11
Other (please specify) 18.5 12
Answered question 65
Skipped question 2
Breakdown of the responses above (showing all how each database was used in conjunction with others)
Medical notes and renal database 33.8 22
Medical notes, renal database, and GP database 24.6 16
Medical notes, renal database, and other 10.8 7
Medical notes, renal database, GP database,
and out of hours database
9.2 6
Medical notes and GP database 6.2 4
Medical notes, renal database, GP database,
out of hours database, and other
4.6 3
Medical notes, renal database, and out of
hours database
3.1 2
Medical notes 3.1 2
Renal database and GP database 1.5 1
Medical notes, renal database, GP database,
and other
1.5 1
Renal database and other 1.5 1
Answered question 65
Skipped question 2
Other
l ACP document and renal care plan document.
l GPs are always informed-and assume they record on their database but this isn’t audited; out of hours service alerted
when a DNR [do not resuscitate] order signed.
l GP informed.
l GP’s informed and asked to add to their database/tell out of hours etc. but we don’t check its done.
l Letters written to GP following decision. Asked to add to Gold Framework Register when clinically indicated.
l Also usually documented In letters to GP following clinic review.
l Registered on Devon wide electronic end of life register (available to GPs/ambulance/out of hours service) when
EOL [end-of-life] care discussed.
l Nursing notes.
l GP informed by letter.
l Palliative Care Register.
l Nurses notes.
l Communicated to GP +/- suggestion to list on palliative care register.
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3.7. If a decision is made not to have dialysis, is this decision reviewed at any time?
Answer options Response per cent Response count
Yes 100 65
No 0 0
Answered question 65
Skipped question 2
3.7.1. When is the decision reviewed?
Answer options Response count
64
Answered question 64
Skipped question 3
The table below was made by grouping the text answers to Question 3.7.1.
Answer options Response per cent Response count
Clinic visit 67.2 43
On patient’s/carer’s request 14.1 9
When patient becomes symptomatic 6.2 4
Others
Answered question 64
Skipped question 3
3.8. Do patients who decide not to have dialysis ever change their mind and start dialysis?
Answer options Response per cent Response count
Yes 98.5 63
No 0 0
Answered question 63
Skipped question 4
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3.8.1. How frequently is the change of mind due to the following reasons? Please indicate how frequently each
of the reasons listed below cause the change of mind
Answer options Never
Very
rarely Rarely Occasionally Frequently
Very
frequently
Response
count
Because patients change their
mind after having had longer to
think about their decision
2 9 14 32 5 0 62
25 32 5
Because a patient’s family wants
them to have dialysis and a
patient agrees
0 9 6 38 8 1 62
15 38 9
Because patients are acutely
admitted to hospital and dialysis
is started without time for a full
discussion between family and
clinical team
6 9 16 21 4 5 61
31 21 9
Because patients present
unconscious without having
recorded their wishes in writing
and the family insist on dialysis
14 16 19 10 2 0 61
49 10 2
Because patients have symptoms
that cannot be controlled with
conservative treatment
12 9 12 21 5 2 61
33 21 7
Other 1 0 0 4 4 0 9
(Please specify) 13
Answered question 62
Skipped question 5
Other
l Patient becomes symptomatic in some way.
l Not ready to die.
l Patients get scared and life becomes very precious when they actually face their own mortality.
l Patients think they don’t want dialysis until actually comes to it or death+ basically refuse to make decision.
l Some people leave decision until the point they need dialysis.
l Most frequently patients change their minds when they start to feel unwell – the most common situation is an inability
on the patient’s part to accept the need for dialysis until life threatening symptoms develop.
l Patients say they don’t want dialysis but then change their minds when symptomatic and faced with the reality of
uraemia/death.
l Patient changes mind. Doesn’t like the idea of RRT, but when becomes symptomatic realises decline is now imminent
and wants RRT.
l Fear of dying when the reality hits home.
l When confronted with the prospect of dying within weeks or months, some change their minds about dialysis.
l Some patients just change their mind. This has nothing to do with the length of time they have had to make their
decision. Some patients will not make a decision about having dialysis and say they will only have it if it is absolutely
necessary and refuse to have access formed, they are hard to classify as either pre dialysis or conservative management.
They allow us to manage symptoms but not prepare for dialysis.
l Acute admission+AKI and patient then chooses dialysis above death – this is very common, understandably and not to
be discouraged.
l Not enough to comment. Usually because the ignorably theoretical has turned into unignorable reality.
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3.9. Is vascular access ever created for patients who have opted for conservative care?
Answer options Response per cent Response count
Yes 15.4 10
No 84.6 55
Answered question 65
Akipped question 2
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4. Working with primary care and general practitioners
4.1. Once a decision has been made that a patient aged 75 years and over with CKD5 will not have dialysis,
how are GPs involved in their care? Please tick one
Answer options Response per cent Response count
Patients are primarily kept under the care of the renal unit with little
GP involvement
11.3 7
Patients are referred back to GPs but care of patients is shared between GPs
and the renal unit (e.g. patients are seen by GPs who liaise with the renal
unit regarding renal symptom control)
19.4 12
Patients are referred back to GPs and cared for under primary care only 0.0 0
Mix of all three as it varies between nephrologists 14.5 9
Mix of all three as it varies by patient/patient preference 47.7 31
Other (please specify) 9.2 6
Answered question 65
Skipped question 2
Other
l Renal unit continues to care for patient but GP and palliative teams informed, so that as symptom burden increases,
there are increasing inputs form primary and palliative care.
l Mix of approaches depending on the patient and the individual GP . . . but the GP would be informed of the decision
in writing.
l Primarily remain under the care of renal team with involvement from GP, community nurses & Hospice as required.
l Under GP, Conservative Care CNS [consultant nurse] liaises and is available if symptomatic and/or needs IV Iron/Epo.
l Generally care is shared between renal unit and primary care agencies.
l Depends on the reasons for decision. If GFR 14 and patient dying of cancer, back to GP. If GFR 10, anaemia and low
calcium but otherwise OK, we’ll do most of it. if GFR 4 and symptomatic of uraemia, with no other co-morbs, we’ll
share palliative type care with GP or palli care team.
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4.2. What is the role of GPs in the management of CKD5 patients receiving conservative care? Please tick all
that apply
Answer options Response per cent Response count
GPs liaise with the renal unit for specialist support 90.8 59
GPs arrange and interpret blood tests 26.2 17
GPs arrange blood tests but liaise with renal unit for their interpretation 52 34
GPs check patients’ medication 52.3 34
GPs regularly (not on demand) assess patients in the GP surgery 13.8 9
GPs regularly (not on demand) assess patients via home visits 20.0 13
GPs/primary care staff provide/organise palliative care support at the end of life 67.7 44
GPs discuss ACP with patients 26.2 17
Other (please specify) 18.5 12
Answered question 65
Skipped question 2
Other
l GP involvement variable-not able to give a definite answer.
l A mixture of approaches.
l We ask for patient’s to be placed on their GSF and keep a record of these patients ourselves.
l All of the above possible.
l Primary and secondary care work collaboratively to manage pt’s effectively.
l Gps take their cue from patient wishes and consultant discussion.
l Also pre dialysis specialist nurses liaise with GPs/primary care staff regarding the provision and organisation of palliative
care support and provide information and advice on symptom management.
l Renal/CKD organise bloods, palliative care referral and home visits.
l GPs sometimes assess patients either in the pt’s home or in the GP Surgery.
l District nurses, community matron or long term conditions teams involved also in ACP.
l Most patients choose to stay under the care (?) of the renal unit with GPs providing blood tests (moved to GPs arrange
blood tests but liaise with renal unit for their interpretation).
l The list typifies the attitude of the unit to these patients. That they remain under our care. It does not suggest that
primary care cannot and does not provide the full range of interventions in some patients. We see ACP as our
responsibility though clearly many patients will talk to their GPs.
4.3. Do you provide GPs and/or their practice team with information or advice regarding the treatment of CKD5
patients receiving conservative care?
Answer options Response per cent Response count
Yes 87.7 57
No 12.3 8
Answered question 65
Skipped question 3
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4.3.1. What do you provide to GPs regarding the treatment of CKD5 patients receiving conservative care? Please
tick all that apply
Answer options Response per cent Response count
Verbal advice 80.7 46
Written advice/guidelines 96.5 55
Educational meetings 31.6 18
Other (please specify) 15.8 9
Answered question 57
Skipped question 10
Other
l Coordination between palliative teams in secondary care and GPs.
l Currently by letter but leaflet in preparation.
l Email advice.
l We usually write a letter explaining the likely course of the patient’s condition, symptoms commonly encountered and
management advice.
l Tell re Renal LPC.
l Email help.
l E-mail advice service.
l As needed for that patient.
l Renal page on local cancer care website.
4.3.2. Please tell us why information/advice regarding conservative care is not provided to GPs and/or their
practice team. Please tick all that apply
Answer options Response per cent Response count
Lack of time 62.5 5
Lack of funding 25.0 2
Opinion of consultants 12.5 1
Opinion of clinical directors 0.0 0
Opinion of other staff members 0.0 0
GPs do not wish to have any information/advice
from the renal unit
0.0 0
Other (Please specify) 37.5 3
answered question 8
skipped question 59
Breakdown of responses to Question 4.3.2
Lack of time 38 3
Lack of time and funding 12 1
Lack of time, funding, and opinion of consultants 12 1
Other 38 3
Total 100 8
Other
l Information regarding this mostly provided by the palliative care physician and services which are embedded in the
renal unit, but act independent of the renal unit outside hospitals.
l No comment provided by respondent.
l Not sure what you mean. We would inform individual GPs when they have a patient in that situation. No general GP
info programme.
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5. End-of-life care
5.1. Does your unit have a written guideline for renal end of life care?
Answer options Response per cent Response count
Yes 55.4 36
No, but in preparation 16.9 11
No 27.7 18
Answered question 65
Skipped question 2
5.2. Do you identify conservative care patients approaching end of life through use of a register?
Answer options Response per cent Response count
Yes 55.4 36
No 44.6 29
Answered question 65
Skipped question 2
APPENDIX 6
NIHR Journals Library www.journalslibrary.nihr.ac.uk
172
5.2.1. How likely are the following factors to influence a decision to add a patient to the end of life register?
Please indicate how strongly each of the factors listed below influence this decision
Answer options
Not
at all
Very
little Little Somewhat Strongly
Very
strongly
Response
count
Surprise question 3 1 1 4 15 11 35
5 4 26
Estimated GFR level 1 4 1 10 13 6 35
6 10 19
Measured GFR level 10 7 0 6 4 4 31
17 6 8
Comorbidities 0 1 1 6 19 8 35
2 6 27
Frailty 0 0 0 4 19 12 35
0 4 31
Unexpected weight loss 0 2 3 8 15 7 35
5 8 22
Quality of life 0 1 2 5 19 8 35
3 5 27
Symptoms 1 0 0 6 17 11 35
1 6 28
Frequent hospitalisation 0 0 2 3 15 15 35
2 3 30
Other 0 0 0 1 2 2 5
(Please specify and rate) 5
Answered question 36
Skipped question 31
Other
l Functional status and change thereof.
l Low albumin high POS-s score.
l Functional status.
l Patient request running out of access.
l Repeated question, once maximum conservative care is decided upon then added to register.
5.3. Is ACP used in end of life care by renal staff?
Answer options Response per cent Response count
Yes 78.5 51
No 21.5 14
Answered question 65
Skipped question 3
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5.3.1. Who is involved in advance care planning in your unit? Please tick all that apply
Answer options Response per cent Response count
Consultant nephrologist(s) 80.4 41
Nurse(s) 94.1 48
Palliative care specialist(s) 49.0 25
Social worker(s) 31.4 16
Counsellor(s)/psychologist(s) 23.5 12
Other (please specify) 13.7 7
Answered question 51
Skipped question 16
Breakdown of responses to Question 5.3.1
Consultant nephrologist(s) and nurse(s) 25 13
Consultant nephrologist(s), nurse(s) and
palliative care consultant(s)
16 8
Consultant nephrologist(s), nurse(s), palliative
care consultant(s), social worker(s) and
counsellor(s)
12 6
Consultant nephrologist(s), nurse(s), palliative
care consultant(s), and social worker(s)
6 3
Other combinations 41 21
Total 100 51
Other
l GP.
l All MDT for inpatient but not for outpatient.
l Primary care.
l Advanced practitioners.
l Renal GPs.
l GPs.
l The patient and carers!
5.4. Have any of your staff had any training in palliative/end of life care specifically for renal patients?
Please tick one
Answer options Response per cent Response count
Yes, everyone has 3.1 2
Yes, the majority of the staff have 10.9 7
Yes, about half of the staff have 14.1 9
Yes, but only the small number of the staff have 60.9 39
No 10.9 7
Answered question 64
Skipped question 3
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5.5. With which services does your unit liaise for patients receiving conservative care approaching end of life?
Please tick all that apply
Answer options Response per cent Response count
Specialist palliative care services within the hospital 90.8 59
Specialist palliative care services from local hospice 78.5 51
Specialist palliative care services in the community
(e.g. Macmillan nurses)
84.6 55
Primary care team 89.2 58
None 0.0 0
Other (please specify) 6.2 4
Answered question 65
Skipped question 2
Other
l Marie Curie nurses.
l Renal pt counsellors often help with special funding applications and others in individual patients e.g. heart failure
support team, dementia, head injury.
l Specialist nurses in heart failure & diabetes.
l Expect primary care to get in local comm services as needed.
5.5.1. Where do patients receive these services? Please tick all that apply
Answer options Response per cent Response count
Within the hospital as inpatients 81.5 53
Within the hospital as outpatients 58.5 38
At home 90.8 59
At hospice where patient is admitted at end of life 84.6 55
At GP practice 50.8 33
Other (Please specify) 4.6 3
Answered question 65
Skipped question 2
Other
l Nursing homes with palliative support.
l Depends on patients preference, especially preferred place of care for patients at end of life.
l Our surrounding DGHs and cottage hospitals (are they still called that).
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5.5.2. What services do they provide for renal patients receiving conservative care in your unit? Please tick all
that apply
Answer options Response per cent Response count
They help to write guidelines on how to treat
patients receiving conservative care
32.3 21
They provide symptom management at the end
of life
93.8 61
They support patients at home out of hours 83.1 54
They discuss ACP with patients 64.6 42
Admission to the hospice as required 80.0 52
Other (please specify) 10.8 7
Answered question 62
Skipped question 3
Other
l Palliative specialists rarely involved.
l I didn’t understand this question.
l Palliative care team have written guidelines on symptom control.
l Home visits by palliative care consultant as required.
l Try to avoid hospital admission with appropriate support where possible.
l Shared care with GPS.
l Tend to be advanced symptoms in the community.
5.6. Do you provide palliative care specialists with training or advice regarding the management of
renal patients?
Answer options Response per cent Response count
Yes 64.6 42
No 35.4 23
Answered question 65
Skipped question 2
5.6.1. What do you provide? Tick all that apply
Answer options Response per cent Response count
Verbal advice 83.3 35
Written advice/guidelines 57.1 24
Educational meetings 52.4 22
Other (please specify) 14.3 6
Answered question 42
Skipped question 25
Other
l Middle grade training.
l Liaise on medication prescription.
l Joint mortality meetings.
l They attend and learn in renal clinics.
l 3 monthly MDT.
l Training for pallitive care trainees.
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6. The evaluation of the provision of conservative care in
your unit
6.1. Is the quality of conservative care provided in your unit regularly evaluated?
Answer options Response per cent Response count
Yes 38.5 25
No 61.5 40
Answered question 65
Skipped question 2
6.1.1. What measures or information do you use? Please tick all that apply
Answer options Response per cent Response count
Symptoms 76.0 19
Survival 64.0 16
Hospitalisation 56.0 14
Quality of life 64.0 16
Carer burden 24.0 6
Place of death 88.0 22
Survey with patients/carers about their
experience of conservative care
36.0 9
Other (please specify) 16.0 4
Answered question 25
Skipped question 42
Other
l EOL [end-of-life] meetings every 3–4 months to discuss patients on GSF, patients eligible for GSF, GSF recording,
dialysis patients who are failing and may need a discussion regarding withdrawal, difficult cases (patient/family issues),
deaths, recording of DNACPR etc.
l Annual audit of all the above.
l Use of DNACPR and ACP and Register.
l Survey currently being developed.
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6.2. Which factors do you think could help improve the provision of conservative care in your unit? Please
indicate how strongly you agree or disagree with each of the following
Answer options
Strongly
agree Agree
Neither agree
nor disagree Disagree
Strongly
disagree
Response
count
Increasing the number of staff dedicated
to conservative care
21 19 19 3 2 64
40 19 5
Increasing the number of times
conservative care patients are seen
by staff
5 12 29 14 2 62
17 29 16
Increasing clinic time 9 20 24 9 2 64
29 24 11
Providing better end of life care by
implementing ACP
13 30 17 3 1 64
43 17 4
Improving computer systems by
integrating primary care data with
renal data
24 24 13 2 1 64
48 13 3
Increasing involvement of allied
health-care professionals (e.g. social
worker) in treatment decision-making
15 30 13 5 1 64
45 13 6
Increasing communication/involvement
with GPs
16 36 8 2 2 64
52 8 4
Increasing communication/involvement
with community teams
17 33 11 2 1 64
50 11 3
Increasing communication/involvement
with other hospitals
9 25 24 4 2 64
34 24 6
Increasing communication/involvement
with palliative care teams
13 36 9 5 1 64
49 9 6
Providing renal staff members with more
education/training regarding
conservative care
22 30 9 2 1 64
52 9 3
Providing GPs with more education/
training regarding conservative care
13 38 9 3 1 64
51 9 4
Providing palliative care teams with more
education/training regarding renal
conservative care
10 34 8 10 1 64
44 8 11
Providing patients with better decision
aids about conservative care
10 30 16 7 1 64
40 16 8
More funding to develop conservative
care within unit
21 27 10 5 1 64
48 10 6
Having funding models specifically
designed to reimburse the costs of
delivering CKM
24 18 17 2 2 63
42 17 4
Having a written conservative care policy 15 22 18 7 2 64
37 18 9
Having dedicated conservative care clinics 9 14 28 9 4 64
23 28 13
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6.2. Which factors do you think could help improve the provision of conservative care in your unit? Please
indicate how strongly you agree or disagree with each of the following
Answer options
Strongly
agree Agree
Neither agree
nor disagree Disagree
Strongly
disagree
Response
count
Establishing a system for evaluating the
provision of conservative care
12 35 12 4 0 63
47 12 4
Having better evidence of the
comparative outcomes between patients
who receive conservative care and those
who receive dialysis
22 29 7 3 3 64
51 7 6
Having better evidence of the
comparative costs between patients who
receive conservative care and those
who receive dialysis
10 17 20 7 10 64
27 20 17
Other 2 0 2 0 1 5
(Please specify and rate) 3
Answered question 64
Skipped question 3
Other
l Greater/easier access to community palliative care resources via patchy depending on geographical area.
l More community/GP support.
l We are already undertaking the above agreed aspects of care.
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6.3. What, if any, of the following changes are planned in your unit regarding the provision of conservative
care? Please tick all that apply
Answer options Response per cent Response count
Increasing the number of staff dedicated to conservative care 25.4 16
Increasing the number of times conservative care patients are seen by staff 6.3 4
Increasing clinic time 19.0 12
Providing better end of life care by implementing ACP 52.4 33
Improving computer systems by integrating primary care data with renal data 33.3 21
Increasing involvement of allied healthcare professionals (i.e. social worker) in
treatment decision-making
22.2 14
Increasing communication/involvement with GPs 50.1 32
Increasing communication/involvement with community teams 38.1 24
Increasing communication/involvement with other hospitals 14.3 9
Increasing communication/involvement with palliative care teams 39.7 25
Providing renal staff members with more education/training regarding
conservative care
57.1 36
Providing GPs with more education/training regarding conservative care 30.2 19
Providing palliative care teams with more education/training regarding renal
conservative care
17.5 11
Providing patients with better decision aids about conservative care 30.2 19
Obtaining funding to develop conservative care 15.9 10
Writing up a conservative care policy 25.4 16
Having dedicated conservative care clinics 19.1 12
Establishing a system for evaluating the provision of conservative care 33.3 21
None planned 6.3 4
Other (please specify) 12.7 8
Answered question 63
Skipped question 4
Other
l Hospices are also integral, and deliver important care, especially to some of our patients further from the main centre.
We often communicate with them to facilitate discharge, or avoid admission (e.g. for infections, blood transfusions etc).
We are implementing a register to facilitate all this. I have not seen hospices mentioned much in this questionnaire.
l Involve counselling team and patient decision making and decision aids.
l Better recording centrally of treatment decisions.
l Planning or wish list?
l Would like all of the above but no funding agreed either from within hospital or from primary care.
l Comment after ‘none planned’ – no funding is available and kidney care project is finishing.
l Small sense that is working well. Small enough to know everyone and pick up a phone!
l Increase psychology input.
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7. Future research
7.1. Would your unit consider it appropriate to enter a patient aged 75 and over with CKD5 into a randomised
clinical trial comparing conservative care versus dialysis? (An abstract of the proposed design is provided below)
Answer options Response per cent Response count
Yes, for some patients 64.6 42
No, never 35.4 23
Answered question 65
Skipped question 2
7.1.1. Would your unit be willing to participate in such a trial?
Answer options Response per cent Response count
Yes, definitely 42.9 18
Maybe 47.6 20
No 2.4 1
Other (please specify) 7.1 3
Answered question 42
Skipped question 25
Other
l We would need to allocate specific staffing to this, as part of our plan to increase commitment to conservative care.
We’d struggle to service study needs before then.
l Difficult to recruit patients. Very small number.
l Don’t know.
7.2. Would your unit consider entering CKD5 patients aged 75 and over into a prospective multicentre
observational study to compare conservative care and dialysis, which addresses the major selection bias?
(The same abstract shown previously is provided below again)
Answer options Response per cent Response count
Yes, for some patients 92.3 60
No, never 7.7 5
Answered question 65
Skipped question 2
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7.2.1. Would your unit be willing to participate in such a study?
Answer options Response per cent Response count
Yes, definitely 46.7 28
Maybe 46.7 28
No 0.0 0
Other (please specify) 6.7 4
Answered question 60
Skipped question 7
Other
l RRT choice – treatment or conservative care MUST be based on patients choice and by informed consent. If a study
allows freedom of choice/informed consent and then observed outcome – this would be acceptable.
l As above.
l Would need to discuss with the team although my feeling is no.
l Don’t know.
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Appendix 7 The specific data required from both
laboratory and renal units sources
Laboratory data required Renal data required
Date of birth
Gender
NHS number
Date of index eGFR (i.e. first of the two eGFRs
used to define CKD5)
Most recent eGFR and date
Date of birth
Gender
NHS number
Date referred to renal unit
eGFR at date of referral to renal unit
Current treatment status (i.e. CKD, CKM, dialysis,
transplant, deceased)
Date of first dialysis/transplant
Date of discharge to GP
Date of death
Most recent eGFR and date
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Appendix 8 The semistructured interview guide
used for general practitioner telephone interviews
Topic guide for general practitioner structured
telephone interviews
A. Seeing chronic kidney disease patients in practice
1. Can you tell me what experience you have in managing patients who have chronic kidney disease?
And patients who have kidney failure?
2. Can you tell me a little bit about patients with chronic kidney disease stage 5 that you currently look
after or that you have looked after most recently?
(a) How old? What comorbidities? Seen how often? For what?
3. For patients with kidney failure, where are they in terms of management? (e.g. transplant, on dialysis,
likely to be on dialysis in the future, conservative care)
4. Can you tell me approximately how many patients you have seen with established kidney failure in the
last 6 months?
5. How often would you/your practice tend to see patients with CKD stage 5?
B. Referring chronic kidney disease patients to secondary care
6. How would your practice normally identify patients with chronic kidney disease or kidney failure?
What is the most common way kidney disease is identified?
7. If you identified a patient with new CKD5 what action(s) would you/your practice routinely take?
8. Can you tell me about a time when you told someone they had chronic kidney disease? How did you
tell them? What words did you use? What about stage 5?
9. What questions do patients have about CKD? What do they think of when they are told?
10. What proportion of the patients, with CKD5, on your practice list get referred to secondary care?
i. What are the reasons for referral?
ii. What are the reasons for non-referral?
iii. Do you have any guidelines about when to refer? National or local?
11. How is referral to secondary care discussed with the patient?
12. How is non-referral to secondary care discussed with the patient?
13. Do you notify the renal unit about patients who are not being referred? How? What is their reaction?
14. If a patient is not referred, how is this recorded in their notes? (e.g. secondary care if admitted
to hospital).
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C. Managing patients with stage 5 chronic kidney disease
15. What role do you as a GP play in the management of CKD5 patients who are under nephrology?
16. Do you have a systematic approach to following-up patients with chronic kidney disease?
17. What are the components of patient care if they are not under nephrology?
18. How do you feel about CKD5 patients being referred back to primary care if they opt not to have
active treatment/opt for conservative treatment?
19. What agencies/health care professions are involved in CKD management/treatment? How were those
connections made? GP referral?
20. How are the palliative care needs of CKD5 patients addressed?
21. Do you have any concerns about managing CKD patients? Do you think you need any training in
managing CKD? Would you like any training?
22. What, in an ideal world, would you like to see happen with the management of these patients? What
role would GPs play? What are the barriers to achieving this?
Conclusion
23. Are there any other relevant issues we haven’t covered that you would like to mention?
24. Are there any questions you that would like to ask me?
Demographic questions
1. Gender.
2. Age.
3. Years in practice.
4. Years in current surgery.
5. Special interests (e.g. kidney disease, palliative care, care of the elderly).
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